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Abstract: Nucleoside analogues are widely employed as 
bioactive compounds against cancer and viral infections. 
Consequently, it is important to develop efficient synthetic 
methods to access them with high efficiency and structural 
diversity. Herein, we present a full account of our work on the 
synthesis of nucleoside analogues via annulations of donor 
acceptor aminocyclopropanes and aminocyclobutanes. 
Thymine- and uracil- derived diester cyclopropanes were 
accessed from the corresponding nucleobases via vinylation 
and rhodium-catalyzed cyclopropanation, and were then 
used in (3+2) annulations with aldehydes, ketones and enol 
ethers.  
The obtained analogues could be transformed into important 
hydroxymethyl derivatives. Thymine and fluoro-uracil derived 
diester cyclobutanes obtained from the nucleobases via 
vinylation and (2+2) cycloaddition could also be used in a 
(4+2) annulation with aldehydes. Finally, purine-derived 
diester cyclopropanes could be accessed using the 
condensation of nucleobases with chloromethyl ethylidene 
malonates, but annulation reactions with this class of 
substrates was not successful. 
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1. Introduction 
Nucleoside analogues are widely employed as 
bioactive compounds against a broad diversity of 
illnesses such as HIV and different types of cancer. 
Nevertheless, the emerging resistance towards 
nucleoside-based antiviral and anticancer agents is 
alarming.[1] Therefore, the development of new bioactive 
nucleoside analogues is urgently needed. Nucleosides 
exhibiting biological activity have structurally diverse 
cores, including the most common tetrahydrofuranyl 
amines such as the FDA approved drugs azidothymidine 
(1) and didanosine (2), and more rare six carbon based 
scaffolds such as the antiviral compounds anydrohexitol-
g (3) and cyclohexenyl-g (4). Carbonucleoside analogues 
such as the antiviral compounds aristeromycin (5), 
abacavir (6) and cyclohexenyl-g (4) are also of great 
interest. In comparison with the corresponding 
tetrahydrofuranyl amine derivatives, they display 
increased metabolic stability. 
Despite the fact that nucleoside analogues are of high interest 
and were extensively studied, there are only few methods for 
accessing them with high diversity and efficiency.[2] 
Nucleoside analogues are generally synthesized using the 
Vorbrüggen reaction.[2a] This transformation consists of the 
substitution of a leaving group on the ribose by a nucleobase, 
providing compounds derived from natural ribose. This 
method allows variation of the nucleobase. However, if 
unnatural modifications of the ribose core are desired, multi-
step procedures are usually required.[3] A frequently used 
approach to access carbonucleoside analogues is to use the 
Vince lactam,[3a,b] which after opening delivers a 
cyclopentenylamine precursor for carbonucleoside 
derivatives.  
 
Figure 1. Bioactive nucleoside analogues. 
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Further elegant work to access nucleoside analogues with a 
cyclopentyl core have been developed during the last years, 
proceeding via Pauson-Khand reaction,[3c] ring-closing 
methathesis[3d] or desymetrization of meso compounds such 
as cyclopentadiene or diols.[3e-g] Although these novel 
synthesis strategies increased the diversity of scaffolds 
accessible, they are often substrate specific and their scope is 
typically narrow. 
Consequently, we decided to to develop a straightforward 
synthetic method for the synthesis of nucleoside analogues 
with broad structural diversity. Our goal was to take 
advantage of the strain release upon ring-opening of small 
rings such as cyclopropanes and cyclobutanes. Indeed 28 
kcal/mol of energy is released during the ring opening of 
cyclopropane, which can be used to initiate chemical 
transformations. Donor-acceptor (DA) cyclopropanes and 
DA cyclobutanes in particular are versatile substrates as 
selective C-C bond cleavage is possible under mild 
conditions.[4] Thanks to the induced bond polarization, they 
can act as formal 1,3-dipoles and are suitable substrates for 
annulation with dipolarophiles providing an effective method 
for the synthesis of highly substituted five- or six-membered 
rings. Nitrogen-based DA cyclopropanes have been 
extensively studied in our group.[5] During these studies, we 
discovered that the protecting group on the nitrogen atom is 
key in the success of the annulation reactions. In particular, 
phthalimide-substituted DA cyclopropanes and cyclobutanes 
were excellent precursors for the synthesis of 
tetrahydrofuranyl and tetrahydropyranyl amines and 
cyclopentyl and cyclohexyl amines via formal (4+2) and 
(3+2) annulations (Scheme 1, A). In order to apply this 
methodology to the synthesis of nucleoside analogues, 
deprotection of the phthalimide group is required to introduce 
the nucleobase. Unfortunately, the removal of the 
phthalimide on tetrahydrofuranyl amines was not possible. 
Furthermore, even if the deprotection worked for cyclopentyl 
amines, the poor convergence of this strategy led us to design 
a new method for the synthesis of nucleoside analogues.  
The new strategy consisted of having the nucleobase directly 
linked to the small ring, serving as the donor group (Scheme 
1, B). With thymine and uracil-substituted DA cyclopropanes 
and cyclobutanes, five or six membered ring nucleoside 
analogues become accessible through (3+2) or (4+2) 
annulations with dipolarophiles such as ketones, aldehydes or 
enol ethers in a single step.[6] Herein, we would like to give a 
full account of this work, including details on the synthesis of 
the cyclopropanes, reaction optimization and scope of the 
annulation reactions. First attempts towards the synthesis of 
purine-based nucleoside analogues will be also described. At 
this stage, the nucleoside analogues are only obtained as 
racemic mixtures, but this could also be an advantage if both 
enantiomers are needed for biological testing. 
 
Scheme 1. Strategy to access nucleoside analogues from 
nitrogen-substituted strained rings. 
2. Synthesis of Nucleoside Analogues via 
Annulation reactions 
We planned to synthesize the required pyrimidine 
cyclopropanes via cyclopropanation of the corresponding 
enamides. Therefore, a robust synthesis of vinyl 
pyrimidines was needed. When we started our work there 
was only a few reports of vinylation methods applied to 
pyrimidine nucleobases: N(1) alkylation followed by 
elimination,[7] Chan-Lam coupling using trimethoxyvinyl 
silane as vinyl source along with tetrabutyl ammonium 
fluoride (TBAF) and stoichiometric amount of Cu(II),[8] 
and nucleophilic attack of TMS-protected thymine on 
vinyl acetate in presence of trimethylsilyl 
trifluoromethane sulfonate (TMSOTf). [9] In our hands the 
preparation of N(1) vinyl thymine 10a following these 
reported procedures failed (Scheme 2). With 
dibromoethane, we were not able to isolate the desired 
product 8 (Scheme 2, A). This is in agreement with a later 
report of Nawrot and co-workers, who showed that 
alkylation of thymine under these conditions only led to 
bicyclic side products.[10] Even after intensive 
optimization, the desired products could be obtained only 
in 10% yield. Some conversion was observed in the 
Chan-Lam coupling leading to a mixture of N(3) and N(1) 
vinylated products 9 and 10a, which were isolated in 24% 
and 13% yield respectively with N(3) vinylated thymine 
(9) as major product (Scheme 2, B). In addition to the low 
yield of the N(1) vinyl thymine (10a), the separation of 
the regioisomers was laborious, prohibiting the use of 
this reaction for the preparation of larger amounts of N(1) 
vinyl thymine (10a). In conclusion, the reported 
procedures were not suitable to prepare enough N(1) 
vinyl thymine (10a) for the further development of our 
methodology.  
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Scheme 2. Attempts for the preparation of N(1) vinyl thymine 
using reported procedures.  
In a precedent report of our group, we described the 
preparation of vinyl phthalimide, maleimide and succinimide 
via palladium cross coupling.[5e] For this transformation, the 
palladium(II) sources used were sodium tetrachloropalladate 
or palladium dichloride with lithium chloride.  However, 
these transformations were performed in vinylacetate (11) as 
solvent in which thymine (7a) is not soluble. Solubility 
experiments with different co-solvents were conducted with 
dichloromethane (DCM), dichloroethane (DCE), chloroform, 
methanol (MeOH), ethanol (EtOH), acetonitrile (ACN), 
tetrahydrofuran (THF), dioxane, dimethylformamide (DMF) 
and water. The solubility of thymine (7a) was highest in hot 
water and hot mixtures of alcohol (MeOH or EtOH) and water 
(60 °C), followed by dioxane and DMF (both at 60 °C) in 
which no complete dissolution was observed. Attempts at 
palladium coupling in dioxane were not successful, but better 
results were obtained in DMF. Na2PdCl4 or PdCl2 with or 
without LiCl were not suitable catalysts for the vinylation of 
thymine (7a) (Table 1, entries 1 to 3): only traces of N(1) 
vinyl thymine (10a) were detected (a mixture of N(3) and 
N(1) vinyl thymine 9 and 10a is observed with PdCl2 (entry 
1)). With Pd(OAc)2 only 3% of conversion was observed, but 
selectively to N(1) vinylthymine (10a) (entry 4). No 
dependence on the equivalents of vinyl acetate (11) used was 
observed (entries 5 and 6). Further investigation with 
increased amount of Pd(OAc)2 showed that higher loading in 
palladium led to better conversion (entries 7 and 8). Inspired 
by the work of Toti et al.[9] and Nawrot et al.,[10] who reported 
the alkylation or vinylation of thymine (7a) in presence of 
TMSOTf, we performed the reaction with a stoichiometric 
amount of TMSOTf. The conversion increased from 3% to 
17% with 4% of Pd(OAc)2 (entry 9). When the amount of 
TMSOTf was increased to 2.4 equivalents and the reaction 
time was extended to 24 h, the reaction conversion reached 
32% and 51% respectively (entries 10 and 11).  
 
 
Table 1. Screening of reaction conditions for N(1) vinylation of 
thymine (7a). 
 
Entry Catalyst Loading[a] Additive[b] equiv 11 Time Ratio[c] 
1 PdCl2 4 - 1.2 10 h <2%
[d] 
2 Na2Pd2Cl4 4 - 1.2 10 h <2% 
3 PdCl2 4 LiCl 1.2 24 h <2% 
4 Pd(OAc)2 4 - 1.2 24 h 3% 
5 Pd(OAc)2 4 - 1.6 10 h 3% 
6 Pd(OAc)2 4 - 2 10 h 3% 
7 Pd(OAc)2 7 - 1.2 10 h 6% 
8 Pd(OAc)2 20 - 1.2 10 h 11% 
9 Pd(OAc)2 4 TMSOTf 1.2 10 h 17% 
10 Pd(OAc)2 4 TMSOTf
[e] 1.2 10 h 32% 
11 Pd(OAc)2 4 TMSOTf
[e] 1.2 24 h 51% 
12 Pd(OAc)2 4 
TMSOTf[e] 
NEt3
[e] 
1.2 24 h 83% 
Reaction conditions: Thymine (7a) (0.1 g, 0.8 mmol), palladium 
catalyst and additives in DMF (2 mL) were stirred in a flame-
dried flask under nitrogen and heated to 70 °C. [a] In mol%. [b] 
1.2 equiv. [c] NMR ratio (10a/(7a+10a)) of the integration of the 
C=C-H thymine signals. [d] Mixture of N(1) and N(3) vinyl 
thymine. [e] 2.4 equiv additive was used. 
Finally after adding an additional base (triethylamine) the 
conversion went to 83% and the isolated yield reached 79% 
of the sole N(1) vinyl-thymine (10a) (entry 12). Fortunately, 
the vinylation worked well also on uracil (7b) and 5-fluoro-
uracil (7c) with complete regioselectivity and respectively 
69% and 57% isolated yield (products 10b and 10c).  
To access the desired cyclopropanes, protection of the imide 
nitrogen was performed, followed by cyclopropanation using 
the corresponding diazomalonate and the rhodium Espino 
catalyst developed by Du Bois and co-workers (Scheme 3).[11] 
For thymine (7a) and uracil (7b), a tert-butoxycarbonyl 
protecting group was used. When protection of fluoro-uracil 
(7c) was attempted, a mixture of carbonates and carbamate 
was obtained in poor yield. In this case a benzoyl group could 
be installed selectively on the nitrogen. The three pyrimidine 
cyclopropanes 13a, 13b and 13c were obtained in good 
overall yields. 
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Scheme 3. Synthesis of cyclopropanes 13. Reaction conditions: 
a) 4 mol% Pd(OAc)2, vinylacetate, TMSOTf, NEt3, 70 °C, DMF. 
b) Boc2O, DMAP, CH2Cl2 or BzCl DMAP, NEt3. c) 0.02 mol% 
Rh2(esp)2, diazodimethylmalonate, CH2Cl2. 
Surprisingly, when the cyclopropanation of vinyl-uracil 12b 
was performed with 1.2 equivalents instead of an equimolar 
amount of the diazomalonate, a new pyrimidine cyclopropane 
was isolated containing two malonate moieties with an intact 
thymine double bond (Scheme 4). After extensive 
spectroscopic investigations, we identified this compound as 
14. The formation of cyclopropane 14 can be tentatively 
explained by the unusual formation of epoxide I instead of 
cyclopropanation of the thymine double bond through the 
reaction with one additional equivalent of diazomalonate 
mediated by the rhodium Espino catalyst. Then, an 
intramolecular rearrangement via opening of the epoxide, 
followed by the migration of the Boc group to the oxygen 
atom would afford pyridone cyclopropane 14. 
 
Scheme 4. Unexpected formation of pyridone cyclopropane 14 
and tentative mechanism. Reaction conditions: a) 0.5 mol% 
Rh2(esp)2, 1.2 equiv diazodimethylmalonate, CH2Cl2. Yields: 13b 
28% and 14 64%.[12] 
Starting again from vinyl thymine 10a, a [2+2] cycloaddition 
gave access to the thymine DA cyclobutane 16a. As the 
reported procedure of our group to synthesize thymine 
cyclobutanes through [2+2] cycloaddition using FeCl3 on 
aluminium oxide as catalyst[5i] gave low yield (Table 2, entry 
1), other Lewis acids were screened. Low conversion was 
obtained with Zn(OTf)2, AuCl3, Sn(OTf)2 and Sc(OTf)3 
(entries 2 to 5). Complete decomposition of the starting 
material was observed when Hf(OTf)4 and TiCl4 were used 
(entries 6 and 7). With In(OTf)3, Cu(OTf)2 and Yb(OTf)3 as 
Lewis acid catalysts, the reaction exhibited low conversion 
(entries 8 to 10). Nevertheless, using FeCl3 on aluminium 
oxide the conversion was increased from 13% after 14 hours 
to 35 % after 24 hours (entries 1 and 11). The reaction was 
shut down when other solvents were used such as MeOH, 
DMF, dioxane, CCl4 or a mixture of DCM/MeOH. ACN 
allows the reaction to proceed, but with lower conversion. 
Using DCE as solvent gave roughly similar conversion to the 
DA cyclobutane 16a.  
Table 2. Optimization of the [2+2] reaction. 
 
Entry LA Ratio[a] Entry LA Ratio[a] 
1 FeCl3•Al2O3 13% 7 TiCl4 dec. 
2 Zn(OTf)2 <2% 8 Cu(OTf)2 5% 
3 AuCl3 <2% 9 Yb(OTf)3 5% 
4 Sc(OTf)3 <2% 10 In(OTf)3 10% 
5 Sn(OTf)2 <2% 11 FeCl3•Al2O3 35%
[b] 
6 Hf(OTf)4 dec.    
Reaction conditions: Vinyl thymine 10a (50 mg, 0.33 mmol), 2 
equiv methylidene malonate 15, dry CH2Cl2, 0.3 M, stirred under 
N2. [a] NMR ratio (16a/(10a+16a)) of the integration of the C=C-
H signals. [b] 24 hour reaction. 
When the reaction is conducted with freshly prepared 
FeCl3•Al2O3 and methylidene malonate on preparative scale, 
the isolated yield of 16a reached 43% (Scheme 5). However, 
(4+2) cycloaddition was not successful with this substrate 
(vide infra). Thymine cyclobutane 16a was therefore 
protected with a tert-butoxy carbonyl group to avoid side 
reactions. However, the Boc group exhibited high lability and 
was removed in presence of Lewis acids.  
 
Scheme 5. Synthesis of thymine cyclobutanes. Reaction 
conditions: a) 0.2 equiv FeCl3•Al2O3, methylidene 
dimethylmalonate (15), DCM, 43%. b) Boc2O, DMAP, ACN, 81%. 
c) BzCl, DMAP, NEt3, DCM, 86%. 
Benzoyl as protecting group was then examined, as it was 
expected to be more stable than tert-butoxycarbonyl group. 
Benzoylation of 16a gave protected cyclobutane 18a in 86% 
yield. Using the same reaction sequence, fluoro-uracil 
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derived cyclobutane 18b could be also obtained in good yield 
(Scheme 6).  
  
Scheme 6. Preparation of 5-fluoro uracil cyclobutane 18b. 
Having the pyrimidine-based DA cyclopropanes 13a-c and 
DA cyclobutanes 18a, b in hand, we then examined the 
corresponding (3+2) and (4+2) formal cycloadditions 
catalyzed by Lewis acids with ketones, aldehydes and enol 
ethers as partners to access 5- and 6- membered nucleoside 
analogues. Using the conditions described for the (3+2) 
reaction with aldehydes and phthalimide-substituted DA 
cyclopropanes, the desired five-membered ring 22a was 
isolated in low yield with the thymine-substituted DA 
cyclopropane 13a (Table 3, entry 1).  
Table 3. Optimization of the [3+2] annulation.  
 
Entry Partner[a] LA Loading[b] T Time Yield[c] 
1 19 FeCl3•Al2O3 5 rt 3 days 27% 
2 19 In(OTf)3 20 rt 1 h 86% 
3 19 Hf(OTf)4 20 rt 1 h 49%
[d] 
4 20 SnCl4 5 -78 °C 2 days 6% 
5 21 SnCl4 10 -78 °C 2 days 52% 
6 20 SnCl4 5 -20 °C 30 min 60% 
7 21 SnCl4 10 -20 °C 30 min 60% 
[a] Reaction conditions: 1.2 equiv 19, 20 or 21, dry DCM, 0.3 M, 
stirred under N2. [b] In mol%. [c] Isolated yield. [d] Yield of the 
nucleoside without the protecting group. Deprotection occurred 
under these conditions.  
When the Lewis acid was changed from FeCl3•Al2O3 to 
In(OTf)3, the isolated yield increased to 86% (entry 2). 
Interestingly, with Hf(OTf)4 as catalyst, the yield was 
moderate, but gave a direct access to the deprotected product 
22b (entry 3). However, this yield could not be improved. In 
our previous work, when ketones and enol ethers were used 
as dipolarophiles with phthalimide cyclopropanes, the best 
Lewis acid was SnCl4 at low temperature.[5a-b] Using these 
conditions with thymine cyclopropane 13a over two days led 
to low yield with acetophenone (20) and moderate yield with 
TIPS protected acetophenone (21) (entries 4 and 5). 
Increasing the temperature to -20 °C, resulted in complete 
conversion after 30 minutes (entries 6 and 7). The two desired 
nucleoside analogues 23a and 24a, synthesized from the 
ketone 20 and the enol ether 21, respectively, were isolated in 
60% yields.  
As the Boc group on thymine is thermally labile, an efficient 
two step procedure, consisting in the Lewis acid-catalyzed 
(3+2) annulation, followed by filtration (to remove the Lewis 
acid catalyst) and tert-butoxycarbonyl removal at 70 °C for 
18 h was developed (Scheme 7). When the two step procedure 
was applied to the (3+2) reaction with benzaldehyde (19), the 
unprotected nucleoside 22b was isolated in 87% yield 
(Scheme 7, A). The two step protocol gave better yield of 
nucleoside analogues in the case of acetophenone (20): 94% 
yield of 23b was obtained instead of 60% of 23a without 
deprotection (Scheme 7, B). Carbonucleoside 24b was 
isolated in 84% yield by using the two step procedure.  
 
Scheme 7. Optimized conditions for annulation-deprotection. 
The (4+2) reaction was then investigated using thymine 
cyclobutane 16a with different Lewis acids (Zn(OTf)2, AuCl3, 
Sn(OTf)2, Sc(OTf)3 TiCl4, Hf(OTf)4, In(OTf)3, Cu(OTf)2, 
FeCl3•Al2O3 and Yb(OTf)3). No conversion was observed for 
most of the Lewis acids, except with In(OTf)3 and Hf(OTf)4: 
these catalysts gave access to tetrahydropyranyl amine in low 
yield due to degradation. A screening of Lewis acids was also 
conducted with Boc protected thymine cyclobutane 17, 
including Zn(OTf)2, AuCl3, Sn(OTf)2, Sc(OTf)3, TiCl4, SnCl4, 
Hf(OTf)4, In(OTf)3, Cu(OTf)2, FeCl3•Al2O3 and Yb(OTf)3. 
Encouraging results were obtained with Hf(OTf)4 and 
FeCl3•Al2O3: the desired nucleosides analogues were isolated 
in 59% and 56% yield respectively. However, partial loss of 
the Boc protecting group was again observed. Therefore, we 
focused our efforts on these two Lewis acids with benzoyl 
protected thymine cyclobutane 18a. Even in this case, a 
partial benzoyl group removal was observed, thus 
deprotection using an ammonium hydroxide solution in 
ethanol was systematically performed directly after 
annulation.[13] As benzoyl deprotection was quantitative, the 
optimization focused on the conditions for the (3+2) 
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annulation (Table 4). With hafnium triflate, the two step 
procedure gave moderate yield after 14 hours (entry 1) due to 
partial decomposition of the product 25a. When the reaction 
time was shortened to 30 min, the product 25a was isolated 
in an increased 76% yield (entry 2). The optimum time was 
found to be 15 minutes (entry 3), as the conversion is 
complete and the degradation minimized. If the reaction time 
was shortened to 10 and 5 minutes (entries 4 and 5), the 
reaction was not complete and lower yields were obtained. 
The reaction with iron trichloride supported on alumina went 
to completion only after 14 hours, providing 25a in moderate 
yield (entry 6). Therefore, a stoichiometric amount of 
FeCl3•Al2O3 was used in order to shorten the reaction time. 
Complete conversion was reached after 30 min, but the yield 
was not improved (entry 7). The same observation was made 
when the reaction was performed at a 0.3 mmol scale. The 
reaction was stopped after completion (15 minutes in this 
case), after filtration and deprotection 60% yield was 
obtained (entry 8).  
Table 4. Screening of conditions for the [4+2] annulation. 
 
Entry Lewis acid Loading Time Yield[a] 
1 Hf(OTf)4 20 mol% 14 h 51% 
2 Hf(OTf)4 20 mol% 30 min 76% 
3 Hf(OTf)4 20 mol% 15 min 87% 
4 Hf(OTf)4 20 mol% 10 min 55%
[b] 
5 Hf(OTf)4 20 mol% 5 min 44%
[b] 
6 FeCl3·Al2O3 20 mol% 14 h 59% 
7 FeCl3·Al2O3 100 mol% 30 min 62% 
8 FeCl3·Al2O3 100 mol% 15 min 60%
[c] 
9 Hf(OTf)4 20 mol% 15 min 78%
[c] 
Reaction conditions: 18a (20 mg, 0.050 mmol), 1.5 equiv 
benzaldehyde (19), 0.05 M in dry DCM, stirred under N2. Then 
filtration, NH4OH, EtOH, 16 hours. [a] NMR yields after isolation 
due to benzamide poisoning (not removable by column), all [4+2] 
annulations went to full conversion, otherwise stated. [b] [4+2] 
annulation not complete. [c] 0.3 mmol scale. 
Finally, the (4+2) annulation was performed on larger scale 
with 0.3 mmol of cyclobutane 18a with hafnium triflate, 
providing the nucleoside analogue 25a in 78% isolated yield 
(entry 9). Unfortunately, the (4+2) annulation conducted with 
TIPS enol ether 21 gave only traces of product even after 24 
hours. With acetophenone 20, the desired benzoyl protected 
nucleoside was obtained in 54% yield after 24 hours, but the 
conversion was not complete. 
Having the optimized conditions in hand for the (3+2) and the 
(4+2) annulations, we investigated the scope of the reaction 
and its limitations. The reaction was examined with 
aldehydes first (Scheme 8, A). The nucleoside 22c 
synthesized from 4-fluoroacetophenone, was obtained in 79% 
yield and high diastereoselectivity. The diastereoselectivity 
was lower in the case of cinnamaldehyde, but product 22d 
was still obtained in 96% yield. The (3+2) reaction worked 
also with the sterically hindered aliphatic isobutyraldehyde, 
providing 22e in 75% yield and complete diastereoselectivity. 
We then examined the use of 2-hydroxy acetaldehyde 
derivatives in the reaction to provide nucleoside analogues 
22f-h with the hydroxymethyl group often required for the 
bioactivity of drugs. Unfortunately, this type of aldehydes 
was more prompt to polymerization and no conditions to 
obtain the nucleoside derivatives could be found.  
We then turned to ketones as substrates (Scheme 8, B). 
Aromatic ketones (acetophenone (20) and 4-fluoro 
acetophenone) afforded the nucleoside analogues 23b and 
23c in high yield and diastereoselectivity. In the case of an 
alkenyl ketone, the product 23d was isolated in good yield 
and poor diastereoselectivity. Aliphatic ketones also worked 
well in the annulation reaction: the phenethyl substituted 
nucleoside derivative 23e and the bicyclic nucleoside 23f 
were obtained in 85% and 97% yield respectively. Using TBS 
protected 2-hydroxyacetacetone, nucleoside 23g bearing a 
hydroxymethyl group could be accessed in 38% yield.  
Carbonucleoside derivatives were then synthesized with enol 
ethers as dipolarophiles (Scheme 8, C). 24b-d were obtained 
in high yield and diastereoselectivity with enol ethers 
substituted with aromatic groups. When a dibenzylester 
thymine cyclopropane was used with enol ether 21, the yield 
reached 95% (product 24c). The styrenyl carbonucleoside 
24e was isolated with 13:1 diastereoselectivity in 55% yield. 
One more stereocenter is formed using a tri-substituted enol 
ether and the highly substituted nucleoside analogue 24f was 
obtained as a single diastereoisomer in 79% yield.  
The annulation reaction was also conducted with 5-fluoro 
uracil cyclopropane 13c and uracil cyclopropane 13b under 
the conditions optimized for thymine cyclopropane 13a 
(Scheme 8, D). For the deprotection of the benzoyl group on 
the 5-fluorouracil nucleoside, we used again NH4OH in EtOH, 
and the mixture was stirred at room temperature for 18 hours. 
Nucleoside analogues synthesized from benzaldehyde 
bearing uracil and 5-fluoro-uracil nucleobases 26a and 26b 
were obtained in 62% and 72% yield. With acetophenone, the 
yields remain similar, 76% and 71% for 26c and 26d, 
respectively. Finally, carbonucleoside derivatives 26e and 
26f were isolated in moderate to high yields (81% and 51% 
respectively). 
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Scheme 8. Scope of the [3+2] annulation. The products were obtained as a single diastereoisomer, unless stated otherwise.  
 
We then examined the scope of the (4+2) annulation 
with thymine and 5-fluoro uracil cyclobutanes 18a and 
18b and aldehydes (Scheme 9). The (4+2) annulation 
worked with electron neutral, benzaldehyde, electron 
poor 4-fluoro-benzaldehyde and thiophene-2-
carbaldehyde, providing pure compounds 25a, 25b and 
25c in 70 to 79% yield and 7:1 to >20:1 
diastereoselectivity after column chromatography and 
recrystallization to remove the benzamide side product. 
Aldehydes bearing electron rich aromatic groups, such 
as meta-methoxy benzaldehyde and para-methoxy 
benzaldehyde, gave the corresponding nucleosides 25d 
and 25e in 76% yield. Styryl-substituted product 25f 
could also be obtained, but with a loss of 
stereoselectivity as previously noticed in the [3+2] 
reaction. 5-Fluoro-uracil cyclobutane 18b, efficiently 
provided the desired nucleoside analogue 27 with good 
diastereoselectivity. 
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Scheme 9. Scope of the [4+2] annulation. Yield and 
diastereoselectivity are given after column 
chromatography and recrystallization. 
In order to increase the diversity of our compounds and 
to provide potentially bioactive molecules, methods to 
access the hydroxymethyl substituted derivatives were 
examined. As discussed above, only -hydroxylated 
ketones could be used directly in the annulation 
reaction. However, TBS deprotection of product 23g 
led to a complex mixture containing a major compound 
tentatively identified as lactone 28,[14] and the desired 
free alcohol could not be accessed (Scheme 10). 
 
Scheme 10. Attempted deprotection of nucleoside 
analogue 23g. 
Consequently, we investigated modification of the 
esters to access the desired hydroxy methyl group. The 
Krapcho decarboxylation[15a,b] was first examined. 
With different salts (NaCl, LiCl, LiI and Li2SO4), and 
DMF or DMSO as solvent at high temperature (from 
80 °C to 130 °C), no mono ester derivatives was 
isolated. Alternative methods for ester hydrolysis 
(Ba(OH)2,[15c] Me3SnOH[15d]) or reduction (DiBAl-H, 
LiAlH4, Me(EtO)2SiH with Zn(OAc)2[15e]) were then 
investigated. Unfortunately, either no reaction was 
observed or degradation occurred. However, in MeOH 
at 70 °C with an excess KOH, the compound 23b 
underwent saponification of both dimethylesters, 
followed by a diastereoselective decarboxylation, 
providing cleanly the carboxylic acid derivative 29 in 
high yield and diastereoselectivity (Scheme 11, A).  
 
Scheme 11. Synthesis of hydroxymethyl nucleoside 
analogues. 
The use of four equivalents fine powdered and dry 
KOH in combination with dry MeOH was important to 
obtain reproducibly high yields and selectivity. 
Reduction of the carboxylic acid with boron 
dimethylsulfide complex gave then access to 4’-
hydroxymethyl nucleoside derivatives. This efficient 
method was applied to the synthesis of nucleoside 
analogues 30a-d in good yield, but with lower 
diastereoselectivity for 30b and 30d (Scheme 11, B).  
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When carbonucleoside derivatives were submitted to 
the saponification decarboxylation reaction, a mixture 
of unsaturated five membered rings was obtained due 
to silanol elimination. Consequently, we turned our 
attention to benzyl diester 24c, which can be converted 
to the diacids under milder, non-basic conditions. The 
benzyl protecting groups were smoothly removed 
under hydrogenolysis conditions, then the diacid 
obtained was heated neat at 80 °C to allow 
decarboxylation to proceed providing the mono-acid 
31 (Scheme 12). In this case, a controlled elimination 
of the silanol was observed. Finally, olefin 
hydrogenation followed by reduction of the carboxylic 
acid and protection of the corresponding alcohol afford 
the protected hydroxymethyl derivatives 32 in an 
efficient manner. Protection prior to isolation was 
preferred, as the free alcohol was unstable. 
  
Scheme 12. Preparation of hydroxymethyl 
carbonucleoside derivative 32. a) 10% Pd/C, 1 atm H2, 
EtOH, 57 °C, then neat, 80°C, 64%. b) 5% Pd/C, 1 atm 
H2, EtOH, 85%. c) BH3•SMe2, THF. d) TIPSCl, DMF, 
imidazole, 55% over two steps. 
We were also interested in the synthesis of 4’-
hydroxymethyl nucleoside analogues. Thus, we 
investigated the transformation of the styrene group of 
compounds 22b, 24b, and 30b into the corresponding 
aldehyde, which could lead after reduction, to the 
targeted alcohol (Scheme 13). Ozonolysis generally led 
to degradation of the starting materials. 
Dihydroxylation followed by oxidative cleavage, using 
several reported procedures (cat. OsO4 with NaIO4 and 
lutidine, cat. OsO4 with PIDA and lutidine,[16a] cat. 
OsO4 with NMO and citric acid followed by NaIO4[16b]) 
was also not successful, leading to inseparable 
mixtures of unidentified products along with 
decomposition of the starting materials.[17] 
 
Scheme 13. Attempted synthesis of 4’-hydroxymethyl 
nucleoside analogues. 
After the synthesis of pyrimidine nucleoside analogues 
had been achieved via annulation reactions of strained 
rings, we turned our attention to purine nucleoside 
analogues. As substituents on the cyclopropane, we 
chose adenine, 6-chloro-2-amino purine and 6-chloro 
purine. 6-Chloro-2-amino purine derivatives are 
interesting, as they can be used as precursors for both 
adenine and guanine derivatives.[18]  
In order to synthesize purine cyclopropanes, we firstly 
thought about using the protocol developed for the 
pyrimidines. However, the palladium catalyzed 
vinylation was not successful with purines. As an 
alternative approach, a tandem Michael 
addition/cyclopropane formation of purines on 
chloromethyl-ethylidene malonates was envisaged. 
Indeed, Geen and co-workers had reported a single 
example of synthesis of a 6-chloro-2-amino purine 
derived diester cyclopropane using this approach.[19]  
As described by Lehnert, chloromethyl-ethylidene 
malonates can be prepared via a Knoevenagel 
condensation of chloroacetaldehyde on malonate 
derivatives in presence of two equivalents of titanium 
tetrachloride and four of pyridine.[20] Unfortunately, in 
our hand this reaction turned out to give the product in 
highly fluctuating yields (from 60% to 0%), as 
polymerization of the starting material was often 
observed. Deshmuck and co-workers have described 
the condensation of trichloroacetaldehyde on 
diethylmalonate using Montmorillonite K-10 in Ac2O 
at 150 °C for five hours.[21] These conditions were then 
examined with chloroacetaldehyde 34, but after only 
10 minutes of reaction, complete degradation was 
observed. When the temperature was lowered to 
110 °C complete conversion was obtained after 1 h to 
the desired product 35, together with the aldol dimer 36 
of chloroacetaldehyde. As the two compounds were 
difficult to separate, the reaction conditions were 
optimized in order to avoid dimer formation. At 70 °C 
for 7 hours, the reaction was complete giving access to 
the desired ethylidene malonate 35 along with some 
remaining malonate 33, which was easily removed by 
column chromatography (Scheme 14). The product 
was isolated up to 61% on a five gram scale reaction. 
 
Scheme 14. Preparation of chloromethyl-ethylidene 
dimethylmalonate (35).  
Furthermore, chloromethyl-ethylidene malonate 37 
bearing pentyl esters was synthesized in order to 
increase the solubility of the purine cyclopropanes in 
organic solvents. It was obtained from the malonic acid 
through esterification with the corresponding pentyl 
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alcohol followed by the optimized Knoevenagel 
reaction.  
The obtained alkylidene malonates 35 and 37 were then 
submitted to the previously reported conditions for 
cyclopropanation (Scheme 15).[19] Purine 
cyclopropanes were obtained in moderate to excellent 
yields, always with complete regioselectivity. 
Generally, cyclopropanes with geminal dimethyl ester 
38a, 38b and 38c were obtained in lower yields. 
Purification was a major issue due to their poor 
solubility in organic solvents and to their high polarity. 
The other three cyclopropanes 38d, 38e and 38f with 
pentyl ester chains were isolated in higher yields (62 to 
93%), as they were well soluble in organic solvents.  
 
Scheme 15. Synthesis of purine cyclopropanes.  
The solubility of dimethyl ester cyclopropanes 38a-c 
was poor in all common organic solvents, even if the 
6-chloropurine cyclopropane 38c exhibited a slightly 
improved solubility. Only partial solubility in hot 
acetonitrile or DMF was observed. In contrast, the 
purine cyclopropanes 38d-f bearing pentyl esters were 
completely soluble in dichloromethane at room 
temperature. In order to prevent any potential catalyst 
deactivation or side-reaction and also improve its 
solubility, the free amine of the 6-chloro-amino-purine 
cyclopropane 38b was protected with two tert-
butoxycarbonyl groups to give product 39 (Scheme 16). 
The yield of the protection step is highly dependent on 
the solvent: In THF or DMSO, the isolated yields were 
typically around 40%, whereas in acetonitrile the 
product was obtained in 85% yield.  
 
Scheme 16. Preparation of the protected purine 
cyclopropane. 
Attempts to protect the free amine with a benzyl group 
via a SN2 reaction using a phase transfer reagent[22] or 
through reductive amination[23] failed, as did protection 
with dimethylcarbonate. 
Cyclopropanes 38a-f were then examined in the 
(3+2) annulation with benzaldehyde (19) as partner and 
a broad range of Lewis acids. The first cyclopropane 
tested was the adenine cyclopropane 38a bearing 
methyl esters. The screening was initially planned in 
dichloromethane, which had been the solvent of choice 
for the (3+2) annulation of thymine-substituted 
cyclopropanes. Unfortunately, adenine cyclopropane 
38a displayed extremely poor solubility in DCM, THF 
and ACN. Even with slightly more soluble purine 
cyclopropanes 38b no reaction was observed using 
In(OTf)3 as catalyst in several solvents (DCM, DCE, 
DCM/MeOH, CCl4, THF, ACN, toluene, MeOH, 
benzene, DMF and DMSO). We hypothesized that the 
lack of reactivity of this cyclopropane may be the 
consequence of catalyst poisoning due to the 
coordination of the Lewis acid to the free amine of the 
substrate. Therefore, the annulation of 38c was 
examined with different Lewis acids (Zn(OTf)2, AuCl3, 
Sn(OTf)2, Sc(OTf)3, Hf(OTf)4, In(OTf)3, 
stoichiometric In(OTf)3, Cu(OTf)2, FeCl3•Al2O3 and 
Yb(OTf)3). However, also in this case, no conversion 
to the desired nucleoside analogues was observed.  
No reaction was observed with pentyl esters-
substituted adenine cyclopropane 38d as well as the 
other purines cyclopropane 38e and 38f, even though 
the solubility in DCM at room temperature was high 
and a wide range of Lewis acids were examined 
(Zn(OTf)2, FeCl3, AuCl3, AuCl, Sn(OTf)2, Sc(OTf)3, 
Hf(OTf)4, In(OTf)3, Cu(OTf)2, Yb(OTf)3). Another 
possibility for the lack of reactivity observed, may be 
the hindrance created by the pentyl side chains around 
the esters avoiding the catalyst to chelate the malonate 
and therefore the reaction to proceed. However, when 
the soluble protected 6-chloro-2-amino purine 
dimethylester cyclopropane 39 was submitted to the 
conditions for (3+2) annulation with indium triflate as 
catalyst in either DCM or THF, only removal of the 
tert-butoxycarbonyl was observed. 
To completely exclude catalyst poisoning by the 
substrate, we performed a competition experiment 
between pyrimidine cyclopropane 13c and purine 
analogue 38e under the conditions for (3+2) annulation 
(Scheme 17). After 45 minutes of reaction, complete 
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conversion of the pyrimidine cyclopropane 13c into the 
corresponding nucleoside analogue 40 was observed, 
while the purine cyclopropane 38e stayed untouched.  
 
 
Scheme 17. Competition experiment. a) 0.2 equiv 
In(OTf)3, 2.4 equiv benzaldehyde (19), DCM. 
From this result, we can conclude that purine 
cyclopropanes 38a-f do not coordinate too strongly to 
the Lewis acid. However, purine cyclopropanes 38a-f 
are not suitable substrates for the (3+2) annulation, 
probably due to their different electronic properties 
leading to too low reactivity. In the future, further 
modulation of the DA cyclopropane structure will be 
required to extend the developed annulation processes 
to this important class of substrates. 
3. Conclusions 
A short synthesis of pyrimidine DA cyclopropanes and 
cyclobutanes was designed based on a regioselective 
vinylation followed by cyclopropanation or (2+2) 
cycloaddition. Purine DA cyclopropanes were 
prepared from chloromethyl-ethylidene malonates via 
a tandem Michael addition intramolecular substitution 
sequence. Pyrimidine nucleosides analogues were 
accessed from the DA cyclopropanes and DA 
cyclobutanes via (3+2) and (4+2) annulation reactions, 
opening a new chemical space for further biological 
investigations. Unfortunately, purine DA 
cyclopropanes remain unreactive in the (3+2) 
annulation reactions.  
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1. General methods. 
 
All reactions were carried out in flamed-dried glassware under an atmosphere of nitrogen, 
unless stated otherwise. HPLC grade solvents purchased from Sigma-Aldrich or freshly 
distilled solvents were used for flash chromatography. Reaction solvents were dried by 
passage over activated alumina under nitrogen atmosphere (H2O content < 30 ppm, Karl-
Fischer titration). Commercially available reagents were purchased from Acros, Aldrich, Fluka, 
VWR, Aplichem, Merck or TCI and used without any further purification. Chromatographic 
purification was performed as flash chromatography using Macherey-Nagel silica 40-63, 60 Å, 
using the solvents indicated as eluent with 0.1-0.5 bar pressure. TLC was performed on Merck 
silica gel 60 F254 TLC plates and visualized with UV light and permanganate stain. Melting 
points were measured on a calibrated Büchi B-540 melting point apparatus using open glass 
capillaries. 1H NMR spectra were measured on a Brucker DPX-400, 400 MHz spectrometer, 
all signals are reported in ppm with the corresponding internal solvent peak or TMS as 
standard. The data is being reported as (s = singlet, d = doublet, t = triplet, q = quadruplet, qi 
= quintet, m = multiplet or unresolved, br = broad signal, coupling constant(s) in Hz, integration; 
interpretation). 13C NMR spectra were carried out with 1H-decoupling on a Brucker DPX-400 
100 MHz. All signals are reported in ppm with the corresponding internal solvent signal or TMS 
as standard. Infrared spectra were obtained on a JASCO FT-IR B4100 spectrophotometer with 
an ATR PRO410-S and a ZnSe prisma and are reported as cm-1 (w = weak, m = medium, s = 
strong, sh = shoulder). High resolution mass spectrometric measurements were performed by 
the mass spectrometry service of ISIC at the EPFL on a MICROMASS (ESI) Q-TOF Ultima 
API. All experimental procedures to synthesize the compounds described in the article are 
given. Only spectra of compounds which were not described in our previous publications are 
given. For compounds 10a-c, 12a-c, 13a-c, 14, 16a,b, 17, 18a,b, 22a-f, 23a-f, 24a-f, 25a-f, 
26a-f, 27, 29, 30a-d, 31 and 32, please refer to the previous reports.1 
  
                                                 
1 a) S. Racine, F. de Nanteuil, E. Serrano, J. Waser, Angew. Chem. Int. Ed. 2014, 53, 8484–8487. b) D. Perrotta, 
S. Racine, J. Vuilleumier, F. de Nanteuil, J. Waser, Org. Lett. 2015, 17, 1030–1033. c) F. de Nanteuil, J. 
Waser, Angew. Chem. Int. Ed. 2013, 52, 9009–9013. 
2 
 
2. Starting materials. 
2.1 Diazomalonates. 
Dibenzyl 2-diazomalonate (42). 
 
In flame dried flask under nitrogen, 4-acetamidobenzenesulfonyl azide (1.27 g, 5.28 mmol, 1.5 
equivuiv) was dissolved in acetonitrile (15 mL) and triethylamine (1.17 mL, 8.44 mmol, 2.4 
equivuiv) and dibenzyl malonate (41) (0.88 mL, 3.5 mmol, 1equivuiv) were added. The reaction 
mixture was stirred at room temperature for 2 days. The solvent was evaporated and the crude 
product was filtered on coton with acetonitrile (30 mL). The crude mixture was concentrated 
under reduced pressure and filtered on coton one more time with DCM (30 mL) and finally 
purified by column chromatography, eluting with pentane/AcOEt (9:1) and 1% NEt3 mixture to 
obtain the pure diazo-compound 42 (1.02 g, 3.29 mmol, 93%) as a slightly yellow solid. 
 
RF (AcOEt/Pent (1:9) = 0.22. 
 
Mp 54.8-55.4°C. (Decomposition)  
 
1H NMR (400 MHz, Chloroform-d) δ 7.39- 7.34 (m, 10H, Ar-H), 5.28 (s, 4H, CH2). 
 
13C NMR (101 MHz, Chloroform-d) δ 160.8, 135.3, 128.7, 128.5, 128.3, 67.1. 
One carbon is not resolved. 
 
IR 3035 (w), 2141 (s), 1757 (s), 1689 (m), 1388 (s), 1271 (m), 1077 (s), 760 (s). 
 
HRMS (ESI) calcd for C17H14N2NaO4+ [M+Na]+ 333.0846; found 333.0856. 
 
Dimethyl 2-diazomalonate (44). 
 
In a flame dried flask under nitrogen, 4-acetamidobenzenesulfonyl azide (6.82 g, 28.4 mmol, 
1.5 equiv) was dissolved in acetonitrile (80 mL) and triethylamine (6.3 mL, 45 mmol, 2.4 equiv) 
and dimethyl malonate (33) (2.2 mL, 19 mmol, 1 equiv) were added. The reaction mixture was 
stirred at room temperature for 1 day. The solvent was evaporated and the crude product was 
filtered on coton with acetonitrile (30 mL). The crude mixture was concentrated under reduced 
pressure and filtered on coton one more time with DCM (30 mL) and finally purified by column 
chromatography, eluting with pentane/AcOEt (9:1) and 1% NEt3 mixture to obtain the pure 
diazo-compound 44 (2.67 g, 16.9 mmol, 94%) as a slightly yellow oil (solid at 4 °C). 
 
1H NMR (400 MHz, Chloroform-d) δ 3.84 (s, 4H, CH2). 
 
1H NMR values correspond to the literature.2  
 
2.2 Methylidene and ethylidene malonates. 
 
Dimethyl 2-methylenemalonate (15). 
                                                 
[2] F. de Nanteuil, J. Waser, Angew. Chem. Int. Ed.,2011, 50, 12075–12079. 
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Following the described procedure of De Nanteuil et al.,1c paraformaldehyde (2.7 g, 90 mmol, 
2.0 equiv) and diisopropylamine 2,2,2-trifluoroacetate (9.7 g, 45 mmol, 1.0 equiv) were added 
in a flame dried 250 mL round flask with a condenser. Then, tetrahydrofuran (65 mL), dimethyl 
malonate (33) (5.1 mL, 45 mmol, 1.0 equiv) and trifluoroacetic acid (0.35 mL, 4.5 mmol, 0.1 
equiv) were added into the flask under nitrogen atmosphere and the suspension was stirred to 
reflux for 2 hours. Paraformaldehyde (2.7 g, 90 mmol, 2.0 equiv) was added to the reaction 
mixture and the reflux was restarted for 12 hours. The reaction mixture was cooled to room 
temperature and THF was removed under reduced pressure. The crude product was dissolved 
in diethyl ether (25 mL) and filtrated trough cotton. The organic layer was washed two times 
with 1 M HCl (25 mL), the aqueous layers were combined and washed three times with diethyl 
ether (50 mL). The combined organic layers were dry over magnesium sulfate, filtrated and 
concentrated under reduced pressure. The crude mixture was obtained as a colorless oil (15) 
(2.5 g). 
 
1H NMR (400 MHz, Chloroform-d) δ 6.58 (s, 2H, CH2), 3.83 (s, 6H, ester CH3). 
 
1H NMR values correspond to the literature.2 
 
Dimethyl 2-(2-chloroethylidene)malonate (35). 
 
Following an adapted procedure from Deshmukh et al.,3 Montmorillonite K-10 clay (0.50 g), 
Ac2O (4.6 mL, 48 mmol, 1.3 equiv), 2-chloroacetaldehyde (3.1 mL, 45 mmol, 1.2 equiv), 
dimethyl malonate (33) (4.3 mL, 4.4 mmol, 1 equiv) were stirred under nitrogen atmosphere in 
flamed dried flask at 70 °C for 3 h 30. The reaction was cooled down to room temperature and 
saturated solution of NaHCO3 (20 mL) was added, the mixture was extracted with ether (3x 20 
mL). The combined organic layers were dry over magnesium sulfate, filtrated and concentrated 
under reduced pressure. The crude residue was purified by column chromatography using a 
mixture of pentane and ethyl acetate (100% pentane to 80:20% pentane/ ethyl acetate) 
affording the pure product 35 (4.33 g, 22.5 mmol, 61% yield) as a slightly yellow liquid. 
 
RF (AcOEt/Pent (1:9) = 0.43. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.08 (t, J = 7.3 Hz, 1H, C=CH), 4.34 (d, J = 7.3 Hz, 2H, 
CH2), 3.88 (s, 3H, Me ester), 3.85 (s, 3H, Me ester). 
 
13C NMR (101 MHz, Chloroform-d) δ 164.3, 163.6, 144.2, 129.1, 52.8, 52.7, 39.2. 
 
IR 2951 (w), 1732 (s), 1439 (m), 1282 (s), 1227 (s), 1058 (w), 769 (w). 
 
HRMS (ESI) calcd for C7H9ClNaO4+ [M+Na]+ 215.0082; found 215.0087. 
                                                 
3 A. R. A. S. Deshmukh, D. G. Panse, B. M. Bhawal, Synth. Commun. 1999, 29, 1801–1809. 
4 
 
 
Dipentyl malonate (46). 
 
Following the procedure described by Tian et al.4, 4-methylbenzenesulfonic acid monohydrate 
(0.033 g, 0.19 mmol, 0.01 equiv), pentan-1-ol (4,6 mL, 42 mmol, 2.2 equiv), malonic acid (45) 
(2.00 g, 19.2 mmol, 1 equiv) were stirred at 85 °C in a flame dried flask under nitrogen in 
benzene (40 mL) for 3 h. The mixture was cooled down to room temperature and a saturated 
solution of NaHCO3 (20 mL) was added, the mixture was extracted with ethyl acetate (3x 20 
mL). The combined organic layers were washed with saturated solution of Na2CO3 (20 mL), 
dry over magnesium sulfate, filtrated and concentrated under reduced pressure. The crude 
product 46 (3.4 g, 14 mmol, 73% yield) obtained as a yellow liquid after concentration under 
reduced pressure was clean enough to be used for the next step without further purification. 
 
1H NMR (400 MHz, Chloroform-d) δ 4.17 (t, J = 6.8 Hz, 4H, pentyl CH2), 3.40 (s, 2H, 
C=OCH2C=O), 1.80 – 1.58 (m, 4H, pentyl CH2), 1.36 (m, 8H, pentyl CH2), 1.02 – 0.82 (m, 6H, 
pentyl CH3). 
 
13C NMR (101 MHz, CDCl3) δ 166.7, 65.7, 41.7, 28.2, 27.9, 22.3, 14.0. 
 
NMR value correspond to literature.3 
 
Dipentyl 2-(2-chloroethylidene)malonate (37). 
 
Following an adapted procedure from Deshmukh et al.,3 Montmorillonite K-10 clay (80 mg), 
Ac2O (2.5 mL, 27 mmol, 1.3 equiv), 2-chloroacetaldehyde (1.7 mL, 25 mmol, 1.3 equiv), 
dipentyl malonate (46) (5.0 g, 20 mmol, 1 equiv) were stirred under nitrogen atmosphere in a 
flamed dried flask at 70 °C for 16 hours. The reaction was cooled down to room temperature 
and a saturated solution of NaHCO3 (20 mL) was added, the mixture was extracted with ether 
(3x 20 mL). The combined organic layers were dried over magnesium sulfate, filtrated and 
concentrated under reduced pressure. The crude oil was used without any purification. In 
general, the crude contain a ratio 7:3 product 37 to product 46. 
 
2.3 Pyrimidine cyclopropanes. 
1-Vinylthymine (10a). 
 
Thymine (7a) (0.50 g, 3.9 mmol, 1.0 eq), diacetoxypalladium (0.036 g, 0.16 mmol, 0.04 eq) 
were suspended in DMF (10 mL) in a flame-dried sealed microwave vial under nitrogen 
atmosphere. Vinyl acetate (11) (0.82 g, 9.5 mmol, and 2.4 eq), triethylamine (1.3 mL, 9.5 mmol, 
2.4 eq) and TMSOTf (1.7 mL, 9.5 mmol, and 2.4 eq) were added to the reaction mixture and 
stirred at 70 °C for 24 hours. The reaction mixture was cooled down to room temperature and 
the solvent was removed under reduced pressure. The crude mixture was purified by column 
                                                 
4 Y. Tian, E. Akiyama, Y. Nagase, J. Mater. Chem. 2003, 13, 1253. 
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chromatography, eluting with a mixture of ethyl acetate/ pentane (7:3). The pure 1-vinylthymine 
(10a) (0.47 g, 3.1 mmol, 79% yield) was obtained as white solid. 
 
RF (Hex/AcOEt (1:1)) = 0.5.  
 
Mp 208.0-209.1°C.  
 
1H NMR (400 MHz, Chloroform-d) δ 9.17 (s, 1 H, NH), 7.34 (s, 1 H, thymine C=C-H), 7.21 (dd, 
1 H, J =16.0, 9.1 Hz, -vinyl-CH), 5.07 (dd, 1 H, J = 16.0, 2.1 Hz, vinyl-CH2), 4.91 (dd, 1 H, J = 
9.1, 2.1 Hz, vinyl-CH2), 1.99 (s, 3 H, thymine-CH3).  
 
13C NMR (101 MHz, Chloroform-d) δ 163.6, 149.3, 134.5, 129.6, 112.1, 100.5, 12.6. 
 
IR 3173 (w), 3048 (w), 1698 (s), 1644 (s), 1459 (w), 1381 (w), 1344 (m), 1278 (m), 1129 (w).  
 
HRMS (ESI) calcd for C7H9N2O2+ [M+H]+ 153.0659; found 153.0653. 
 
Tert-butyl 5-methyl-2,6-dioxo-3-vinyl-2,3-dihydropyrimidine-1(6H)-carboxylate (12a). 
 
1-Vinylthymine 10a (0.92 g, 6.1 mmol, 1.0 equiv), di-tert-butyl dicarbonate (2.64 g, 12.1 mmol, 
2.0 equiv) and dimethylaminopyridine (1.48 g, 12.1 mmol, 2.0 equiv) were stirred in acetonitrile 
(25.0 mL) for 12 h in a flame-dried flask under nitrogen. Silica and triethylamine (0.5 mL) were 
added to the reaction and the solvent was removed under reduced pressure. The dry residue 
was purified by column chromatography using a mixture of hexane/ethyl acetate/1% NEt3 (95:5 
to 80:20) as eluting solvent. The pure product 12a (1.15 g, 4.56 mmol, 75% yield) was obtained 
as a white solid. 
 
RF (Hex/AcOEt (9:1)) = 0.2. 
 
Mp 109.9-111.2 °C.  
 
1H NMR (400 MHz, Chloroform-d) δ 7.31 (m, 1H, thymine C=C-H), 7.15 (dd, J = 16.0, 9.1 Hz, 
1H, -vinyl-CH), 5.09 (dd, J = 16.0, 2.2 Hz , 1H, vinyl-CH2), 4.94 (dd, J = 9.1, 2.2 Hz , 1H, vinyl-
CH2), 1.99 (s, 3 H, thymine-CH3), 1.60 (s, 9 H, Boc).  
 
13C NMR (400 MHz, Chloroform-d) δ 161.0, 147.6, 147.5, 134.0, 129.6, 111.8, 101.3, 87.1, 
27.5, 12.7. 
 
IR 2982 (w), 2937 (w), 1778 (s), 1721 (s), 1672 (s). 
 
HRMS (ESI) calcd for C12H16N2NaO4+ [M+Na]+ 275.1002; found 275.1008. 
 
Dimethyl 2-(3-(tert-butoxycarbonyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)cyclopropane-1,1-dicarboxylate (13a). 
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Diazomalonate 44 (1.80 g, 10.5 mmol, 1.2 equiv), Rh2(esp)2 (0.013 g, 0.017 mmol, 0.02 mol%) 
and tert-butyl 5-methyl-2,6-dioxo-3-vinyl-2,3-dihydropyrimidine-1(6H)-carboxylate (12a) (2.2 g, 
8.7 mmol, 1.0 equiv) were stirred at room temperature in DCM (18 mL) in a flame-dried flask 
under nitrogen. After 40 min. NEt3 (0.4 mL) and silica were added and the solvent was removed 
under reduced pressure. The dried residue was purified by column chromatography using a 
mixture of pentane/ethyl acetate/1% NEt3 (1:1) as solvent gradient. The pure product 13a (3.30 
g, 8.63 mmol, 99% yield) was obtained as a slightly yellow foamy oil. The cyclopropane 13a 
was obtained in 64% yield over the three steps. 
 
RF (hexane/AcOEt/1% NEt3 (1:1)) = 0.26. 
 
1H NMR (400 MHz, Chloroform-d) δ 6.94 (m, 1H, thymine C=CH), 4.01 (dd, J = 8.3, 6.4 Hz, 
1H, cyclopropane-CH), 3.79 (s, 3H, ester-CH3), 3.71 (s, 3H, ester-CH3), 2.27 (t, J = 6.5 Hz, 1H, 
cyclopropane-CH2), 1.91 (m, 4H, thymine-CH3 and cyclopropane-CH2), 1.58 (s, 9H, Boc). 
 
13C NMR (101 MHz Chloroform-d) δ 167.6, 166.2, 161.2, 149.1, 147.4, 138.2, 110.5, 86.8, 
53.3, 53.2, 42.9, 35.0, 27.5, 20.0, 12.5. 
 
IR 3431 (w), 3364 (w), 2943 (m), 2866 (m), 2092 (w), 1705 (s), 1628 (m), 1505 (m), 1364 (m), 
1167 (s). 
 
HRMS (ESI) calcd for C17H22N2NaO8+ [M+Na]+ 405.1268; found 405.1271. 
 
Dibenzyl 2-(3-(tert-butoxycarbonyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)cyclopropane-1,1-dicarboxylate (47). 
 
Tert-butyl 5-methyl-2,6-dioxo-3-vinyl-2,3-dihydropyrimidine-1(6H)-carboxylate (12a) (0.30 g, 
1.2 mmol, 1.0 equiv) and Rh2(esp)2 (1.8 mg, 2.4 µmol, 0.02 mol%) were stirred in a flame-dried 
flask under nitrogen atmosphere with anhydrous DCM (2.3 mL) and diazomalonate 42 (0.45 
g, 1.4 mmol, 1.2 equiv) was added at 0 °C. Then, the reaction mixture was allowed to warm 
up to room temperature and stirred for 14 h. Silica and triethylamine (0.5 mL) were added and 
the solvent was removed under reduced pressure. The dried residue was purified by column 
chromatography using a mixture of pentane/ethyl acetate/1% NEt3 (9:1) as eluting solvent to 
afford dibenzyl 2-(3-(tert-butoxycarbonyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)cyclopropane-1,1-dicarboxylate (47) (0.60 g, 1.1 mmol, 93% yield) as a slightly yellow foam. 
The cyclopropane 47 was obtained in 60% yield over the three steps. 
 
 
MP 76.9-82.1 °C. 
 
RF (pent/AcOEt (7:3)) = 0.29. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.35 – 7.22 (m, 10 H, Ar-H), 6.83 (q, J = 1.1 Hz, 1H, 
thymine vinyl-CH), 5.27 – 5.10 (m, 4H, benzylic-CH2), 4.05 (dd, J = 8.3, 6.5 Hz, 1H, 
cyclopropane-NCH), 2.31 (t, J = 6.6 Hz, 1H, cyclopropane -CH2), 1.93 (dd, J = 8.3, 6.6 Hz, 1H, 
cyclopropane -CH2), 1.78 (d, J = 1.3 Hz, 3H, thymine methyl), 1.59 (s, 9H, Boc). 
 
13C NMR (101 MHz, Chloroform-d) δ 167.2, 165.4, 161.1, 149.2, 147.5, 138.0, 135.0, 134.8, 
128.6, 128.6, 128.5, 128.4, 128.2, 110.5, 86.8, 68.3, 68.0, 43.1, 35.3, 27.5, 20.3, 12.4. 
One carbone not resolved. 
7 
 
 
IR 3066 (w), 2984 (w), 2932 (w), 1783 (s), 1725 (s), 1670 (s), 1433 (m), 1373 (m), 1316 (s), 
1146 (s). 
 
HRMS (ESI) calcd for C29H30N2NaO8+ [M+Na]+ 557.1894; found 557.1885. 
 
1-Vinylpyrimidine-2,4(1H,3H)-dione (10b). 
 
Palladium acetate (0.036 g, 0.040 mmol, 0.04 equiv), vinyl acetate (11) (0.87 mL, 10 mmol, 
2.4 equiv), uracil (7b) (0.45 g, 4.0 mmol, 1.0 equiv), TMSOTf (1.7 mL, 9.5 mmol, 2.4 equiv) 
and triethylamine (1.4 mL, 9.5 mmol, 2.4 equiv) were stirred in DMF (11.5 mL) for 16 hours at 
70 °C in a flame-dried sealed flask under nitrogen atmosphere. Then the reaction mixture was 
cooled down to room temperature and filtered on celite with AcOEt (50 mL). The crude mixture 
was concentrated under reduced pressure and purified by column chromatography, eluting 
with pentane and AcOEt mixture (2:8) to obtain the pure product 10b (0.38 g, 2.7 mmol, 69% 
yield) as a white solid. 
 
RF (AcOEt/pentane (1:1)) = 0.20. 
 
MP 175.2-176.7°C. 
 
1H NMR (400 MHz, Acetone) δ 9.21 (s, 1H, uracil N-H), 7.53 (d, J = 8.1 Hz, 1H, uracil CH), 
7.23 (dd, J = 16.0, 9.0 Hz, 1H, vinyl-CH), 5.86 (dd, J = 8.1, 1.3 Hz, 1H, uracil CH), 5.13 (dd, J 
= 16.0, 2.3 Hz, 1H, vinyl-CH2), 5.00 (dd, J = 9.0, 2.3 Hz, 1H, vinyl-CH2). 
 
13C NMR (101 MHz, Acetone) δ 162.5, 149.3, 139.1, 129.7, 102.8, 99.7. 
 
IR 3015 (w), 2823 (w), 1698 (s), 1640 (s), 1385 (s), 1278 (m), 1203 (m), 827 (s). 
 
HRMS (ESI) calcd for C6H7N2O2+ [M+H]+ 139.0502; found 139.0507. 
 
Tert-butyl 2,6-dioxo-3-vinyl-3,6-dihydropyrimidine-1(2H)-carboxylate (12b). 
 
1-Vinyluracil (10b) (0.25 g, 1.8 mmol, 1.0 equiv), di-tert-butyl dicarbonate (0.78 g, 3.6 mmol, 
2.0 equiv) and dimethylaminopyridine (0.44 g, 3.6 mmol, 2.0 equiv) were stirred in acetonitrile 
(8.5 mL) for 12 h in a flame-dried flask under nitrogen. Silica and triethylamine (0.5 mL) were 
added to the reaction and the solvent was removed under reduced pressure. The dry residue 
was purified by column chromatography eluting with pentane/AcOEt mixture (2:8) as solvent. 
The pure product 12b (0.43 g, 1.8 mmol, quantitative yield) was obtained as a yellow oil. 
 
RF (AcOEt/pentane (1:1)) = 0.40. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.51 (d, J = 8.2 Hz, 1H, uracil CH), 7.15 – 7.02 (m, 1H, 
vinyl-CH), 5.80 (d, J = 8.2 Hz, 1H, uracil CH), 5.14 (dd, J = 16.0, 2.4 Hz, 1H, vinyl-CH2), 4.96 
(dd, J = 9.0, 2.5 Hz, 1H, vinyl-CH2), 1.55 (s, 9H, Boc). 
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13C NMR (101 MHz, Chloroform-d) δ 160.0, 147.5, 147.4, 138.6, 129.5, 103.0, 102.5, 87.0, 
27.4. 
 
IR 3104 (w), 2984 (w), 1783 (s), 1673 (s), 1440 (m), 1372 (s), 1280 (s), 1144 (s), 803 (m). 
 
HRMS (ESI) calcd for C11H14N2NaO4+ [M+Na]+ 261.0846; found 261.0859. 
 
Dimethyl 2-(3-(tert-butoxycarbonyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)cyclopropane-1,1-dicarboxylate (13b). 
 
 
 
Diazomalonate 44 (0.28 g, 1.8 mmol, 1.0 equiv), Rh2(esp)2 (2.7 mg, 3.5 µmol, 0.02 mol%) and 
product 12b (0.42 g, 1.8 mmol, 1.0 equiv) were stirred at room temperature in DCM (18 mL) in 
a flame-dried flask under nitrogen. After 2 hour. NEt3 (0.1 mL) and silica were added and the 
solvent was removed under reduced pressure. The dried residue was purified by column 
chromatography using a mixture of pentane/AcOEt (3:7) as eluting solvent. The pure 
cyclopropane 13b (0.56 g, 1.5 mmol, 87% yield) was obtained as a colorless foam. The 
cyclopropane 13b was obtained in 60% yield over the three steps. 
 
 
RF (AcOEt/pentane (1:1)) = 0.20.  
 
MP 45.0-46.2°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.08 (d, J = 8.1 Hz, 1H, uracil CH), 5.64 (d, J = 8.2 Hz, 
1H, uracil CH), 3.98 (dd, J = 8.2, 6.5 Hz, 1H, cyclopropane-CH), 3.73 (s, 3H, ester CH3), 3.65 
(s, 3H, ester CH3), 2.19 (t, J = 6.6 Hz, 1H, cyclopropane-CH2), 1.88 (dd, J = 8.5, 6.8 Hz, 1H, 
cyclopropane-CH2), 1.51 (s, 9H, Boc). 
 
13C NMR (101 MHz, Chloroform-d) δ 167.5, 166.1, 160.2, 149.1, 147.2, 142.4, 101.9, 87.0, 
53.3, 53.2, 43.0, 34.9, 27.4, 19.8. 
 
IR 1780 (w), 1723 (m), 1676 (s), 1435 (w), 1312 (m), 1145 (s), 733 (s). 
 
HRMS (ESI) calcd for C16H20N2NaO8+ [M+Na]+ 391.1112; found 391.1106. 
 
Dimethyl 2-(4-(2-((tert-butoxycarbonyl)oxy)-1,3-dimethoxy-1,3-dioxopropan-2-yl)-2-
oxopyrimidin-1(2H)-yl)cyclopropane-1,1-dicarboxylate (14). 
 
Dimethyl 2-diazomalonate (44) (0.51 g, 3.2 mmol, 1.2 equiv), Rh2(esp)2 (4 mg, 5 µmol, 0.02 
mol%) and product 12b (0.64 g, 2.7 mmol, 1.0 equiv) were stirred at room temperature in DCM 
(18 mL) in a flame-dried flask under nitrogen. After 2 hour. NEt3 (0.1 mL) and silica were added 
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and the solvent was removed under reduced pressure. The dried residue was purified by 
column chromatography using a mixture of pentane/AcOEt (3:7) as eluting solvent. The pure 
product 14 (0.51 g, 1.0 mmol, 64% yield5) was obtained as white solid and the pure product 
13b (0.33 g, 0.90 mmol, 28% yield) as colorless foam. 
 
RF (AcOEt/pentane (1:1)) = 0.18.  
 
MP 159.1-160.3 °C. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.47 (d, J = 7.4 Hz, 1H, uracil CH), 6.12 (d, J = 7.3 Hz, 
1H, uracil CH), 4.22 (dd, J = 8.2, 6.7 Hz, 1H, cyclopropane-CH), 3.88 (m, 6H, ester CH3), 3.83 
(s, 3H, ester CH3), 3.66 (s, 3H, ester CH3), 2.31 (t, J = 6.7 Hz, 1H, cyclopropane-CH2), 2.00 
(dd, J = 8.2, 6.6 Hz, 1H, cyclopropane-CH2), 1.52 (s, 9H, Boc). 
 
13C NMR (101 MHz, CDCl3) δ 169.0, 167.8, 166.0, 163.0, 160.6, 154.4, 146.6, 94.9, 85.0, 53.8, 
53.1, 53.1, 44.4, 34.9, 27.6, 19.4. Two carbons are not resolved. 
 
IR 3101 (w), 2956 (w), 1737 (s), 1678 (s), 1539 (s), 1455 (m), 1330 (s), 1119 (s), 798 (m). 
 
HRMS (ESI) calcd for C21H27N2O12+ [M+H]+ 499.1559; found 499.1554. 
 
 
5-Fluoro-1-vinylpyrimidine-2,4(1H,3H)-dione (10c). 
 
Palladium acetate (0.013 g, 0.056 mmol, 0.04 equiv), vinyl acetate (11) (1.7 mL, 3.4 mmol, 2.4 
equiv), fluoro-uracil 7c (0.18 g, 1.4 mmol, 1.0 equiv), TMSOTf (0.60 mL, 3.4 mmol, 2.4 equiv) 
and triethylamine (0.47 mL, 3.4 mmol, 2.4 equiv) were stirred in DMF (4 mL) for 16 hours at 
70 °C in a flame-dried sealed flask under nitrogen atmosphere. Then the reaction mixture was 
cooled down to room temperature and filtered on celite with AcOEt (50 mL). The crude mixture 
was concentrated under reduced pressure and purified by column chromatography, eluting 
with pentane and AcOEt mixture (1:1) to obtain the pure product 10c (0.12 g, 0.58 mmol, 57% 
yield) as a white solid. 
 
RF (AcOEt/pentane (6:4)) = 0.51. 
 
MP 135.1-137.0°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.52 (d, J = 5.8 Hz, 1H, F-uracil vinyl-CH ), 7.12 (ddd, J = 
15.9, 9.1, 1.8 Hz, 1H, vinyl-CH), 5.11 – 4.79 (m, 2H, vinyl-CH2). 
 
13C NMR (101 MHz, Chloroform-d) δ 156.1 (d, J = 27.3 Hz), 147.3, 141.1 (d, J = 241.8 Hz), 
129.3, 123.1 (d, J = 34.2 Hz), 101.3. 
 
IR 3031 (w), 2844 (w), 1661 (s), 1377 (s), 1268 (s), 1122 (s), 970 (m), 913 (m). 
 
HRMS (ESI) calcd for C6FH6N2O2+ [M+H]+ 157.0408; found 157.0414. 
 
3-Benzoyl-5-fluoro-1-vinylpyrimidine-2,4(1H,3H)-dione (12c). 
                                                 
5 Yield calculated from diazomalonate. If calculated with uracil as reference; 13b: 33%, 14: 38%. 
10 
 
 
In a flame-dried flask under nitrogen, 1-vinyl-fluorouracil (10c) (0.12 g, 0.79 mmol, 1.0 equiv) 
was stirred with pyridine (2 mL), and added dropwise over 10 min to a solution of benzoyl 
chloride (0.34 g, 2.4 mmol, 3 equiv) in pyridine (0.7 mL) and stirred for 2 h at room temperature. 
Then the crude mixture was partitioned between water (10 mL) and AcOEt (10 mL). The 
aqueous layer was extracted three times with AcOEt (10 mL) and the organic layers were dried 
over anhydrous MgSO4. The solvent was removed under reduced pressure and the dry residue 
was purified by column chromatography using a mixture of pentane/AcOEt (7:3 to 1:1) as 
eluting solvent. The pure product 12c (0.15 g, 0.58 mmol, 73% yield) was obtained as a white 
solid. 
 
RF (AcOEt/pentane (1:1)) = 0.54. 
 
MP 128.6-129.3°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.95 (dd, J = 8.3, 1.4 Hz, 2H, Ar-H), 7.75 – 7.64 (m, 2H, 
Ar-H and F-uracil vinyl-CH), 7.52 (t, J = 7.9 Hz, 2H, Ar-H), 7.12 (ddd, J = 15.9, 9.0, 1.8 Hz, 1H, 
vinyl-CH), 5.13 (dd, J = 15.8, 2.7 Hz, 1H, vinyl-CH2), 4.99 (dd, J = 9.0, 2.8 Hz, 1H, vinyl-CH2). 
 
13C NMR (101 MHz, Chloroform-d) δ 166.8, 155.8 (d, J = 27.5 Hz), 146.8, 140.6 (d, J = 242.6 
Hz), 135.7, 130.7, 130.6, 129.4, 129.0, 123.6 (d, J = 34.2 Hz), 102.2. 
 
IR 1756 (m), 1665 (s), 1448 (w), 1368 (s), 1276 (m), 1229 (m), 909 (m). 
 
HRMS (ESI) calcd for C13H9FN2NaO3+ [M+Na]+ 283.0489; found 283.0485. 
 
Dimethyl 2-(3-benzoyl-5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclopropane-
1,1-dicarboxylate (13c). 
 
Diazomalonate 44 (0.21 g, 1.3 mmol, 1.2 equiv), Rh2(esp)2 (0.002 g, 0.002 mmol, 0.02 mol%) 
and product 12c (0.29 g, 0.11 mmol, 1.0 equiv) were stirred at room temperature in DCM (11 
mL) in a flame-dried flask under nitrogen. After 1 hour, NEt3 (0.1 mL) and silica were added 
and the solvent was removed under reduced pressure. The dried residue was purified by 
column chromatography using a mixture of pentane/AcOEt (3:7) as eluting solvent. The pure 
cyclopropane 13c (0.40 g, 1.0 mmol, 93% yield) was obtained as a white foamy solid. The 
cyclopropane was obtained in 39% yield over the three steps. 
 
RF (AcOEt/pentane (3:7)) = 0.33. 
 
MP 62.7-64.4°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.85 – 7.78 (m, 2H, Ar-H), 7.62 – 7.55 (m, 1H, Ar-H), 7.45 
– 7.39 (m, 2H, Ar-H), 7.32 (d, J = 5.6 Hz, 1H, F-uracil vinyl-CH), 3.89 (dd, J = 8.0, 6.3 Hz, 1H, 
cyclopropane-CH), 3.68 (s, 3H, ester CH3), 3.58 (s, 3H, ester CH3), 2.09 (t, J = 6.5 Hz, 1H, 
cyclopropane-CH), 1.91 (dd, J = 8.1, 6.6 Hz, 1H, cyclopropane-CH). 
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13C NMR (101 MHz, Chloroform-d) δ 167.1, 166.7, 156.0 (d, J = 27.2 Hz), 148.7, 139.7 (d, J = 
240.3 Hz), 135.6, 130.8, 130.7, 129.2, 128.0 (d, J = 33.7 Hz), 53.3, 53.3, 42.9, 34.8, 20.3. 
 
One C=O of methyl-ester is not resolved. 
 
IR 3084 (w), 2953 (w), 1755 (m), 1717 (s), 1440 (m), 1296 (s), 1227 (s), 911 (m), 729 (s). 
 
HRMS (ESI) calcd for C18H15FN2NaO7+ [M+Na]+ 413.0755; found 413.0763. 
 
The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and 
allocated the deposition number: CCDC 99618. 
 
 
2.4 Pyrimidine cyclobutane. 
Dimethyl 2-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclobutane-1,1-
dicarboxylate (16a). 
 
Following an adapted described procedure of De Nanteuil et al.,1c 5-methyl-1-vinylpyrimidine-
2,4(1H,3H)-dione (10a) (0.43 g, 2.9 mmol, 1.0 equiv) and iron trichloride supported on alumina 
(1.0 mmol/g, 0.57 g, 0.57 mmol, 0.2 equiv) were added in a flame dried microwave vial under 
nitrogen atmosphere. Then, dry dichloromethane (7 mL) and a solution of crude freshly 
prepared dimethyl 2-methylenemalonate (14) (0.82 g, 5.7 mmol, 2.0 equiv) in dichloromethane 
(3 mL) were added into the vial and the reaction mixture was stirred at room temperature for 
14 hours. The reaction mixture was filtrated over a pad of alumina eluting with ethyl acetate 
(25 mL) and concentrated under reduced pressure. The crude mixture was purified via column 
chromatography, eluting with a mixture of ethyl acetate/ pentane (6:4 to 9:1). The pure product 
16a (0.36 g, 1.2 mmol, 43% yield) was obtained as a white solid. 
 
RF (Pent/AcOEt (2:8)) = 0.21. 
 
Mp: 180.4- 182.1°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.99 (s, 1H, NH), 7.05 (d, J = 1.3 Hz, 1H, thymine C=C-
H), 5.33 (t, J = 9.2 Hz, 1H, cyclobutane-CH), 3.77 (s, 3H, ester CH3), 3.69 (s, 3H, ester CH3), 
2.79 – 2.67 (m, 2H, cyclobutane-CH2), 2.35 (q, J = 8.5 Hz, 1H, cyclobutane-CH2), 2.27 – 2.16 
(m, 1H, cyclobutane-CH2), 1.93 (d, J = 1.2 Hz, 3H, thymine-CH3). 
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13C NMR (101 MHz, Chloroform-d) δ 170.0, 168.8, 163.9, 151.0, 137.7, 110.3, 59.1, 55.0, 
53.2, 53.1, 23.7, 22.8, 12.5. 
 
IR: 3190 (w), 3034 (w), 2958 (w), 2361 (m), 1733 (s), 1690 (s), 1439 (w), 1278 (m), 1113 (w), 
915 (w), 735 (w). 
 
HRMS (ESI) calcd for C13H16N2NaO6+ [M+Na]+ 319.0901, found 319.0904. 
 
Dimethyl 2-(3-(tert-butoxycarbonyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)cyclobutane-1,1-dicarboxylate (17). 
 
Cyclobutane 16a (0.20 g, 0.68 mmol, 1.0 equiv) and dimethyl-4-aminopyridine (0.12 g, 1.0 
mmol, 1.5 equiv) were dissolved in acetonitrile (3.0 mL) in a flame dried flask under nitrogen 
atmosphere. A solution of di-tert-butyl dicarbonate (0.29 g, 1.4 mmol, 2.0 equiv) in acetonitrile 
(0.5 mL) was added to the reaction mixture and it was stirred at room temperature for 14 hours. 
The solvent was evaporated under reduced pressure and the crude product was purified by 
column chromatography, eluting with a mixture of pentane/ ethyl acetate (8:2 to 6:4). The pure 
product 17 (0.22 g, 0.55 mmol, 81% yield) was obtained as slightly yellow oil. 
 
RF (Pent/AcOEt (4:6)) = 0.28. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.05 (d, J = 1.3 Hz, 1H, thymine C=C-H), 5.25 – 5.18 (m, 
1H, cyclobutane-CH), 3.76 (s, 3H, ester CH3), 3.69 (s, 3H, ester CH3), 2.98 – 2.83 (m, 1H, 
cyclobutane-CH2), 2.83 – 2.72 (m, 1H, cyclobutane-CH2), 2.38 – 2.28 (m, 1H, cyclobutane-
CH2), 2.19 – 2.10 (m, 1H, cyclobutane-CH2), 1.93 (d, J = 1.3 Hz, 3H, thymine-CH3), 1.59 (s, 
9H, Boc). 
 
13C NMR (101 MHz, Chloroform-d) δ 170.2, 168.6, 161.4, 149.2, 147.9, 138.1, 110.1, 86.8, 
59.2, 56.3, 53.3, 53.3, 27.6, 23.7, 23.0, 12.6. 
 
NMR values correspond to the literature.1c 
 
Dimethyl 2-(3-benzoyl-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclobutane-
1,1-dicarboxylate (18a). 
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In a flame dried microwave vial under nitrogen atmosphere, cyclobutane 16a (0.32 g, 1.1 mmol, 
1.0 equiv) and dimethyl-4-aminopyridin (0.13 g, 1.1 mmol, 1.0 equiv) were dissolved in dry 
dichloromethane (10 mL). Then, triethylamine (0.60 mL, 4.3 mmol, 4.0 equiv) was added and 
the solution was cooled to 0°C. Benzoyl chloride (0.38 mL, 3.2 mmol, 3.0 equiv) was added 
dropwise and the reaction mixture was stirred at room temperature for 14 hours. A saturated 
solution of NaHCO3 (8 mL) was added to the reaction mixture and the layers were separated. 
The aqueous layer was extracted with dichloromethane (2 x 20 mL). The combined organic 
layers were washed with 1 M HCl (2 x 40 mL) and with water (30 mL), dried over MgSO4 and 
concentrated under reduce pressure. The crude product was purified by column 
chromatography, eluting with a mixture of pentane/ ethyl acetate (4:6 to 2:8). The pure product 
18a (0.37 g, 0.93 mmol, 86% yield) was obtained as colorless foam. 
 
RF (Pent/AcOEt (4:6)) = 0.32. 
 
Mp: 153.8-155.4°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.96 – 7.90 (m, 2H, Ar-H), 7.65 – 7.59 (m, 1H, Ar-H), 7.50 
– 7.44 (m, 2H, Ar-H), 7.16 (d, J = 1.2 Hz, 1H, thymine C=C-H), 5.17 (t, J = 9.5 Hz, 1H, 
cyclobutane-CH), 3.69 (s, 3H, ester CH3), 3.66 (s, 3H, ester CH3), 2.94 – 2.82 (m, 1H, 
cyclobutane-CH2), 2.74 (td, J = 11.0, 3.1 Hz, 1H, cyclobutane-CH2), 2.35 (dtd, J = 11.6, 8.8, 
3.1 Hz, 1H, cyclobutane-CH2), 2.18 (dt, J = 11.7, 8.9 Hz, 1H, cyclobutane-CH2), 1.95 (d, J = 
1.2 Hz, 3H, thymine-CH3). 
 
13C NMR (101 MHz, Chloroform-d) δ 170.2, 168.9, 168.7, 162.8, 150.1, 138.7, 135.0, 131.6, 
130.7, 129.1, 110.4, 58.8, 56.9, 53.3, 53.2, 23.9, 22.7, 12.6. 
 
IR: 3006 (w), 2959 (w), 2358 (w), 2257 (w), 1737 (s), 1702 (m), 1655 (s), 1438 (m), 1266 (s), 
1107 (m), 984 (w), 914 (w), 733 (s). 
 
HRMS (ESI) calcd for C20H20N2NaO7+ [M+Na]+ 423.1163; found 423.1168. 
 
Dimethyl 2-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclobutane-1,1-
dicarboxylate (16b). 
 
5-Fluoro-1-vinylpyrimidine-2,4(1H,3H)-dione (10b) (0.60 g, 3.8 mmol, 1.0 equiv) and iron 
trichloride supported on alumina (1.0 mmol/g, 0.77 g, 0.77 mmol, 0.2 equiv) were added in a 
flame dried microwave vial under nitrogen atmosphere. Then, dry dichloromethane (8 mL) and 
a solution of crude freshly prepared dimethyl 2-methylenemalonate (14) (2.2 g, 15 mmol, 4.0 
equiv) in dichloromethane (2 mL) were added into the vial and the reaction mixture was stirred 
at room temperature for 14 hours. The reaction mixture was filtrated over a pad of alumina 
eluting with ethyl acetate (50 mL) and concentrated under reduced pressure. The crude 
mixture was purified via column chromatography, eluting with a mixture of ethyl acetate/ 
pentane (5:5 to 2:8). The pure product 16b (0.78 g, 2.6 mmol, 67% yield) was obtained as a 
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colorless oil. 
 
RF (Pent/AcOEt (4:6)) = 0.28. 
 
1H NMR (400 MHz, Chloroform-d) δ 9.54 (s, 1H, NH), 7.36 (d, J = 6.1 Hz, 1H, F-uracil C=C-
H), 5.28 (t, J = 9.0 Hz, 1H, cyclobutane-CH), 3.78 (s, 3H, ester CH3), 3.73 (s, 3H, ester CH3), 
2.68 – 2.61 (m, 2H, cyclobutane-CH2), 2.41 – 2.32 (m, 1H, cyclobutane-CH2), 2.32 – 2.25 (m, 
1H, cyclobutane-CH2). 
 
13C NMR (101 MHz, Chloroform-d) δ 169.7, 168.8, 156.8 (d, J = 26.7 Hz), 149.7, 140.2 (d, J = 
237.5 Hz), 126.3 (d, J = 33.7 Hz), 59.0, 55.2, 53.3, 53.3, 23.7, 23.0. 
 
IR: 3211 (w), 3085 (w), 2960 (w), 2362 (w), 2336 (w), 1726 (s), 1439 (w), 1361 (w), 1273 
(m), 1110 (w), 915 (w), 735 (m). 
 
HRMS (ESI) calcd for C12H13FN2NaO6+ [M+Na]+ 323.0650; found 323.0654. 
 
 
Dimethyl 2-(3-benzoyl-5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclobutane-
1,1-dicarboxylate (18b). 
 
In a flame dried microwave vial under nitrogen atmosphere, 16b (0.70 g, 2.3 mmol, 1.0 equiv) 
and dimethyl-4-aminopyridin (0.28 g, 2.3 mmol, 1.0 equiv) were dissolved in dry 
dichloromethane (12 mL). Triethylamine (1.3 mL, 9.3 mmol, 4.0 equiv) was added and the 
solution was cooled to 0°C. Then, benzoyl chloride (0.81 mL, 6.9 mmol, 3.0 equiv) was added 
dropwise and the reaction mixture was stirred at room temperature for 16 hours. A saturated 
solution of NaHCO3 (8 mL) was added to the reaction mixture and the layer were separated. 
The aqueous layer was extracted with dichloromethane (2 x 20 mL). The combined organic 
layers were washed with 1 M HCl (2 x 40 mL) and with water (30 mL), dried over MgSO4 and 
concentrated under reduce pressure. The pure product 18b (0.61 g, 1.5 mmol, 65%) was 
obtained as colorless foam. 
 
RF (Pent/AcOEt (4:6)) = 0.55. 
 
Mp: 60.9- 62.5°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.93 – 7.89 (m, 2H, Ar-H), 7.66 – 7.59 (m, 1H, Ar-H), 7.50 
– 7.43 (m, 3H, Ar-H and F-uracil C=C-H), 5.12 (t, J = 9.4 Hz, 1H, cyclobutane-CH), 3.69 (s, 
3H, ester CH3), 3.64 (s, 3H, ester CH3), 2.73 (q, J = 10.0 Hz, 1H, cyclobutane-CH2), 2.66 – 
2.58 (m, 1H, cyclobutane-CH2), 2.33 (dtd, J = 10.6, 8.4, 2.4 Hz, 1H, cyclobutane-CH2), 2.23 
(dt, J = 11.6, 8.9 Hz, 1H, cyclobutane-CH2). 
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13C NMR (101 MHz, Chloroform-d) δ 169.8, 168.7, 167.1, 156.3 (d, J = 27.1 Hz), 148.6, 139.8 
(d, J = 239.4 Hz), 135.5, 131.0, 130.9, 129.3, 127.1 (d, J = 33.6 Hz), 58.7, 56.8, 53.4, 53.3, 
23.9, 22.8. 
 
IR: 3090 (w), 3009 (w), 2958 (w), 2361 (w), 2262 (w), 1723 (s), 1668 (s), 1598 (w), 1445 (m), 
1357 (w), 1266 (s), 1106 (m), 982 (w), 912 (m), 851 (w), 732 (s). 
 
HRMS (ESI) calcd for C19H17N2FNaO7+ [M+Na]+ 427.0917; found 427.0920. 
2.5 Purine cyclopropanes. 
 
Dimethyl 2-(6-amino-9H-purin-9-yl)cyclopropane-1,1-dicarboxylate (38a). 
 
Following the procedure described by Geen et al.,6 dry K2CO3 (2.0 g, 14 mmol, 1.5 equiv), 
dimethyl 2-(2-chloroethylidene)malonate (35) (2.0 g, 10.5 mmol, 1.1 equiv), adenine (1.3 g, 9.5 
mmol, 1 equiv) were stirred in a flame dried flask under nitrogen in dry DMF (25 mL) for 16 h. 
The reaction mixture was filtered on cotton with DMF (10 mL) and concentrated under high 
vacuo. The residue was purified by column chromatography using a mixture of pentane AcOEt 
(from 1:1 to 7:3 AcOEt/pentane) to afford the pure cyclopropane 38a (2.2 g, 7.3 mmol, 69% 
yield) as a white powder. 
 
RF (MeOH/DCM (0.5:9.5) = 0.39. 
 
Mp 199.2-202.1 °C. (Decomposition)  
 
 1H NMR (400 MHz, DMSO-d6) δ 8.17 (s, 1H, Adenine CH), 8.15 (s, 1H, Adenine CH), 7.27 (s, 
2H, NH2), 4.48 (dd, J = 8.5, 6.3 Hz, 1H cyclopropane NCH), 3.77 (s, 3H, Me ester), 3.31 (s, 
3H, Me ester), 2.85 (t, J = 6.5 Hz, 1H, cyclopropane CH2), 2.19 – 2.05 (m, 1H, cyclopropane 
CH2). 
 
13C NMR (101 MHz, DMSO) δ 168.2, 165.9, 156.4, 152.9, 150.9, 140.9, 119.1, 53.4, 52.9, 
37.9, 35.2, 18.4. 
 
IR 3434 (w), 3083 (w), 3001 (w), 1719 (s), 1602 (s), 1431 (m), 1299 (s), 1200 (s), 893 (w), 768 
(w). 
 
HRMS (ESI) calcd for C12H14N5O4+ [M+H]+ 292.1040; found 292.1045 
 
Dimethyl 2-(2-amino-6-chloro-9H-purin-9-yl)cyclopropane-1,1-dicarboxylate (38b). 
 
Following the procedure described by Geen et al.6, dry K2CO3 (3.42 g, 24.8 mmol, 1.5 equiv), 
dimethyl 2-(2-chloroethylidene)malonate (35) (3.50 g, 18.2 mmol, 1.1 equiv) and 6-chloro-7H-
                                                 
6 G. R. Geen, P. M. Kincey, B. M. Choudary, Tetrahedron Lett. 1992, 33, 4609–4612. 
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purin-2-amine (2.80 g, 1.5 mmol, 1 equiv) were stirred in a flame dried flask under nitrogen in 
dry DMF (28 mL) for 16 h. The reaction mixture was filtered on cotton with DMF (10 mL) and 
concentrated under high vacuo. The residue was purified by column chromatography using a 
mixture of dichloromethane methanol (from pure dichloromethane to 8:2 
dichloromethane/methanol) to afford the pure cyclopropane 38b (4.30 g, 13.2 mmol, 51% 
yield) as a white powder. 
 
RF (MeOH/DCM (1:9) = 0.56.  
 
MP 215.3-218.6 °C. (Decomposition)  
 
1H NMR (400 MHz, DMSO-d6) δ 8.16 (s, 1H, purine CH), 7.05 (s, 2H, NH2), 4.41 (dd, J = 8.6, 
6.3 Hz, 1H, cyclopropane NCH), 3.38 (s, 3H, Me ester), 3.34 (s, 3H, Me ester), 2.82 (t, J = 6.5 
Hz, 1H, cyclopropane CH2), 2.10 (dd, J = 8.6, 6.7 Hz, 1H, cyclopropane CH2).  
 
13C NMR (101 MHz, DMSO) δ 168.1, 165.8, 160.4, 155.4, 149.8, 143.0, 123.6, 53.5, 53.1, 
37.8, 35.2, 18.5. 
 
IR 3436 (w), 3163 (w), 1725 (s), 1563 (s), 1288 (s), 1210 (s), 1108 (s), 911 (s), 787 (w), 716 
(m). 
 
HRMS (ESI) calcd for C12H13ClN5O4+ [M+H]+ 326.0651; found 326.0654. 
 
Dimethyl 2-(6-chloro-9H-purin-9-yl)cyclopropane-1,1-dicarboxylate (38c). 
 
Following the procedure described by Geen et al.,6 dry K2CO3 (5.7 g, 41 mmol, 1.5 equiv), 
dimethyl 2-(2-chloroethylidene)malonate (35) (5.8 g, 30 mmol, 1.1 equiv) and 6-chloro-purine 
(4.22 g, 27.3 mmol, 1 equiv) were stirred in a flame dried flask under nitrogen in dry DMF (55 
mL) for 16 h. The reaction mixture was filtered on cotton with DMF (10 mL) and concentrated 
under high vacuo. The residue was purified by column chromatography using a mixture of 
dichloromethane methanol (from pure dichloromethane to 8:2 dichloromethane/methanol) to 
afford the pure cyclopropane 38c (2.5g, 8.1 mmol, 30% yield) as foam. 
 
RF (AcOEt/pentane (7:3) = 0.31 
 
MP 120.1-123.6 °C.  
 
1H NMR (400 MHz, Chloroform-d) δ 8.77 (s, 1H, purine CH), 8.10 (s, 1H, purine CH), 4.49 (dd, 
J = 8.4, 6.2 Hz, 1H, cyclopropane NCH), 3.87 (s, 3H, Me ester), 3.47 (s, 3H, Me ester), 2.82 
(t, J = 6.4 Hz, 1H, cyclopropane CH2), 2.18 (dd, J = 8.4, 6.7 Hz, 1H, cyclopropane CH2). 
 
13C NMR (101 MHz, CDCl3) δ 167.7, 165.4, 152.6, 152.5, 151.4, 145.1, 131.5, 53.5, 53.3, 37.7, 
35.0, 19.2. 
 
IR 2938.34 (w), 1729 (s), 1603 (w), 1333 (s), 1230 (s), 1204 (s), 1142 (s), 941 (m). 
 
HRMS (ESI) calcd for C12H12ClN4O4+ [M+H]+ 311.0542; found 311.0542. 
 
Dimethyl 2-(6-amino-9H-purin-9-yl)cyclopropane-1,1-dicarboxylate (38d). 
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Following the procedure described by Geen et al.6, dry K2CO3 (1.2 g, 8.9 mmol, 1.5 equiv), 
dimethyl 2-(2-chloroethylidene)pentylmalonate (37) (3.0 g, 6.5 mmol, 1.1 equiv, 66% Wt) and 
adenine (0.80 g, 5.9 mmol, 1 equiv) were stirred in a flame dried flask under nitrogen in dry 
DMF (11 mL) for 16 h. The reaction mixture was filtered on cotton with DMF (5 mL) and 
concentrated under high vacuo. The residue was purified by column chromatography using a 
mixture of dichloromethane methanol (from pure dichloromethane to 9.8:0.2 
dichloromethane/methanol) to afford the pure cyclopropane 38d (2.22 g, 5.49 mmol, 93% 
yield) as a white sticky powder. 
 
RF (MeOH/DCM (0.2:9.8) = 0.51. 
 
Mp 68.2-70.0 °C.  
 
1H NMR (400 MHz, DMSO-d6) δ 8.15 (s, 2H, adenine CH), 7.26 (s, 2H, adenine NH2), 4.46 
(dd, J = 8.6, 6.3 Hz, 1H, cyclopropane NCH), 4.27 – 4.18 (m, 2H, pentyl CH2), 3.70 (td, J = 6.4, 
4.6 Hz, 2H, pentyl CH2), 2.86 (t, J = 6.5 Hz, 2H, cyclopropane CH2), 2.05 (dd, J = 8.7, 6.7 Hz, 
2H, cyclopropane CH2), 1.71 – 1.49 (m, 2H, pentyl CH2), 1.31 (ddt, J = 18.8, 7.9, 4.0 Hz, 4H, 
pentyl CH2), 1.02 – 0.81 (m, 5H, pentyl CH2 and pentyl CH3), 0.78 (t, J = 7.3 Hz, 3H, pentyl 
CH3). 
 
13C NMR (101 MHz, DMSO) δ 167.9, 165.4, 156.4, 153.1, 151.0, 140.6, 119.2, 66.0, 65.7, 
37.8, 35.7, 28.1, 27.9, 27.7, 27.5, 22.2, 22.0, 18.0, 14.3, 14.1. 
 
IR 3312 (w), 3135 (w), 2958 (m), 1726 (s), 1601 (m), 1471 (m), 1294 (s), 1197 (s), 967 (m), 
735 (m). 
 
HRMS (ESI) calcd for C20H30N5O4+ [M+H]+ 404.2292; found 404.2300. 
 
Dipentyl 2-(2-amino-6-chloro-9H-purin-9-yl)cyclopropane-1,1-dicarboxylate (38e). 
 
 
Following the procedure described by Geen et al.6, dry K2CO3 (0.71 g, 5.1 mmol, 1.5 equiv), 
dimethyl 2-(2-chloroethylidene)pentylmalonate (37) (2.87 g, 3.77 mmol, 1.1 equiv, 40% Wt) 
and 6-chloro-7H-purin-2-amine (0.58 g, 3.4 mmol, 1 equiv) were stirred in a flame dried flask 
under nitrogen in dry DMF (7 mL) for 16 h. The reaction mixture was filtered on cotton with 
DMF (2 mL) and concentrated under high vacuo. The residue was purified by column 
chromatography using a mixture of dichloromethane methanol (from pure dichloromethane to 
9.8:0.2 dichloromethane/methanol) to afford the pure cyclopropane 38e (1.35 g, 3.08 mmol, 
90% yield) as a white powder. 
 
RF (MeOH/DCM (0.5:9.5) = 0.47. 
 
Mp 127.1-128.3 °C. (Decomposition) 
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1H NMR (400 MHz, Chloroform-d) δ 8.13 (s, 1H, purine CH), 7.04 (s, 2H, purine NH2), 4.37 
(dd, J = 8.6, 6.3 Hz, 1H, cyclopropane NCH), 4.26 – 3.99 (m, 2H, pentyl CH2), 3.75 (td, J = 6.5, 
2.5 Hz, 2H, pentyl CH2), 2.82 (t, J = 6.5 Hz, 1H, cyclopropane CH2), 2.01 (dd, J = 8.6, 6.8 Hz, 
1H, cyclopropane CH2), 1.61 (dd, J = 9.2, 4.9 Hz, 2H, pentyl CH2), 1.31 (h, J = 3.7 Hz, 4H, 
pentyl CH2), 1.10 (dq, J = 14.3, 7.3, 6.6 Hz, 4H, pentyl CH2), 0.99 – 0.81 (m, 5H, pentyl CH2 
and pentyl CH3), 0.77 (t, J = 7.3 Hz, 3H, pentyl CH3). 
 
13C NMR (101 MHz, CDCl3) δ 172.7, 170.1, 165.1, 160.2, 154.6, 147.4, 128.5, 70.9, 70.6, 42.4, 
40.5, 32.8, 32.7, 32.5, 32.3, 26.9, 26.8, 22.7, 19.0, 18.8. 
 
IR 3441 (w), 3305 (w), 3201 (w), 2955 (w), 1699 (m), 1641 (s), 1560 (m), 1479 (w), 1309 (s), 
1222 (s), 1186 (m), 959 (m), 912 (m), 785 (w). 
 
HRMS (ESI) calcd for C20H28ClN5NaO4 [M+Na] 460.1727; found 460.1727. 
 
Dipentyl 2-(6-chloro-9H-purin-9-yl)cyclopropane-1,1-dicarboxylate (38f). 
 
 
Following the procedure described by Geen et al.6, dry K2CO3 (1.99 g, 14.4 mmol, 1.5 equiv), 
dimethyl 2-(2-chloroethylidene)pentylmalonate (37) (6.5 g, 11 mmol, 1.1 equiv, 50% Wt) and 
6-chloro-purine (1.5 g, 9.6 mmol, 1 equiv) were stirred in a flame dried flask under nitrogen in 
dry DMF (20 mL) for 16 h. The reaction mixture was filtered on cotton with DMF (10 mL) and 
concentrated under high vacuo. The residue was purified by column chromatography using a 
mixture of AcOEt pentane (from 1:1 to 7:3 AcOEt/pentane) to afford the pure cyclopropane 38f 
(2.5 g, 5.9 mmol, 62% yield) as a yellow oil. 
 
RF (pentane/AcOEt (8:2) = 0.18. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.80 (s, 1H, purine CH), 8.12 (s, 1H, purine CH), 4.52 (dd, 
J = 8.4, 6.2 Hz, 1H, cyclopropane NCH), 4.32 (dt, J = 10.8, 6.8 Hz, 1H, pentyl CH2), 4.25 (dt, 
J = 10.7, 6.7 Hz, 1H, pentyl CH2), 3.87 (ddt, J = 33.9, 10.8, 6.7 Hz, 2H, pentyl CH2), 2.84 (t, J 
= 6.4 Hz, 1H, cyclopropane CH2), 2.17 (dd, J = 8.4, 6.6 Hz, 1H, cyclopropane CH2), 1.44 – 
1.26 (m, 4H, pentyl CH2), 1.26 – 1.17 (m, 2H, pentyl CH2), 1.14 – 1.04 (m, 2H, pentyl CH2), 
0.99 – 0.90 (m, 5H, pentyl CH2 and pentyl CH3), 0.85 (t, J = 7.3 Hz, 3H, pentyl CH3). 
 
13C NMR (101 MHz, CDCl3) δ 167.5, 165.0, 152.7, 152.4, 151.3, 145.0, 131.5, 66.7, 66.5, 37.5, 
35.52, 28.1, 27.9, 27.8, 27.6, 22.2, 22.1, 18.8, 13.9, 13.8.  
 
IR 2953 (w), 2866 (w), 1723 (s), 1587 (w), 1563 (m), 1284 (s), 1201 (s), 1134 (s), 958 (m). 
 
HRMS (ESI) calcd for C20H28ClN4O4+ [M+H]+ 423.1794; found 423.1794. 
 
Dimethyl 2-(2-ditButylcarboxylate-amino-6-chloro-9H-purin-9-yl)cyclopropane-1,1-
dicarboxylate (39). 
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Cyclopropane 38b (0.050 g, 0.15 mmol, 1.0 equiv), di-tert-butyl dicarbonate (0.14 g, 0.66 
mmol, 4.3 equiv) and dimethylaminopyridine (1.8 mg, 0.015 mmol, 0.1 equiv) were stirred in 
acetonitrile (2.5 mL) for 5 h in a flame-dried flask under nitrogen.  After removal of the solvent, 
EtOAc (10 mL) was added and the solution was washed with 1 N HCl (3 mL) and then with 
brine (3 x 10 mL). Then the mixture was dried over anhydrous MgSO4, filtered and 
concentrated. Then the crude residue was purified by column chromatography using a mixture 
of pentane and ethyl acetate (from 90:10 to 70:30 pentane/ ethyl acetate) affording the pure 
product 39 (0.069 g, 0.13 mmol, 85% yield, 90% purity) as a slightly yellow sticky oil. 
 
RF (Pent/AcOEt (7:3) = 0.41. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.04 (s, 1H, purine CH), 4.38 (dd, J = 8.4, 6.1 Hz, 1H, 
cyclopropane NCH), 3.78 (s , 3H, Me ester), 3.43 (s, 3H, Me ester), 2.73 (t, J = 6.4 Hz, 1H, 
cyclopropane CH2), 2.10 (m, 1H, cyclopropane CH2), 1.39 (m, 18H, Boc). 
 
13C NMR (101 MHz, CDCl3) δ 167.6, 165.2, 153.4, 152.3, 151.4, 150.4, 145.8, 129.7, 83.7, 
53.4, 53.2, 37.6, 35.0, 27.8, 19.1. 
Boc carbon peaks are superposed (Methyls, quaternary carbons and C=O.) 
 
IR 3546 (w), 3117 (w), 2981 (w), 1792 (m), 1730 (s), 1568 (m), 1280 (s), 1103 (s), 856 (m), 
779 (m). 
 
HRMS (ESI) calcd for C22H28ClN5NaO8+ [M+Na]+ 548.1519; found 548.1515. 
 
 2.5 Dipolarophiles. 
Triisopropyl((1-phenylvinyl)oxy)silane (21). 
 
Acetophenone (20) (1.0 g, 8.3 mmol, 1 equiv) was solubilized in DCM (8 mL) and triethylamine 
(1.73 mL, 12.5 mmol, 1.5 equiv) was added at room temperature. Then at 0 °C triisopropylsilyl 
trifluoromethanesulfonate (2.7 mL, 10 mmol, 1.2 equiv) was added dropwise and the reaction 
mixture was stirred at room temperature for 8 h. The solvent was evaporated under a flow of 
nitrogen. The crude product was purified by column chromatography, eluting with pentane and 
1% NEt3 to obtain the pure enol-ether 21 (2.0 g, 7.2 mmol, 86% yield) as a colorless oil. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.70 – 7.64 (m, 2H, Ar-H), 7.41 – 7.27 (m, 3H, Ar-H), 4.87 
(d, J = 1.8 Hz, 1H, C=CH2), 4.44 (d, J = 1.9 Hz, 1H, C=CH2), 1.33 (m, 3H, TIPS-CH), 1.16 (m, 
18H, TIPS-CH3). 
 
1H NMR values correspond to the literature.1 
 
((1-(4-Fluorophenyl)vinyl)oxy)triisopropylsilane (49). 
 
(4-Fluorophenyl)ethanone (48) (0.44 mL, 3.6 mmol, 1equiv) was solubilized in THF (15 mL) at 
-78 °C and NaHMDS (2M solution in THF, 2.1 mL, 4.1 mmol, 1.1 equiv) was added dropwise. 
The mixture was stirred 1 hour at room temperature and cooled down to -78 °C. TIPS-Cl (0.86 
mL, 4.1 mmol, 1.1 equiv) was added dropwise and the reaction mixture was stirred at room 
temperature for 8 h. The solvent was evaporated and the crude product was purified by column 
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chromatography, eluting with pentane and 1% NEt3 to obtain the pure enol-ether 49 (0.62 g, 
2.1 mmol, 58% yield) as a slightly yellow oil. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.61 (dd, J = 8.9, 5.4 Hz, 2H, Ar-H), 7.00 (t, J = 8.8 Hz, 
2H, Ar-H), 4.77 (d, J = 1.9 Hz, 1H, C=CH), 4.39 (d, J = 1.9 Hz, 1H, C=CH), 1.39 – 1.20 (m, 
3H, TIPS-CH), 1.34-1.12 (m, 18H, TIPS-CH3 ).  
 
1H NMR values correspond to the literature.1 
 
(E)-Triisopropyl((4-phenylbuta-1,3-dien-2-yl)oxy)silane (51). 
 
(E)-4-Phenylbut-3-en-2-one (50) (0.42 g, 2.9 mmol, 1 equiv) was solubilized in DCM (3 mL) 
and triethylamine (0.60 mL, 4.3 mmol, 1.5 equiv) was added at room temperature. Then 
triisopropylsilyl trifluoromethanesulfonate (0.93 mL, 3.4 mmol, 1.2 equiv) was added at 0 °C 
dropwise and the reaction mixture was stirred at room temperature for 8 h. The solvent was 
evaporated under a flow of nitrogen. The crude product was purified by column 
chromatography, eluting with pentane and 1% NEt3 to obtain the pure enol ether 51 (0.87 g, 
2.9 mmol, quantitative yield) as a colorless oil. 
 
RF (pentane) = 0.88. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.64 – 7.54 (m, 2H, Ar-H), 7.45 (m, 2H, Ar-H), 7.40 – 7.32 
(m, 1H, Ar-H), 7.15 (d, J = 15.6 Hz, 1H, C=CH), 6.74 (d, J = 15.7 Hz, 1H, C=CH), 4.61 – 4.59 
(s, 1H, C=CH2), 4.58 (s, 1H, C=CH2), 1.54 – 1.42 (m, 3H, TIPS-CH), 1.34 (d, J = 7.8 Hz, 18H, 
TIPS-CH3). 
 
13C NMR (101 MHz, Chloroform-d) δ 155.6, 137.1, 129.4, 128.7, 127.8, 126.9, 126.7, 95.9, 
18.3, 13.1.  
 
IR 4319 (w), 4056 (w), 2945 (m), 2867 (m), 1638 (w), 1464 (m), 1327 (s), 1026 (s), 883 (s). 
 
HRMS (ESI) calcd for C19H31OSi+ [M+H]+ 303.2139; found 303.2140. 
 
(Z)-Triisopropyl((1-phenylprop-1-en-1-yl)oxy)silane (53). 
 
Propiophenone (52) (0.50 mL, 3.7 mmol, 1 equiv) was solubilized in THF (15 mL) at -78 °C 
and NaHMDS (2 M solution in THF, 2.1 mL, 4.1 mmol, 1.1 equiv) was added dropwise. The 
mixture was stirred 1 hour at room temperature and cooled down to -78 °C. TIPS-Cl (0.86 mL, 
4.1 mmol, 1.1 equiv) was added dropwise and the reaction mixture was stirred at room 
temperature for 8 h. The solvent was evaporated and the crude product was purified by column 
chromatography, eluting with pentane and 1% NEt3 to obtain the pure enol-ether 53 (0.46 g, 
1.6 mmol, 43% yield) as a slightly yellow oil. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.50 – 7.38 (m, 2H, Ar-H), 7.33 – 7.18 (m, 3H, Ar-H), 5.06 
(q, J = 6.8 Hz, 1H, C=C), 1.77 (d, J = 6.9 Hz, 3H, CH3), 1.15 – 0.97 (m, 21H, TIPS). 
 
1H NMR values correspond to the literature.1 
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3. Scope of the reaction [3+2] reaction. 
3.1 From thymine cyclopropanes. 
 
General procedures for annulation reaction 
 
a) Conditions A 
Dimethyl 2-(3-(tert-butoxycarbonyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)cyclopropane-1,1-dicarboxylate (13a) (0.15 g, 0.40 mmol 1.0 equiv), aldehyde (0.48 mmol, 
1.2 equiv) and In(OTf)3 (0.045 g, 0.080 mmol, 0.2 equiv) were stirred under nitrogen in a flame-
dried sealed microwave vial with anhydrous DCM (2.0 mL) at room temperature for 2 h. Then, 
NEt3 (0.9 mL) was added to quench the reaction and the crude mixture was concentrated under 
reduced pressure. After a rapid filtration on a silica plug with AcOEt and removal of the solvent, 
the crude product was heated at 70 °C in EtOH (3 mL) in a sealed microwave vial for 18 h. The 
mixture was concentrated under reduced pressure and purified by column chromatography 
with a gradient mixture of pentane/AcOEt from 7:3 up to 1:1 and the column was washed with 
straight AcOEt. 
b) Conditions B 
Dimethyl 2-(3-(tert-butoxycarbonyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)cyclopropane-1,1-dicarboxylate (13a) (0.15 g, 0.40 mmol 1.0 equiv) and the ketone or 
sillylenol ether (0.48 mmol, 1.2 equiv) were stirred under nitrogen in a flame-dried sealed 
microwave vial with anhydrous DCM (2.0 mL) and cooled down to -20 °C. Then, a 0.43 M 
tin(IV) chloride solution (0.09 mL, 0.04 mmol, 0.1 equiv) was added and the reaction mixture 
was stirred for 2 h at -20 °C. NEt3 (0.9 mL) was added at -20 °C to quench the reaction and the 
reaction mixture was allowed to reach room temperature. The crude mixture was concentrated 
under reduced pressure. After a rapid filtration on a silica plug with AcOEt and removal of the 
solvent, the crude product was heated at 70 °C in EtOH (3 mL) in a sealed microwave vial for 
18 h. The mixture was concentrated under reduced pressure and purified by column 
chromatography with a gradient mixture of pentane/AcOEt from 7:3 up to 1:1 and the column 
was washed with straight AcOEt. 
 
Dimethyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyldihydrofuran-
3,3(2H)-dicarboxylate (22b). 
 
Following the conditions A, using benzaldehyde (19) (0.051 g, 0.48 mmol, 1.2 equiv), the pure 
product 22b (0.14 g, 0.35 mmol, 87% yield) was obtained as a white foamy solid. 
 
RF (pent/AcOEt (1:1)) = 0.64.  
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MP 206.9-208.1 °C. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.47 (s, 1H, thymine NH), 7.94 (d, J = 1.6 Hz, 1H, thymine 
vinyl-CH), 7.48 – 7.40 (m, 2H, Ar-H), 7.40 – 7.27 (m, 3H, Ar-H), 6.37 (t, J = 7.6 Hz, 1H, 
tetrahydrofuran-NCH), 5.61 (s, 1H, tetrahydrofuran-CH), 3.81 (s, 3H, ester methyl), 3.13 (s, 
3H, ester methyl), 2.95 (dd, J = 14.5, 7.6 Hz, 1H, tetrahydrofuran-CH2), 2.78 (dd, J = 14.5, 7.7 
Hz, 1H, tetrahydrofuran-CH2), 2.06 (d, J = 1.3 Hz, 3H, thymine methyl). 
 
13C NMR (101 MHz, Chloroform-d) δ 169.9, 169.8, 163.3, 150.4, 135.9, 135.3, 128.7, 128.1, 
126.5, 112.1, 82.4, 81.4, 63.8, 53.1, 52.7, 39.0, 12.8. 
 
IR 3192 (w), 3069 (w), 1729 (s), 1695 (s), 1512 (m), 1281 (s), 1225 (m), 1094 (m), 1054 (m), 
915 (m). 
 
HRMS (ESI) calcd for C19H20N2NaO7+ [M+Na]+ 411.1163; found 411.1168. 
 
Dimethyl-2-(4-fluorophenyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)dihydrofuran-3,3(2H)-dicarboxylate (22c). 
 
Following the conditions A, using 4-fluorobenzaldehyde (0.060 g, 0.48 mmol, 1.2 equiv), the 
pure product 22c (0.13 g, 0.32 mmol, 79% yield) was obtained as a slightly yellow solid. 
 
RF (pent/AcOET (1:1)) = 0.63. 
 
MP 218.8-220.3 °C. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.54 – 8.46 (m, 1H, thymine NH), 7.93 (d, J = 1.5 Hz, 1H, 
thymine vinyl-CH), 7.49 – 7.39 (m, 2H, Ar-H), 7.10 – 6.99 (m, 2H, Ar-H), 6.37 (t, J = 7.6 Hz, 
1H, tetrahydrofuran-NCH), 5.56 (s, 1H, tetrahydrofuran-CH), 3.81 (s, 3H, ester methyl), 3.20 
(s, 3H, ester methyl), 2.93 (dd, J = 14.6, 7.5 Hz, 1H, tetrahydrofuran-CH2), 2.77 (dd, J = 14.6, 
7.8 Hz, 1H, tetrahydrofuran-CH2), 2.05 (d, J = 1.2 Hz, 3H, thymine methyl). 
 
13C NMR (101 MHz, Chloroform-d) δ 169.8, 162.9 (d, J = 249 Hz), 150.4, 135.8, 131.0 (d, J = 
3.2 Hz), 128.5 (d, J = 8.2 Hz), 128.4, 115.2 (d, J = 21.6 Hz), 115,0, 112.2, 81.7, 81.2, 63.6, 
53.2, 52.9, 38.8, 12.8. 
 
IR 3192 (w), 3069 (w), 1729 (s), 1695 (s), 1512 (m), 1281 (s), 1225 (m), 1094 (m), 1054 (m), 
915 (m). 
 
HRMS (ESI) calcd for C19H19FN2NaO7+ [M+Na]+ 429.1068; found 429.1055. 
 
The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and 
allocated the deposition number: CCDC 995573. 
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Dimethyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-((E)-
styryl)dihydrofuran-3,3(2H)-dicarboxylate. (22d) 
 
 
 
Following the conditions A, using cinnamaldehyde (0.063 g, 0.48 mmol, 1.2 equiv), a mixture 
of diastereoisomers (5:1 by integration of methyl esters at 3.76 ppm and 3.71 ppm) 22d (0.16 
g, 0.28 mmol, 96% yield) was obtained as a colorless foam. 
 
RF (pent/AcOET (1:1)) = 0.67. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.82 (s, 1H, NH), 7.70 (d, J = 1.3 Hz, 1H, thymine vinyl-
CH, major diastereoisomer), 7.35 – 7.17 (m, 10H, Ar-H, both diastereoisomers), 7.14 (d, J = 
1.3 Hz, 1H, thymine vinyl-CH, minor diastereoisomer), 6.72 (dd, J = 16.0, 1.3 Hz, 1H vinyl C-
H, major and minor diastereoisomers), 6.20 (t, J = 7.3 Hz, 1H, tetrahydrofuran-NCH, major 
diastereoisomer), 6.16-6.05 (m, 2H, vinyl C-H and tetrahydrofuran-NCH, minor 
diastereoisomer), 6.11(dd, J = 16.0, 6.2 Hz, 1H, vinyl C-H, major diastereoisomer), 5.49 (dd, J 
= 6.2, 1.4 Hz, 1H, tetrahydrofuran-CH, minor diastereoisomer), 5.04 (dd, J = 6.3, 1.4 Hz, 1H, 
tetrahydrofuran-CH2, major diastereoisomer), 3.76 (s, 3H, ester methyl, major 
diastereoisomer), 3.71 (s, 3H, ester methyl, minor diastereoisomer), 3.59 (s, 6H, ester methyl, 
minor and major diastereoisomers), 3.24 (dd, J = 14.3, 6.8 Hz, 1H, tetrahydrofuran-CH2, minor 
diastereoisomer), 2.82 – 2.69 (m, 2H, tetrahydrofuran-CH2, major diastereoisomer), 2.58 (dd, 
J = 14.3, 5.4 Hz, 1H, tetrahydrofuran-CH2, minor diastereoisomer), 1.93 (d, J = 1.3 Hz, 3H, 
thymine methyl, major diastereoisomer), 1.88 (d, J = 1.2 Hz, 3H, thymine methyl minor 
diastereoisomer). 
 
13C NMR (101 MHz, Chloroform-d) δ 169.6, 169.5, 169.1, 169.1, 168.1, 163.6, 150.5, 150.1, 
135.9, 133.7, 133.2, 128.7, 128.4, 128.3, 126.7, 126.7, 123.1, 122.3, 111.7, 110.7, 83.8, 82.2, 
81.5, 64.1, 62.8, 53.3, 53.2, 53.1, 39.7, 38.9, 12.8, 12.6. 
One carbon of the major diastereoisomer in the aromatic region is unresolved. 
Six carbons of the minor diastereoisomer are unresolved. 
 
IR 3201 (w), 3073 (w), 2953 (w), 1731 (s), 1688 (s), 1468 (m), 1435 (m), 1284 (s), 1085 (s), 
972 (m), 913 (m), 734 (s). 
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HRMS (ESI) calcd for C21H23N2O7+ [M+H]+ 415.1500; found 415.1502. 
 
Dimethyl 2-isopropyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)dihydrofuran-3,3(2H)-dicarboxylate (22e). 
 
 
Following the conditions A, using isobutyraldehyde (0.035 g, 0.48 mmol, 1.2 equiv), the pure 
product 22e (0.11 g, 0.30 mmol, 75% yield) was obtained as a colorless foam. 
 
RF (AcOEt/pent (1:1)) = 0.42. 
 
MP 157.7-160.8 °C. 
 
1H NMR (400 MHz, Chloroform-d) δ 9.45 (s, 1H, N-H), 7.62 (d, J = 1.5 Hz, 1H, thymine vinyl-
CH), 6.12 (t, J = 7.1 Hz, 1H, tetrahydrofuran-NCH), 4.14 (d, J = 7.8 Hz, 1H, tetrahydrofuran-
OCH), 3.80 (s, 3H, ester methyl), 3.78 (s, 3H, ester methyl), 2.70 (dd, J = 14.5, 6.5 Hz, 1H, 
tetrahydrofuran-CH2), 2.63 (dd, J = 14.5, 7.6 Hz, 1H, tetrahydrofuran-CH2), 1.98 (d, J = 1.3 Hz, 
3H, thymine methyl), 1.92 (dt, J = 13.7, 7.0 Hz, 1H, iso-propyl C-H), 1.03 (t, J = 6.8 Hz, 6H, 
iso-propyl CH3). 
 
13C NMR (101 MHz, Chloroform-d) δ 170.5, 170.1, 163.9, 150.7, 135.9, 111.1, 87.2, 81.4, 60.6, 
53.0, 41.3, 30.0, 20.1, 19.5, 12.7. 
 
IR 3194 (w), 2960 (w), 2929 (w), 1730 (s), 1683 (s), 1468 (m), 1436 (m), 1275 (s), 1237 (m), 
1205 (m), 1081 (m), 916 (m), 733 (s). 
 
HRMS (ESI) calcd for C16H23N2O7+ [M+H]+ 355.1500; found 355.1502. 
 
Dimethyl-2-methyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-
phenyldihydrofuran-3,3(2H)-dicarboxylate (23b). 
 
Following the conditions B, using acetophenone (20) (0.058 g, 0.48 mmol, 1.2 equiv), the pure 
product 23b (0.15 g, 0.38 mmol, 94% yield) was obtained as a white solid. 
 
RF (AcOEt/pent (1:1)) = 0.36. 
 
MP 246.8-247.3°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.59 (s, 1H, thymine NH), 8.18 (d, J = 1.7 Hz, 1H, thymine 
vinyl-CH), 7.72 – 7.65 (m, 2H, Ar-H), 7.38 – 7.24 (m, 3H, Ar-H), 6.43 (dd, J = 8.2, 5.6 Hz, 1H, 
tetrahydrofuran-NCH), 3.79 (s, 3H, ester methyl), 3.16 (s, 3H, ester methyl), 3.11 (dd, J = 15.0, 
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8.2 Hz, 1H, tetrahydrofuran-CH2) 2.77 (dd, J = 14.9, 5.5 Hz, 1H, tetrahydrofuran-CH2) 2.04 (d, 
J = 1.3 Hz, 3H, thymine methyl), 1.86 (s, 3H, tetrahydrofuran methyl). 
 
13C NMR (101 MHz, Chloroform-d) δ 170.4, 168.8, 163.6, 150.7, 140.5, 136.9, 127.9, 127.8, 
125.8, 110.9, 88.0, 80.7, 67.1, 52.8, 52.6, 39.6, 25.7, 12.8. 
 
IR 1733 (m), 1706 (m), 1663 (m), 1272 (s), 1207 (w), 1126 (w), 1077 (w). 
 
HRMS (ESI) calcd for C20H22NNaO7+ [M+Na]+ 425.1319; found 425.1320. 
 
Dimethyl-2-(4-fluorophenyl)-2-methyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-
1(2H)-yl)dihydrofuran-3,3(2H)-dicarboxylate (23c). 
 
Following the conditions B, using 4-fluoroacetophenone (0.067 g, 0.48 mmol, 1.2 equiv), the 
pure product 23c (0.16 g, 0.37 mmol, 93% yield) was obtained as a white solid. 
 
RF (AcOEt/pent (1:1)) = 0.40. 
 
MP 248.8-250.2 °C. 
 
1H NMR (400 MHz, DMSO-d6) δ 11.47 (s, 1H, thymine NH), 8.07 (d, J = 1.5 Hz, 1H, thymine 
vinyl-CH), 7.70 – 7.60 (m, 2H, Ar-H), 7.20 (t, J = 8.9 Hz, 2H, Ar-H), 6.36 (dd, J = 8.3, 5.5 Hz, 
1H, tetrahydrofuran-NCH), 3.75 (s, 3H, ester methyl), 3.26 (dd, J = 14.9, 8.3 Hz, 1H, , 
tetrahydrofuran-CH2), 3.13 (s, 3H, ester methyl), 2.71 (dd, J = 14.9, 5.6 Hz, 1H, , 
tetrahydrofuran-CH2), 1.87 (d, J = 1.2 Hz, 3H, thymine methyl), 1.79 (s, 3H, tetrahydrofuran 
methyl). 
 
13C NMR (101 MHz, DMSO-d6) δ 170.6, 168.9, 164.1, 161.9 (d, J = 243.9 Hz), 151.1, 137.4 
(d, J = 3.0 Hz), 136.7, 128.4 (d, J = 8.2 Hz), 114.9 (d, J = 21.3 Hz), 109.9, 87.1, 80.6, 67.2, 
53.3, 53.0, 38.5, 25.9, 13.2. 
 
IR 3221 (w), 3072 (w), 2948 (w), 1513 (m), 1439 (w), 1269 (s), 1128 (m), 1077 (m), 964 (w), 
913 (m), 842 (m). 
 
HRMS (ESI) calcd for C20FH22N2O7+ [M+H]+ 421.1406; found 421.1405. 
 
Dimethyl 2-methyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-((E)-
styryl)dihydrofuran-3,3(2H)-dicarboxylate. (23d) 
 
Following the conditions B, using (E)-4-phenylbut-3-en-2-one (0.070 g, 0.48 mmol, 1.2 
equiv), a mixture of unseparable diastereoisomers (ratio 2:1 obtained by integration of methyl 
esters at 3.64 ppm and 3.55 ppm) 23d (0.14 g, 0.34 mmol, 79% yield) was obtained as a 
colorless foam. 
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RF (pent/AcOET (1:1)) = 0.4 
 
1H NMR (400 MHz, Chloroform-d) δ 9.19 (br.s, 1H, N-H), 7.84 (d, J = 1.3 Hz, 1H, , thymine 
vinyl-CH, major diastereoisomer), 7.59 (d, J = 1.3 Hz, 1H, , thymine vinyl-CH, minor 
diastereoisomer), 7.36 – 7.16 (m, 5H, Ar-H), 6.69 (d, J = 15.9 Hz, 1H, vinyl C-H, minor 
diastereomer), 6.65 (d, J = 16.1 Hz, 1H, vinyl C-H, major diastereomer), 6.39 (d, J = 16.1 Hz, 
1H, vinyl C-H, major diastereomer), 6.32 (d, J = 16.0 Hz, 1H, vinyl C-H, minor diastereomer), 
6.25 (m, 1H, tetrahydrofuran-NCH, major and minor diastereoisomers ), 3.75 (s, 3H, ester 
methyl, major diastereoisomer), 3.72 (s, 3H, ester methyl, minor diastereoisomer), 3.64 (s, 3H, 
ester methyl, minor diastereoisomer), 3.55 (s, 3H, ester methyl, major diastereoisomer), 3.13 
(dd, J = 14.7, 7.1 Hz, 1H, , tetrahydrofuran-CH2, minor diastereoisomer), 3.09 (dd, J = 14.9, 
7.8 Hz, 1H, tetrahydrofuran-CH2, major diastereoisomer), 2.57 (dd, J = 14.9, 5.5 Hz, 1H, 
tetrahydrofuran-CH2, major diastereoisomer), 2.51 (dd, J = 14.8, 5.6 Hz, 1H, tetrahydrofuran-
CH2, minor diastereoisomer), 1.91 (d, J = 1.2 Hz, 3H, thymine methyl, minor diastereoisomer), 
1.89 (d, J = 1.2 Hz, 3H, thymine methyl, major diastereoisomer), 1.61 (s, 3H, tetrahydrofuran 
methyl, minor diastereoisomer), 1.52 (s, 3H, tetrahydrofuran methyl, major diastereoisomer). 
 
13C NMR (101 MHz, Chloroform-d) δ 169.9, 169.4, 168.7, 168.5, 164.1, 164.0, 150.8, 150.5, 
136.7, 136.2, 136.0, 130.1, 129.8, 128.8, 128.7, 128.7, 128.7, 128.1, 126.7, 126.6, 110.4, 
109.8, 87.6, 86.4, 84.5, 82.2, 66.5, 66.4, 53.1, 53.1, 53.0, 39.6, 38.9, 24.9, 24.1, 12.8, 12.7. 
3 carbons are unresolved. 
 
IR 3180 (w), 3044 (w), 1736 (s), 1688 (s), 1458 (w), 1258 (s), 1076 (w), 733 (s). 
 
HRMS (ESI) calcd for C22H25N2O7+ [M+H]+ 429.1656; found 429.1660. 
 
Dimethyl-2-methyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-
phenethyldihydrofuran-3,3(2H)-dicarboxylate (23e). 
 
 
Following the conditions B, using 4-phenylbutan-2-one (0.071 g, 0.48 mmol, 1.2 equiv), the 
pure product 23e (0.15 g, 0.34 mmol, 85% yield) was obtained as a slightly yellow solid. 
 
MP 167.9-168.7 °C. 
 
RF (pent/AcOET (1:1)) = 0.19. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.07 (s, 1H, thymine NH), 7.74 (q, J = 1.2 Hz, 1H, thymine 
vinyl-CH), 7.30 (dd, J = 8.5, 6.6 Hz, 2H, Ar-H), 7.24 – 7.17 (m, 3H, Ar-H), 6.18 (dd, J = 7.7, 5.3 
Hz, 1H, tetrahydrofuran-NCH), 3.78 (s, 3H, ester methyl), 3.72 (s, 3H, ester methyl), 3.23 – 
3.05 (m, 1H, tetrahydrofuran-CH2), 2.92 – 2.69 (m, 2H, benzylic-CH2), 2.54 (dd, J = 15.0, 5.4 
Hz, 1H, tetrahydrofuran-CH2), 2.28 (ddd, J = 13.7, 11.7, 6.0 Hz, 1H, CH2), 2.00 – 1.90 (m, 4H, 
thymine methyl and CH2), 1.47 (s, 3H, tetrahydrofuran methyl). 
 
13C NMR (101 MHz, Chloroform-d) δ 170.5, 168.9, 163.5, 150.3, 141.5, 136.6, 128.5, 128.3, 
126.1, 110.2, 87.0, 82.0, 66.2, 53.1, 52.9, 4.5, 38.8, 30.3, 21.9, 12.7. 
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IR 3193 (w), 3060 (w), 2957 (w), 1735 (s), 1692 (s), 1468 (m), 1266 (s), 1097 (m), 914 (m). 
 
HRMS (ESI) calcd for C22H27N2O7+ [M+H]+ 431.1813; found 431.1802. 
 
The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and 
allocated the deposition number: CCDC 994735 
 
Dimethyl 2-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-1-oxaspiro[4.5]decane-
4,4-dicarboxylate. (23f) 
 
Following the conditions B, using cyclohexanone (0.047 g, 0.48 mmol, 1.2 equiv), the pure 
product 23f (0.15 g, 0.39 mmol, 97% yield) was obtained as a colorless foamy solid. 
 
RF (AcOEt/pent (1:1)) = 0.3. 
 
MP 184.1-185.6 °C. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.25 – 8.08 (br s, 1H, thymine NH), 7.70 (d, J = 1.5 Hz, 
1H, thymine vinyl-CH), 6.03 (dd, J = 7.6, 5.2 Hz, 1H, tetrahydrofuran-NCH), 3.71 (s, 3H, ester 
methyl), 3.68 (s, 3H, ester methyl), 3.11 (dd, J = 14.9, 7.6 Hz, 1H, tetrahydrofuran-CH2), 2.39 
(dd, J = 14.9, 5.3 Hz, 1H, tetrahydrofuran-CH2), 1.91 (d, J = 1.2 Hz, 3H, thymine methyl), 1.75 
– 1.47 (m, 8H, cyclohexane C-H), 1.22 – 1.12 (m, 2H, cyclohexane C-H). 
 
13C NMR (101 MHz, Chloroform-d) δ 170.3, 168.7, 163.6, 150.3, 136.6, 109.9, 87.2, 82.0, 65.8, 
52.9, 52.8, 39.6, 32.4, 31.2, 25.0, 22.7, 21.5, 12.7. 
 
IR 3210 (w), 2931 (w), 2856 (w), 1733 (m), 1687 (s), 1437 (w), 1268 (m), 1201 (w), 1095 (m), 
911 (m), 729 (s). 
 
HRMS (ESI) calcd for C18H24N2NaO7 [M+Na] 403.1481; found 403.1488. 
 
 
Dimethyl 2-methyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-((E)-
styryl)dihydrofuran-3,3(2H)-dicarboxylate. (23g) 
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Following the conditions B, using 1-((tert-butyldimethylsilyl)oxy)propan-2-one (0.075 g, 0.48 
mmol, 1.2 equiv), a single diasteroisomer 23g (0.072 g, 0.15 mmol, 38% yield) was obtained 
as a colorless oil. 
 
RF (pent/AcOET (1:1)) = 0.53. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.35 (s, 1H, N-H), 7.61 (d, J = 1.3 Hz, 1H, thymine vinyl-
CH), 6.25 (dd, J = 8.0, 5.8 Hz, 1H, tetrahydrofuran-NCH), 4.09 (d, J = 10.9 Hz, 1H, CH2O), 
3.80 (s, 3H, ester methyl), 3.72 (s, 3H, ester methyl), 3.68 (d, J = 10.9 Hz, 1H, CH2O), 3.05 
(dd, J = 13.3, 5.8 Hz, 1H, tetrahydrofuran-CH2), 2.72 (dd, J = 13.3, 8.1 Hz, 1H, tetrahydrofuran-
CH2), 1.92 (d, J = 1.1 Hz, 3H, thymine methyl), 1.31 (s, 3H, tetrahydrofuran methyl), 0.82 (s, 
9H, TBDMS), 0.05 (s, 6H, TBDMS). 
 
13C NMR (101 MHz, CDCl3) δ 170.1, 168.2, 163.7, 150.1, 135.9, 109.3, 88.0, 85.6, 69.1, 64.2, 
53.1, 52.6, 40.9, 25.6, 21.1, 18.0, 12.8, -5.7, -6.0. 
 
IR 3180 (w), 3126 (w), 2909 (w), 1684 (s), 1443 (s), 1096 (w), 848 (s). 
 
HRMS (ESI) calcd for C21H34N2NaO8Si+ [M+Na]+ 493.1977; found 493.1982. 
 
Dimethyl-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyl-2-
((triisopropylsilyl)oxy)cyclopentane-1,1-dicarboxylate. (24b) 
 
Following the conditions B, using TIPS protected acetophenone (21) (0.17 g, 0.60 mmol, 1.5 
equiv), the pure product 24b (0.19 g, 0.33 mmol, 84% yield) was obtained as a white crystalline 
solid. 
 
RF (pent/AcOEt (1:1)) = 0.56. 
 
MP 81.8-83.2 °C. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.40 (s, 1H, thymine N-H), 7.86 (d, J = 1.6 Hz, 1H, thymine 
vinyl-CH), 7.82 – 7.74 (m, 2H, Ar-H), 7.34 – 7.27 (m, 3H, Ar-H), 5.70 (ddd, J = 11.4, 9.3, 5.7 
Hz, 1H, cyclopentane-NCH), 3.76 (s, 3H, ester methyl), 3.29 (m, 4H, ester methyl and 
cyclopentane-CH2), 3.18 (t, J = 12.4 Hz, 1H, cyclopentane-CH2), 2.52 (dd, J = 12.8, 6.8 Hz, 
1H, cyclopentane-CH2), 2.36 (dd, J = 15.0, 7.3 Hz, 1H, cyclopentane-CH2), 2.00 (d, J = 1.2 Hz, 
3H, thymine methyl), 1.03 – 0.97 (m, 11H, TIPS), 0.97 – 0.90 (m, 10H, TIPS). 
 
13C NMR (101 MHz, Chloroform-d) δ 172.6, 168.1, 163.5, 151.1, 139.9, 137.3, 128.4, 128.1, 
127.4, 111.5, 88.3, 70.3, 52.7, 52.3, 51.5, 43.4, 38.2, 18.2, 13.8, 12.8. 
 
IR 2950 (w), 2868 (w), 1681 (s), 1467 (m), 1434 (w), 1392 (w), 1259 (s), 1135 (m), 1090 (m). 
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HRMS (ESI) calcd for C29H42N2NaO7Si+ [M+Na]+ 581.2653; found 581.2660. 
 
The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and 
allocated the deposition number: CCDC 994948 
Dibenzyl 4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyl-2-
((triisopropylsilyl)oxy)cyclopentane-1,1-dicarboxylate. (24c) 
 
Following the conditions B, using TIPS protected acetophenone 21 (0.17 g, 0.60 mmol, 1.5 
equiv) and the corresponding cyclopropane 37 (0.21 g, 0.40 mmol, 1 equiv), the pure product 
24c (0.27 g, 0.38 mmol, 95% yield) was obtained as a white crystalline solid. 
 
RF (pent/AcOEt (1:1)) = 0.70. 
 
MP 69.4-73.1°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.35 (s, 1H, thymine N-H), 7.84 (d, J = 1.6 Hz, 1H, thymine 
vinyl-CH), 7.77 (dd, J = 7.3, 1.8 Hz, 2H, Ar-H), 7.31 – 7.11 (m, 11H, Ar-H), 6.91 – 6.84 (m, 2H, 
Ar-H), 5.72 (tt, J = 11.5, 6.9 Hz, 1H, cyclopentane-NCH), 5.19 – 5.03 (m, 2H, benzylic-CH2), 
4.76 (d, J = 12.3 Hz, 1H, benzylic-CH2), 4.56 (d, J = 12.2 Hz, 1H, benzylic-CH2), 3.35 (dd, J = 
15.1, 11.1 Hz, 1H, cyclopentane-CH2), 3.21 (t, J = 12.4 Hz, 1H, cyclopentane-CH2), 2.53 (dd, 
J = 12.9, 6.9 Hz, 1H, cyclopentane-CH2), 2.38 (dd, J = 15.2, 7.0 Hz, 1H, cyclopentane-CH2), 
1.94 (d, J = 1.2 Hz, 3H, thymine methyl), 1.03 – 0.92 (m, 21H, TIPS). 
 
13C NMR (101 MHz, Chloroform-d) δ 171.9, 167.4, 163.4, 151.1, 139.7, 137.3, 135.1, 134.4, 
128.6, 128.5, 128.4, 128.4, 128.4, 128.3, 128.0, 127.4, 111.5, 88.3, 70.4, 67.7, 67.5, 51.2, 
43.6, 38.3, 18.3, 13.9, 12.8. 
One carbone not resolved. 
 
IR 3434 (w), 3160 (w), 3035 (w), 2872 (w), 1682 (s), 1456 (w), 1374 (w), 1136 (w), 1025 (m). 
 
HRMS (ESI) calcd for C41H50N2NaO7S + [M+Na]+ 733.3279; found 733.3271. 
 
The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and 
allocated the deposition number: CCDC 995131. 
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Dimethyl-2-(4-fluorophenyl)-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-
((triisopropylsilyl)oxy)cyclopentane-1,1-dicarboxylate. (24d) 
 
Following the conditions B, using ((1-(4-fluorophenyl)vinyl)oxy)triisopropylsilane (49) (0.14 g, 
0.48 mmol, 1.2 equiv), the pure product 24d (0.18 g, 0.32 mmol, 80% yield) was obtained as 
a white foamy solid. 
 
MP 105.6-106.7 °C. 
 
RF (pent/AcOET (1:1)) = 0.45. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.14 (d, J = 3.8 Hz, 1H, thymine-NH), 7.89 – 7.78 (m, 3H, 
Ar-H and thymine vinyl-CH), 7.03 (t, J = 8.7 Hz, 2H, Ar-H), 5.71 (tt, J = 11.4, 7.0 Hz, 1H, 
cyclopentane-NCH), 3.79 (s, 3H, methyl ester), 3.37 (s, 3H, ester methyl), 3.36 – 3.31 (m, 1H, 
cyclopentane-CH2). 3.19 (t, J = 12.3 Hz, 1H, cyclopentane-CH2), 2.54 (dd, J = 12.8, 6.8 Hz, 
1H, cyclopentane-CH2), 2.38 (dd, J = 15.1, 7.2 Hz, 1H, cyclopentane-CH2), 2.03 (d, J = 1.2 Hz, 
3H, thymine methyl), 1.39 – 1.23 (m, 3H, TIPS), 1.09 – 0.85 (m, 18H, TIPS). 
 
13C NMR (101 MHz, Chloroform-d) δ 172.6, 168.1, 162.7 (d, J = 246.7 Hz), 163.3, 151.0, 137.2, 
135.9 (d, J = 3.2 Hz), 130.2 (d, J = 8.1 Hz), 114.2 (d, J = 21.3 Hz), 111.6, 87.7, 70.2, 52.8, 
52.4, 51.4, 43.5, 38.1, 18.2, 13.8, 12.8. 
 
IR 3196 (w), 2951 (w), 2869 (w), 1681 (s), 1513 (w), 1466 (w), 1260 (m), 1098 (m), 911 (m), 
731 (s). 
 
HRMS (ESI) calcd for C29FH42N2O7Si+ [M+H]+ 577.2740; found 577.2719. 
 
Dimethyl 4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-((E)-styryl)-2-
((triisopropylsilyl)oxy)cyclopentane-1,1-dicarboxylate. (24e) 
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Following the conditions B, using (E)-triisopropyl((4-phenylbuta-1,3-dien-2-yl)oxy)silane (51) 
(0.15 g, 0.48 mmol, 1.2 equiv), a mixture of unseparable diastereoisomers (ratio 13:1 by 
integration of the NC-H proton at 5.64 ppm and 4.88 ppm) 24e (0.13 g, 0.22 mmol, 55% 
yield) was obtained as a colorless foam. 
 
RF (pent/AcOET (1:1)) = 0.54 
 
1H NMR (400 MHz, Chloroform-d, Major diastereoisomer) δ 8.58 (s, 1H, N-H), 7.77 (d, J = 1.1 
Hz, 1H, thymine vinyl-CH), 7.34 – 7.21 (m, 5H, Ar-H), 6.85 (d, J = 16.6 Hz, 1H, vinyl C-H), 6.43 
(d, J = 16.5 Hz, 1H, vinyl C-H), 5.64 (tt, J = 11.5, 6.8 Hz, 1H, cyclopentane-NCH), 3.74 (s, 3H, 
ester methyl), 3.52 (s, 3H, ester methyl), 3.23 (dd, J = 15.1, 11.3 Hz, 1H, cyclopentane -CH2), 
2.82 (t, J = 12.1 Hz, 1H cyclopentane -CH2), 2.30 (dd, J = 12.5, 7.0 Hz, 1H, cyclopentane -
CH2), 2.17 (dd, J = 15.1, 6.5 Hz, 1H, cyclopentane -CH2), 1.92 (d, J = 1.2 Hz, 3H, thymine 
methyl), 1.18 (m, J = 1.5 Hz, 3H, TIPS), 1.01 (d, J = 2.5 Hz, 12H, TIPS), 0.96 (dd, J = 3.4, 1.8 
Hz, 6H, TIPS). 
 
13C NMR (101 MHz, Chloroform-d,  Major diastereoisomer) δ 172.4, 168.8, 163.7, 151.1, 137.6, 
136.1, 130.7, 128.8, 128.8, 128.2, 126.7, 111.5, 86.7, 69.9, 53.1, 52.6, 51.4, 41.1, 37.1, 29.7, 
18.2, 18.0, 13.1, 12.8. 
TIPS methyls are giving 2 differents signals(18.2 and 18.0).  
 
IR 2947 (w), 2868 (w), 1689 (m), 1465 (w), 1435 (w), 1260 (m), 1088 (w), 1017 (w), 976 (w), 
911 (m), 732 (s). 
 
HRMS (ESI) calcd for C31H45N2O7Si+ [M+H]+ 585.2991; found 585.3015. 
 
Dimethyl-3-methyl-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyl-2-
((triisopropylsilyl)oxy)cyclopentane-1,1-dicarboxylate. (24f) 
 
Following the conditions B, using triisopropyl((1-phenylprop-1-en-1-yl)oxy)silane (53) (0.14 g, 
0.48 mmol, 1.2 equiv), the pure product 24f (0.18 g, 0.32 mmol, 79% yield) was obtained as a 
shiny foamy solid. The stereochemistry of the methyl was determined by NOE experiments. 
 
RF (pent/AcOET (1:1)) = 0.48. 
 
MP 127.4-128.3 °C. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.06 (s, 1H, thymine NH), 8.01 (d, J = 1.5 Hz, 1H, thymine 
vinyl-CH), 7.73 – 7.66 (m, 2H, Ar-H), 7.39 – 7.25 (m, 3H, Ar-H), 5.36 (td, J = 11.4, 6.8 Hz, 1H 
cyclopentane -NCH), 3.70 (s, 3H, ester methyl), 3.35 (dq, J = 13.6, 6.8 Hz, 1H, tetrahydrofuran-
CH), 3.20 (s, 3H, ester methyl), 3.12 (dd, J = 15.1, 11.3 Hz, 1H, cyclopentane -CH2). 2.33 (dd, 
J = 15.1, 6.8 Hz, 1H, cyclopentane -CH2), 2.02 (d, J = 1.2 Hz, 3H, thymine methyl), 1.56 (s, 
3H, cyclopentane methyl), 1.24 (hept, J = 7.3 Hz, 3H, TIPS), 1.12 – 0.94 (m, 18H, TIPS). 
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13C NMR (101 MHz, Chloroform-d) δ 172.7, 168.1, 163.3, 151.5, 138.6, 137.5, 128.3, 128.2, 
127.4, 111.6, 90.9, 70.4, 56.7, 52.8, 45.2, 35.8, 18.9, 18.8, 15.2, 12.9, 10.6. 
 
IR 3175 (w), 2963 (w), 2870 (w), 1679 (m), 1468 (w), 1257 (m), 1079 (m), 1026 (m), 910 (m), 
731 (s). 
 
HRMS (ESI) calcd for C30H45N2O7Si+ [M+H]+ 573.2991; found 573.2992. 
 
3.2 From uracil and 5-fluoro uracil cyclopropanes.  
General procedure for Benzoyl removal. 
 
The crude product was dissolved in EtOH (2 mL) and stirred at room temperature for 2 hours 
with NH4OH (0.6 mL, 40 equiv, 25%). The mixture was evaporated to dryness and directly 
submitted to the column chromatography using a gradient of solvent from pentane/AcOEt 
(7:3) up to (3:7). 
 
Dimethyl -5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyldihydrofuran-3,3(2H)-
dicarboxylate (26a). 
 
Following the conditions A, using benzaldehyde (0.051 g, 0.48 mmol, 1.2 equiv) and the 
corresponding cyclopropane 12b (0.15 g, 0.40 mmol, 1 equiv), the pure product 26a (0.093 g, 
0.25 mmol, 62% yield) was obtained as a white powder. 
 
RF (AcOEt) = 0.65.  
 
MP 209.0-210.7°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 9.07 (s, 1H, NH), 8.05 (d, J = 8.2 Hz, 1H, uracil CH), 7.42 
– 7.29 (m, 2H, Ar-H), 7.24 (m, 3H, Ar-H), 6.29 (t, J = 7.4 Hz, 1H, tetrahydrofuran N-CH), 5.84 
(d, J = 8.1 Hz, 1H, uracil CH), 5.52 (s, 1H, tetrahydrofuran-CH), 3.72 (s, 3H, ester CH3), 3.03 
(s, 3H, ester CH3), 2.83 (dd, J = 14.7, 7.2 Hz, 1H, tetrahydrofuran-CH2), 2.73 (dd, J = 14.7, 7.8 
Hz, 1H, tetrahydrofuran-CH2). 
 
13C NMR (101 MHz, Chloroform-d) δ 170.0, 169.7, 163.0, 150.5, 140.4, 135.1, 128.8, 128.1, 
126.5, 103.6, 82.6, 81.6, 63.8, 53.2, 52.8, 39.4. 
 
 IR 3100 (w), 2968 (w), 1727 (s), 1694 (s), 1459 (m), 1275 (s), 1077 (s), 1052 (s), 730 (s). 
  
HRMS (ESI) calcd for C18H18N2NaO7+ [M+Na]+ 397.1006; found 397.1004. 
 
Dimethyl -5-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyldihydrofuran-
3,3(2H)-dicarboxylate (26b). 
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Following the conditions A, using benzaldehyde (0.051 g, 0.48 mmol, 1.2 equiv), and the 
corresponding cyclopropane 12c (0.16 g, 0.40 mmol, 1 equiv), followed by the benzoyl 
deprotection, the pure product 26b (0.11 g, 0.29 mmol, 72% yield) was obtained as a white 
powder. 
 
RF (AcOEt/pentane (1:1)) = 0.60. 
 
MP 227.9-228.5°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 9.22 (s, 1H, NH), 8.25 (d, J = 6.1 Hz, 1H, F-uracil CH), 
7.47 – 7.34 (m, 2H, ArH), 7.34 – 7.22 (m, 3H, ArH), 6.31 (ddd, J = 7.8, 6.9, 1.7 Hz, 1H, 
tetrahydrofuran N-CH), 5.53 (s, 1H, tetrahydrofuran CH), 3.74 (s, 3H, ester CH3), 3.08 (s, 3H, 
ester CH3), 2.80 (qd, J = 14.8, 7.4 Hz, 2H, tetrahydrofuran CH2). 
 
13C NMR (101 MHz, Chloroform-d) δ 169.9, 169.6, 156.6 (dd, J = 27.1, 8.7 Hz), 149.1 (d, J = 
7.7 Hz), 141.0 (d, J = 238.8 Hz), 134.8, 129.0, 128.2, 126.4, 124.7 (d, J = 34.8 Hz), 82.7, 81.8, 
63.6, 53.2, 53.0, 39.2. 
 
IR 3196 (w), 3071 (w), 2956 (w), 1723 (s), 1668 (m), 1436 (w), 1273 (s), 1211 (m), 1094 (m), 
1053 (m), 914 (m), 735 (m). 
 
HRMS (ESI) calcd for C18H17FN2NaO7 [M+Na] 415.0917; found 415.0918. 
 
Dimethyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methyl-2-phenyldihydrofuran-
3,3(2H)-dicarboxylate (26c). 
 
Following the conditions B, using acetophenone (20) (0.058 g, 0.48 mmol, 1.2 equiv) and the 
cyclopropane 41 (0.16 g, 0.40 mmol, 1 equiv), the pure product 26c (0.12 g, 0.30 mmol, 76% 
yield) was obtained as a white powder. 
 
RF (AcOEt/pent (1:1)) = 0.2.  
 
MP 235.8-238.4°C. 
 
1H NMR (400 MHz, DMSO-d6) δ 11.44 (s, 1H, NH), 8.18 (d, J = 8.2 Hz, 1H, uracil CH), 7.71 – 
7.51 (m, 2H, ArH), 7.46 – 7.23 (m, 3H, ArH), 6.29 (dd, J = 8.2, 5.1 Hz, 1H, tetrahydrofurane N-
CH), 5.81 (dd, J = 8.2, 2.2 Hz, 1H, uracil CH), 3.72 (s, 3H, ester CH3), 3.27 (dd, J = 14.8, 8.2 
Hz, 1H, tetrahydrofurane-CH2), 3.03 (s, 3H, ester CH3), 2.67 (dd, J = 14.8, 5.2 Hz, 1H, 
tetrahydrofurane-CH2), 1.80 (s, 3H, tetrahydrofurane-CH3). 
 
13C NMR (101 MHz, DMSO-d6) δ 170.6, 168.8, 163.6, 151.1, 141.1, 141.1, 128.2, 126.0, 102.3, 
87.9, 81.2, 67.0, 53.2, 52.9, 25.8. 
 
Two carbons are unresolved. 
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IR 3163 (w), 3035 (w), 2953 (w), 2838 (w), 1735 (s), 1733 (s), 1673 (s), 1436 (m), 1385 (m), 
1263 (s), 1210 (s), 1072 (s), 767 (s). 
 
HRMS (ESI) calcd for C19H20N2NaO7
+ [M+Na]+ 411.1163; found 411.1168. 
 
Dimethyl -5-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methyl-2-
phenyldihydrofuran-3,3(2H)-dicarboxylate (26d). 
 
Following the conditions B, using acetophenone (20) (0.058 g, 0.48 mmol, 1.2 equiv) and the 
corresponding cyclopropane 12c (0.16 g, 0.40 mmol, 1 equiv) at -40 °C, followed by the 
benzoyl deprotection, the pure product 26d (0.12 g, 0.28 mmol, 71% yield) was obtained as a 
white powder. 
 
RF (AcOEt/pentane (1:1)) = 0.42. 
 
MP 209.3-210.2°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 9.98 (d, J = 4.6 Hz, 1H, NH), 8.50 (d, J = 6.5 Hz, 1H, F-
uracil CH), 7.77 – 7.65 (m, 2H, ArH), 7.51 – 7.16 (m, 3H, ArH), 6.42 (ddd, J = 8.2, 5.1, 1.7 Hz, 
1H, tetrahydrofuran N-CH), 3.80 (s, 3H, ester CH3), 3.18 (dd, J = 15.1, 8.2 Hz, 1H, 
tetrahydrofuran CH2), 3.10 (s, 3H, ester CH3), 2.78 (dd, J = 15.1, 5.1 Hz, 1H, tetrahydrofuran 
CH2), 1.88 (s, 3H, CH3). 
 
13C NMR (101 MHz, Chloroform-d) δ 170.5, 168.6, 157.1 (d, J = 26.8 Hz), 149.6, 140.5 (d, J = 
236.4 Hz), 140.0, 128.0, 127.9, 125.7, 125.6 (d, J = 35.1 Hz), 88.6, 81.4, 66.9, 52.9, 52.8, 39.7, 
25.7. 
 
IR 3173 (w), 3065 (w), 2954 (w), 1758 (w), 1718 (s), 1669 (s), 1485 (w), 1421 (w), 1262 (s), 
1205 (m), 1076 (s), 914 (m), 768 (m). 
 
HRMS (ESI) calcd for C19H19FN2NaO7 [M+Na] 429.1074; found 429.1080. 
 
Dimethyl-4-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyl-2-
((triisopropylsilyl)oxy)cyclopentane-1,1-dicarboxylate (26e). 
 
Following the conditions B, using TIPS protected acetophenone 21 (0.17 g, 0.60 mmol, 1.5 
equiv) and the cyclopropane 12b (0.16 g, 0.40 mmol, 1 equiv), the pure product 26e (0.18 g, 
0.33 mmol, 81% yield) was obtained as a colorless foam. 
 
RF (AcOEt/pent (1:1)) = 0.5.  
 
MP 67.7-77.0°C. 
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1H NMR (400 MHz, Chloroform-d) δ 9.92 (s, 1H, NH), 8.11 (d, J = 8.1 Hz, 1H, uracil CH), 7.85 
– 7.65 (m, 2H, ArH), 7.30 (m, 3H, ArH), 5.86 (dd, J = 8.1, 2.2 Hz, 1H, uracil CH), 5.74 (tt, J = 
11.3, 7.0 Hz, 1H, cyclopentane N-CH), 3.76 (s, 3H ester methyl), 3.34 (dd, J = 15.1, 11.1 Hz, 
1H, cyclopentane CH2), 3.29 (s, 3H, ester methyl), 3.18 (t, J = 12.4 Hz, 1H, cyclopentane CH2), 
2.55 (dd, J = 12.9, 6.8 Hz, 1H, cyclopentane CH2), 2.37 (dd, J = 15.1, 7.1 Hz, 1H, cyclopentane 
CH2), 1.02-0.95 (m, 21H, TIPS). 
 
13C NMR (101 MHz, Chloroform-d) δ 172.7, 168.1, 163.7, 151.4, 141.7, 139.8, 128.4, 128.0, 
127.4, 103.2, 88.3, 70.3, 52.8, 52.3, 51.5, 43.5, 38.2, 18.2, 18.2, 13.8. 
 
IR 3183 (w), 3060 (w), 2950 (w), 1686 (s), 1462 (m), 1261 (m), 1113 (w), 990 (w), 885 (w). 
 
HRMS (ESI) calcd for C28H40N2NaO7Si+ [M+Na]+ 567.2497; found 567.2496. 
 
Dimethyl -4-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyl-2-
((triisopropylsilyl)oxy)cyclopentane-1,1-dicarboxylate (26f). 
 
Following the conditions B, using TIPS protected acetophenone 21 (0.17 g, 0.60 mmol, 1.5 
equiv) and the corresponding cyclopropane 12c (0.16 g, 0.40 mmol, 1 equiv) at -40 °C, 
followed by the benzoyl deprotection, the pure product 26f (0.12 g, 0.20 mmol, 51% yield) was 
obtained as a colorless oil. 
 
RF (AcOEt/pentane (1:1)) = 0.75. 
 
1H NMR (400 MHz, Chloroform-d) δ 9.96 (br. m., 1H, NH), 8.33 (d, J = 6.5 Hz, 1H, F-uracil 
CH), 7.76 (dd, J = 7.8, 2.0 Hz, 2H, ArH), 7.39 – 7.21 (m, 3H, ArH), 5.74 (dddd, J = 8.6, 6.5, 
4.6, 1.5 Hz, 1H, tetrahydrofuran N-CH), 3.74 (s, 3H, ester CH3), 3.39 – 3.29 (m, 1H, 
tetrahydrofuran CH2), 3.28 (s, 3H, ester CH3), 3.14 (dd, J = 13.0, 11.7 Hz, 1H, tetrahydrofuran 
CH2), 2.55 (dd, J = 12.9, 7.0 Hz, 1H, tetrahydrofuran CH2), 2.35 (dd, J = 15.2, 6.7 Hz, 1H, 
tetrahydrofuran CH2), 1.01-0.94 (m, 21H, TIPS).  
 
13C NMR (101 MHz, Chloroform-d) δ 172.8, 168.0, 157.0 (d, J = 26.5 Hz), 150.2, 141.0 (d, J = 
237.5 Hz), 139.6, 128.5, 127.9, 127.4, 125.9 (d, J = 33.4 Hz), 88.4, 70.3, 52.9, 52.4, 52.0, 43.4, 
38.0, 18.2, 18.2, 13.9. 
 
IR 3194 (w), 3067 (w), 2951 (w), 2855 (w), 1718 (s), 1466 (w), 1256 (s), 1134 (m), 991 (m), 
788 (m), 740 (m). 
 
HRMS (ESI) calcd for C28H39FN2NaO7Si+ [M+Na]+ 585.2403; found 585.2386. 
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4. Scope of the reaction [4+2] reaction. 
c) General conditions the [4+2] annulation  
 
Hf(OTf)4 (21 mg, 0.030 mmol, 0.1 equiv) was added in a flame dried 25 mL flask and under 
nitrogen atmosphere. Then, dry dichloromethane (4.5 mL) and aldehyde 5 (0.45 mmol, 1.5 
equiv) were added into the flask. A solution of cyclobutane 18a or 18b (0.30 mmol, 1.0 equiv) 
in dry dichloromethane (1.5 mL) was added dropwise to the reaction mixture and stirred at 
room temperature for 15 minutes. The reaction mixture was filtrated on a pad of silica eluting 
with a mixture of ethyl acetate/ pentane (8:2) and concentrated under reduced pressure. The 
crude product was dissolved in ethanol (6 mL) and ammonium hydroxide solution (1.8 mL, 60 
equiv, 25 %) was added. The resulting solution was stirred for 16 hours. The solvent was 
removed under reduced pressure and the crude product was dissolved in ethyl acetate (25 
mL) and extracted with water (3 x 50 mL). The organic layer was dried over magnesium sulfate, 
filtrated and concentrated under reduced pressure. The crude mixture was purified by column 
chromatography eluting with a mixture of ethyl acetate/ pentane (5:5 to 9:1). The product was 
recrystallized in ethanol (2 mL). 
 
 
Dimethyl (5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyldihydro-2H-
pyran-3,3(4H)-dicarboxylate (25a). 
 
Following the general procedure, using benzaldehyde (5a) (46 µL, 0.45 mmol, 1.5 equiv) 
cyclobutane 18a (120 mg, 0.300 mmol, 1.0 equiv), a mixture of diastereoisomers (20:1 by 
integration of methyl esters at 3.52 ppm and 3.49 ppm) 25a (102 mg, 0.255 mmol, 85% NMR 
yield)7 was obtained after column chromatography as a colorless foam. After recrystallization 
in ethanol, the pure product 25a (94 mg, 0.23 mmol, 78% isolated yield) was obtained as a 
colorless foam and as a mixture of diastereoisomers (> 20:1 by integration of methyl esters at 
3.52 ppm and 3.49 ppm). 
RF (Pentane/Ethyl acetate (3:7)) =.0.27.  
MP 226.2- 227.9 °C. 
1H NMR (400 MHz, Chloroform-d, major diastereoisomer) δ 8.38 (s, 1 H, NH), 7.40 - 7.35 (m, 
2 H, Ar-H), 7.34 – 7.27 (m, 4 H, Ar-H and thymine C=C-H), 5.96 (dd, J = 11.1, 2.9 Hz, 1 H, 
tetrahydropyran-NCH), 5.23 (s, 1 H, tetrahydropyran-CH), 3.68 (s, 3 H, ester CH3), 3.52 (s, 3 
H, ester CH3), 2.74 – 2.64 (m, 1 H, tetrahydropyran-CH2), 2.38 (tdd, J = 12.6, 11.0, 4.1 Hz, 1 
H, tetrahydropyran-CH2), 2.25 (td, J = 13.4, 4.1 Hz, 1 H, tetrahydropyran-CH2), 1.99 (d, J = 1.2 
Hz, 3 H, thymine-CH3), 1.97 – 1.90 (m, 1 H, tetrahydropyran-CH2).  
                                                 
7 Benzamide as impurity which is not possible to separate by column chromatography. 
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13C NMR (101 MHz, Chloroform-d, major diastereoisomer) δ 170.3, 169.2, 163.4, 149.9, 137.5, 
135.4, 128.5, 127.7, 127.5, 111.6, 82.3, 82.1, 57.1, 52.8, 52.0, 31.6, 26.6, 12.8.  
IR 3191 (w), 3041 (w), 2954 (w), 2361 (w), 1725 (s), 1693 (s), 1461 (w), 1271 (s), 1096 (w), 
1043 (w), 915 (w), 735 (m).  
HRMS (ESI) calcd for C20H22N2NaO7+ [M+Na]+ 425.1319, found 425.1324. 
 
Dimethyl 2-(4-fluorophenyl)-6-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)dihydro-2H-pyran-3,3(4H)-dicarboxylate (25b). 
 
Following the general procedure, using 4-fluorobenzaldehyde (5f) (48 µL, 0.45 mmol, 1.5 
equiv) cyclobutane 18a (120 mg, 0.300 mmol, 1.0 equiv), a mixture of diastereoisomers (12:1 
by integration of methyl esters at 3.54 ppm and 3.49 ppm) 25b (99 mg, 0.24 mmol, 79% NMR 
yield)7 was obtained after column chromatography as a colorless foam. After recrystallization 
in ethanol, the pure product 25b (88 mg, 0.21 mmol, 70% isolated yield) was obtained as a 
colorless foam and as a mixture of diastereoisomers (12:1 by integration of methyl esters at 
3.54 ppm and 3.49 ppm). 
RF (Pentane/Ethyl acetate (3:7)) = 0.30. 
MP 94.8- 96.9°C. 
1H NMR (400 MHz, Chloroform-d, major diastereoisomer) δ 8.06 (s, 1 H, NH), 7.40 – 7.33 (m, 
2 H, Ar-H), 7.29 (d, J = 1.3 Hz, 1 H, thymine C=C-H), 7.03 – 6.95 (m, 2 H, Ar-H), 5.95 (dd, J = 
11.3, 2.9 Hz, 1 H, tetrahydropyran-NCH), 5.21 (s, 1 H, tetrahydropyran-CH), 3.69 (s, 3 H, ester 
CH3), 3.54 (s, 3 H, ester CH3), 2.74 – 2.63 (m, 1 H, tetrahydropyran-CH2), 2.48 – 2.32 (m, 1 H, 
tetrahydropyran-CH2), 2.32 – 2.20 (m, 1 H, tetrahydropyran-CH2), 1.99 (d, J = 1.2 Hz, 3 H, 
thymine-CH3), 1.93 (dq, J = 9.3, 3.3 Hz, 1 H, tetrahydropyran-CH2).  
13C NMR (101 MHz, Chloroform-d, major diastereoisomer) δ 170.3, 169.1, 163.6, 162.5 (d, J 
= 225.5 Hz), 150.2, 135.2, 133.4 (d, J = 3.3 Hz), 129.3 (d, J = 8.1 Hz), 114.6 (d, J = 21.4 Hz), 
111.8, 82.0, 81.6, 57.0, 52.8, 52.1, 31.4, 26.5, 12.8.  
IR 3203 (w), 3055 (w), 2961 (w), 2361 (w), 2255 (w), 1724 (s), 1691 (s), 1515 (w), 1464 (w), 
1267 (s), 1229 (m), 1100 (m), 1050 (m), 913 (m), 735 (m).  
HRMS (ESI) calcd for C20H21FN2NaO7+ [M+Na]+ 443.1225; found 443.1224. 
Dimethyl 6-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-(thiophen-2-yl)dihydro-
2H-pyran-3,3(4H)-dicarboxylate (25c). 
 
Following the general procedure, using thiophene-2-carbaldehyde (42 µL, .45 mmol, 1.5 equiv) 
cyclobutane 18a (120 mg, 0.300 mmol, 1.0 equiv), a mixture of diastereoisomers (12:1 by 
integration of methyl esters at 3.56 ppm and 3.54 ppm) 25c (111 mg, 0.270 mmol, 90% NMR 
yield)7 was obtained after column chromatography as a white foam. After recrystallization in 
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ethanol, the pure product 25c (97 mg, 0.24 mmol, 79% isolated yield) was obtained as white 
foam and as a mixture of diastereoisomers (7:1 by integration of methyl esters at 3.56 ppm 
and 3.54 ppm). 
RF (Pentane/Ethyl acetate (4:6)) = 0.24. 
MpP186.4-188.3°C. 
1H NMR (400 MHz, Chloroform-d, major diastereoisomer) δ 9.74 (s, 1 H, NH), 7.27 (d, J = 1.4 
Hz, 1 H, , thymine C=C-H), 7.23 (dd, J = 5.1, 1.2 Hz, 1 H, thiophene-H), 7.04 (dd, J = 3.5, 1.1 
Hz, 1 H, thiophene -H), 6.92 (dd, J = 5.1, 3.6 Hz, 1 H, thiophene -H), 5.95 (dd, J = 10.9, 2.8 
Hz, 1 H, tetrahydropyran-NCH), 5.48 (d, J = 0.8 Hz, 1 H, tetrahydropyran-CH), 3.71 (s, 3 H, 
ester CH3), 3.56 (s, 3 H, ester CH3), 2.70 – 2.61 (m, 1 H, tetrahydropyran-CH2), 2.32 – 2.24 
(m, 1 H, tetrahydropyran-CH2), 2.23 – 2.14 (m, 1 H, tetrahydropyran-CH2), 1.95 (d, J = 1.3 Hz, 
3 H, thymine-CH3), 1.92 (dd, J = 7.9, 2.3 Hz, 1 H, tetrahydropyran-CH2).  
13C NMR (101 MHz, Chloroform-d, major diastereoisomer) δ 170.2, 168.9, 163.6, 150.1, 139.8, 
135.2, 126.2, 126.2, 125.5, 111.7, 82.1, 79.1, 57.4, 52.9, 52.5, 31.1, 26.5, 12.8.  
IR 3195 (w), 3042 (w), 2954 (w), 2832 (w), 2362 (w), 2252 (w), 2252 (w), 1690 (s), 1441 (w), 
1375 (w), 1271 (s), 1103 (m), 1050 (w), 913 (m), 734 (m).  
HRMS (ESI) calcd for C18H20N2NaO7S+ [M+Na]+ 431.0883; found 431.0879. 
Dimethyl 2-(2-methoxyphenyl)-6-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)dihydro-2H-pyran-3,3(4H)-dicarboxylate (25d). 
 
Following the general procedure, using o-anisaldehyde (61 mg, 0.45 mmol, 1.5 equiv) and 
cyclobutane 18a (120 mg, 0.300 mmol, 1.0 equiv), a mixture of diastereoisomers (10:1 by 
integration of methyl esters at 3.54 ppm and 3.40 ppm) 25d (108 mg, 0.252 mmol, 84% NMR 
yield)7 was obtained after column chromatography as a white solid. After recrystallization in 
ethanol, the pure product 25d (98 mg, 0.23 mmol, 76% isolated yield) was obtained as white 
solid and as a mixture of diastereoisomers (10:1 by integration of methyl esters at 3.54 ppm 
and 3.40 ppm). 
RF (Pentane/Ethyl acetate (3:7)) = 0.29. 
MP 193.9- 196.2 °C. 
1H NMR (400 MHz, Chloroform-d, major diastereoisomer) δ 8.05 (s, 1 H, NH), 7.77 (dd, J = 
7.8, 1.7 Hz, 1 H, Ar-H), 7.39 (d, J = 1.4 Hz, 1 H, thymine C=C-H), 7.31 – 7.27 (m, 1 H, Ar-H), 
7.01 (td, J = 7.6, 1.1 Hz, 1 H, Ar-H), 6.80 (dd, J = 8.3, 1.1 Hz, 1 H, Ar-H), 5.92 (dd, J = 11.0, 
3.0 Hz, 1 H, tetrahydropyran-NCH), 5.29 (s, 1 H, tetrahydropyran-CH), 3.77 (s, 3 H, O-Me 
CH3), 3.69 (s, 3 H, ester CH3), 3.54 (s, 3 H, ester CH3), 2.63 – 2.55 (m, 2 H, tetrahydropyran-
CH2), 2.05 – 2.01 (m, 1 H, tetrahydropyran-CH2), 1.99 (d, J = 1.3 Hz, 3 H, thymine-CH3), 1.85 
– 1.74 (m, 1 H, tetrahydropyran-CH2).  
13C NMR (101 MHz, Chloroform-d, major diastereoisomer) δ 169.0, 168.9, 163.8, 156.2, 150.0, 
135.7, 129.9, 129.4, 125.6, 120.3, 111.5, 109.4, 82.2, 76.4, 56.9, 55.5, 52.5, 52.3, 31.1, 27.3, 
12.9.  
IR 3191 (w), 3045 (w), 2955 (w), 2841 (w), 2361 (w), 2338 (w), 2253 (w), 1731 (s), 1690 (s), 
1464 (m), 1377 (w), 1259 (s), 1104 (m), 1047 (m), 914 (m), 733 (s).  
HRMS (ESI) calcd for C21H24N2NaO8+ [M+Na]+ 455.1425; found 455.1429. 
39 
 
 
Dimethyl 2-(4-methoxyphenyl)-6-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)dihydro-2H-pyran-3,3(4H)-dicarboxylate (25e). 
 
Following the general procedure, using p-anisaldehyde (55 µL, 0.45 mmol, 1.5 equiv) and 
cyclobutane 18a (120 mg, 0.300 mmol, 1.0 equiv), a mixture of diastereoisomers (5:1 by 
integration of methyl esters at 3.55 ppm and 3.49 ppm) 25e (115 mg, 0.264 mmol, 88% NMR 
yield)7 was obtained after column chromatography as a slightly yellow foam. After 
recrystallization in ethanol, the pure product 25e (99 mg, 0.22 mmol, 76% isolated yield) was 
obtained as a slightly yellow foam and as a mixture of diastereoisomers (7:1 by integration of 
methyl esters at 3.55 ppm and 3.49 ppm). 
RF (Pentane/Ethyl acetate (3:7)) = 0.26. 
MP 97.4- 99.5 °C.  
1H NMR (400 MHz, Chloroform-d, major diastereoisomer) 9.03 (s, 1 H, NH), 7.31 (d, J = 1.3 
Hz, 1 H, thymine C=C-H), 7.30 – 7.27 (m, 2 H, Ar-H), 6.86 – 6.78 (m, 2 H, Ar-H), 5.95 (dd, J = 
11.1, 2.9 Hz, 1H, tetrahydropyran-NCH), 5.16 (s, 1 H, tetrahydropyran-CH), 3.78 (s, 3 H, O-
Me CH3), 3.67 (s, 3 H, ester CH3), 3.55 (s, 3 H, ester CH3), 2.74 – 2.61 (m, 1 H, 
tetrahydropyran-CH2), 2.35 (tdd, J = 12.6, 11.0, 4.1 Hz, 1 H, tetrahydropyran-CH2), 2.22 (td, J 
= 13.4, 4.1 Hz, 1 H, tetrahydropyran-CH2), 1.97 (d, J = 1.3 Hz, 3 H, thymine-CH3), 1.95 – 1.88 
(m, 1 H, tetrahydropyran-CH2).  
13C NMR (101 MHz, Chloroform-d, major diastereoisomer) δ 170.3, 169.3, 163.7, 159.5, 150.2, 
135.4, 129.6, 128.8, 113.0, 111.6, 82.0, 82.0, 57.0, 55.3, 52.7, 52.1, 31.4, 26.6, 12.8.  
IR 3191 (w), 3049 (w), 2954 (w), 2839 (w), 2360 (w), 2257 (w), 1687 (s), 1517 (w), 1461 (m), 
1255 (s), 1109 (m), 1044 (m), 910 (m), 817 (w), 730 (s).  
HRMS (ESI) calcd for for C21H24N2NaO8
+ [M+Na]+ 455.1425; found 455.1428. 
 
(E)-dimethyl 6-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-styryldihydro-2H-
pyran-3,3(4H)-dicarboxylate (25f). 
 
Following the general procedure, using cinnamaldehyde (57 µL, 0.45 mmol, 1.5 equiv) 
cyclobutane 18a (120 mg, 0.300 mmol, 1.0 equiv), a mixture of diastereoisomers (2.5:1 by 
integration of methyl esters at 3.72 ppm and 3.67 ppm) 25f (104 mg, 0.243 mmol, 81% NMR 
yield)7 was obtained after column chromatography as a yellow foam. After recrystallization in 
ethanol, the pure product 25f (89 mg, 0.21 mmol, 69% isolated yield) was obtained as yellow 
foam and as a mixture of diastereoisomers (2.5:1 by integration of methyl esters at 3.72 ppm 
and 3.67 ppm). 
RF (Pentane/Ethyl acetate (3:7)) = 0.37. 
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MP 73.7-75-5 °C. 
1H NMR (400 MHz, Chloroform-d) δ 9.03 (s, 1H, N H, major diastereoisomer), 8.91 (s, 1 H, 
NH, minor diastereoisomer), 7.39 – 7.21 (m, 10 H, Ar-H, major and minor diastereoisomers), 
7.18 (dd, J = 3.4, 2.0 Hz, 2 H, thymine C=C-H, , major and minor diastereoisomers), 6.79 (dd, 
J = 15.7, 1.1 Hz, 1 H, vinyl CH, minor diastereoisomer), 6.61 – 6.49 (m, 2 H, vinyl CH, major 
diastereoisomer), 6.31 (dd, J = 15.7, 8.0 Hz, 1 H, , vinyl CH, minor diastereoisomer), 6.02 (dd, 
J = 11.2, 2.8 Hz, 1 H, tetrahydropyran-NCH, minor diastereoisomer), 5.91 (dd, J = 11.0, 3.0 
Hz, 1 H, tetrahydropyran-NCH, major diastereoisomer), 5.40 (d, J = 8.0 Hz, 1 H, 
tetrahydropyran-CH, minor diastereoisomer), 4.68 (d, J = 5.3 Hz, 1 H, tetrahydropyran-CH, 
major diastereoisomer), 3.87 (s, 3 H, ester CH3, minor diastereoisomer), 3.78 (s, 3 H, ester 
CH3, major diastereoisomer), 3.71 (s, 3 H, ester CH3, major diastereoisomer), 3.66 (s, 3 H, 
ester CH3, minor diastereoisomer), 2.65 (ddd, J = 13.6, 4.2, 2.7 Hz, 1 H, tetrahydropyran-CH2, 
major diastereoisomer), 2.58 – 2.35 (m, 2 H, tetrahydropyran-CH2, minor diastereoisomer), 
2.26 – 2.15 (m, 1 H, tetrahydropyran-CH2, major diastereoisomer), 2.15 – 1.98 (m, 2 H, 
tetrahydropyran-CH2, major diastereoisomer and minor diastereoisomer), 1.95 (d, J = 1.2 Hz, 
3 H, thymine-CH3, major diastereoisomer), 1.93 (d, J = 1.3 Hz, 3 H, thymine-CH3, minor 
diastereoisomer), 1.92 – 1.87 (m, 1 H, tetrahydropyran-CH2, major diastereoisomer), 1.56 – 
1.43 (m, 1 H, tetrahydropyran-CH2, minor diastereoisomer).  
13C NMR (101 MHz, Chloroform-d) δ 170.0, 169.6, 169.0, 168.3, 163.7, 163.7, 150.2, 150.1, 
137.8, 136.5, 135.3, 135.3, 132.7, 128.8, 128.8, 128.6, 128.1, 127.1, 126.8, 125.2, 120.4, 
111.6, 111.4, 81.8, 81.7, 76.1, 57.0, 56.6, 53.4, 53.2, 53.0, 52.6, 30.7, 27.5, 26.8, 24.1, 12.8.8  
IR 3730 (w), 2955 (w), 2361 (s), 2336 (s), 1744 (m), 1699 (s), 1666 (m), 1442 (w), 1275 (m), 
1099 (w), 976 (w), 914 (w), 736 (m).  
HRMS (ESI) calcd for C22H24N2NaO7+ [M+Na]+ 451.1476; found 451.1474. 
 
Dimethyl (5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyldihydro-2H-pyran-
3,3(4H)-dicarboxylate (27). 
 
Following the general procedure, using benzaldehyde (46 µL, 0.45 mmol, 1.5 equiv) and 
cyclobutane 18b (121 mg, 0.300 mmol, 1.0 equiv), a mixture of diastereoisomers (13:1 by 
integration of methyl esters at 3.52 ppm and 3.48 ppm) 27 (78 mg, 0.19 mmol, 64% NMR 
yield)7 was obtained after column chromatography as a white foam. After recrystallization in 
ethanol, the pure product 27 (68 mg, 0.17 mmol, 56% yield) was obtained as white foam and 
as a mixture of diastereoisomers (>20:1 by integration of methyl esters at 3.52 ppm and 3.48 
ppm). 
RF (Pentane/Ethyl acetate (1:1)) = 0.32. 
MP 80.1- 81.7°C. 
1H NMR (400 MHz, Chloroform-d, major diastereoisomer) δ 9.95 (s, 1 H, NH), 7.63 (d, J = 5.8 
Hz, 1 H, Ar-H), 7.39 – 7.34 (m, 2 H, Ar-H), 7.33 – 7.27 (m, 3 H, Ar-H and F-uracil C=C-H), 6.01 
– 5.93 (m, 1 H, tetrahydropyran-NCH), 5.23 (s, 1H, tetrahydropyran-CH), 3.67 (s, 3 H, ester 
CH3), 3.52 (s, 3 H, ester CH3), 2.71 – 2.62 (m, 1 H, tetrahydropyran-CH2), 2.40 – 2.19 (m, 2 H, 
tetrahydropyran-CH2), 2.02 – 1.95 (m, 1 H, tetrahydropyran-CH2).  
                                                 
8 3 carbons of the minor diastereoisomer are not resolved. 
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13C NMR (101 MHz, Chloroform-d, major diastereoisomer) δ 170.1, 169.1, 156.98 (d, J = 26.6 
Hz), 148.9, 140.93 (d, J = 238.5 Hz), 137.2, 128.5, 127.7, 127.4, 124.12 (d, J = 33.6 Hz), 82.2, 
82.1, 56.9, 52.8, 52.1, 31.2, 26.5.   
IR 3204 (w), 3064 (w), 2955 (w), 2361 (m), 2257 (w), 1717 (s), 1457 (w), 1368 (w), 1265 (s), 
1103 (m), 1043 (w), 912 (s), 731 (s).  
HRMS (ESI) calcd for C19H19FN2NaO7+ [M+Na]+ 429.1068; found 429.1065. 
 
6. Thymine based nucleoside analogues derivatizations. 
6.1 Acids. 
General procedure for hydrolysis and decarboxylation reaction 
 
 
Compound 22b, 22e, 23b, and 23c (1 equiv) and KOH (4 equiv) were stirred under nitrogen in 
a dried and sealed microwave vial with dry methanol (0.06 mL) for 2 days at 70 °C. The thick 
yellow mixture was cooled down to room temperature and acidified with a 0.1 M HCl solution 
(0.5 mL). The mixture was extracted 3 times with AcOEt (2 mL), the organic layers were dried 
over anhydrous MgSO4 and concentrated under reduced pressure. The corresponding 
monoacid was obtained after column chromatography with a gradient of DCM to a solvent 
mixture of DCM/MeOH 8:2 and 1% AcOH. 
 
5-(5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyltetrahydrofuran-3-
carboxylic acid (54). 
 
Following the general procedure for hydrolysis and decarboxylation reaction, using compound 
22b (0.050 g, 0.13 mmol, 1 equiv) and KOH (29 mg, 0.52 mmol, 4 equiv) in dry MeOH (0.3 
mL), the pure monoacid 54 (0.034 g, 0.10 mmol, 83% yield) was obtained as a white solid. 
 
RF (AcOEt) = 0.23. 
 
MP 123.2-125.3°C. 
 
1H NMR (400 MHz, Methanol-d4) δ 7.37 (d, J = 8.6 Hz, 3H, Ar-H and thymine vinyl-CH), 7.32 
– 7.22 (m, 3H, Ar-H), 6.20 – 6.08 (m, 1H, tetrahydrofuran-NCH), 5.01 (d, J = 8.7 Hz, 1H, 
tetrahydrofuran-CH), 3.35 – 3.24 (m, 1H, tetrahydrofuran-CH), 2.68 (dt, J = 13.1, 8.1 Hz, 1H 
tetrahydrofuran-CH2), 2.47 (ddd, J = 13.8, 9.5, 4.5 Hz, 1H, tetrahydrofuran-CH2), 1.78 (s, 3H, 
thymine methyl). 
 
42 
 
13C NMR (101 MHz, Methanol-d4) δ 174.0, 165.0, 150.9, 138.9, 137.2, 128.2, 126.2, 110.4, 
85.7, 83.7, 49.9, 35.3, 11.0. 
The acid carbon is not defined. 
 
IR 3429 (w), 3211 (w), 3039 (w), 2529 (w), 1695 (s), 1475 (w), 1272 (m), 1068 (m), 769 (w), 
701 (m). 
 
HRMS (ESI) calcd for C16H16N2NaO5+ [M+Na]+ 339.0951; found 339.0944. 
 
5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-((E)-styryl)tetrahydrofuran-3-
carboxylic acid (55). 
 
Following the general procedure for hydrolysis and decarboxylation reaction, using compound 
22e (0.14 g, 0.34 mmol, 1 equiv) and KOH (0.080 g, 1.4 mmol, 4.0 equiv) in dry MeOH (1.4 
mL). A mixture of unseparable monoacids (ratio 5:1 obtained by integration of the proton at 
5.17 ppm and 4.76 ppm) 55 (82 mg, 0.24 mmol, 71% yield) was obtained as a white solid. 
 
RF diacid (DCM/MeOH (8:2) 1% AcOH) = 0.05. 
RF 56 (DCM/MeOH (8:2) 1% AcOH) = 0.2. 
 
1H NMR (400 MHz, Methanol-d4) δ 7.65 (s, 1H, thymine vinyl-CH, minor diastereoisomer), 7.55 
(s, 1H, thymine vinyl-CH, major diastereoisomer), 7.49 (d, J = 7.8 Hz, 4H, Ar-H, major and 
minor diastereoisomers), 7.40 – 7.25 (m, 6H, Ar-H, major and minor diastereoisomers), 6.76 
(d, J = 15.9 Hz, 2H, vinyl-CH, major and minor diastereoisomers), 6.48 (ddd, J = 16.1, 7.2, 1.7 
Hz, 1H, vinyl-CH, major diastereoisomer), 6.34 (ddd, J = 16.0, 6.7, 1.7 Hz, 1H, vinyl-CH,  minor 
diastereoisomers), 6.26 – 6.17 (m, 2H, tetrahydrofuran-NCH, major and minor 
diastereoisomers), 5.17 (t, J = 7.0 Hz, 1H, tetrahydrofuran-CH, minor diastereoisomer), 4.76 
(t, J = 7.7 Hz, 1H, tetrahydrofuran-CH, major diastereoisomer), 3.25 (q, J = 8.9 Hz, 1H, 
tetrahydrofuran-CH, major diastereoisomer), 3.18 (q, J = 8.9 Hz, , tetrahydrofuran-CH, major 
diastereoisomer), 2.86 – 2.71 (m, 2H, , tetrahydrofuran-CH2, major and minor 
diastereoisomers), 2.47 (m, 2H, tetrahydrofuran-CH2, major and minor diastereoisomers), 1.94 
(s, 3H, thymine methyl, minor diastereoisomer), 1.92 (s, 3H, thymine methyl, major 
diastereoisomer). 
 
13C NMR (101 MHz, Methanol-d4) δ 175.1, 175.0, 166.5, 166.4, 152.4, 152.2, 138.1, 137.8, 
137.7, 137.6, 134.7, 133.6, 129.7, 129.7, 129.6, 129.2, 129.0, 128.5, 127.8, 127.7, 111.7, 
111.5, 87.7, 86.9, 84.9, 84.8, 49.6, 49.4, 49.2, 49.0, 48.8, 48.6, 48.4, 36.7, 36.5, 12.5. 
For the major diastereoisomer, the acid carbon is not define and an aromatic one neither. 
One carbon is missing for the minor diastereoisomer. 
 
IR 3442 (w), 3184 (w), 3031 (w), 2531 (w), 1684 (s), 1485 (w), 1407 (w), 1369 (w), 1271 (m), 
1204 (w), 1115 (w), 1072 (m), 980 (w), 751 (w), 695 (m). 
 
HRMS (ESI) calcd for C18H19N2O5+ [M+H]+ 343.1288; found 343.1294. 
 
.2-Methyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-
phenyltetrahydrofuran-3-carboxylic acid (29). 
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Following the general procedure for hydrolysis and decarboxylation reaction, using compound 
23b (0.020 g, 0.050 mmol, 1 equiv) and KOH (6 mg, 0.1 mmol, 4 equiv), the pure monoacid 
29 (0.014 g, 0.042 mmol, 83% yield) was obtained as a white solid. The stereochemistry of the 
acid was determined by NOE experiment. 
 
RF (AcOEt) = 0.18. 
 
MP 236.2-236.7 °C. 
 
1H NMR (400 MHz, Acetone-d6) δ 11.39 (br s, 1H, COOH ), 10.01 (s, 1H, thymine NH), 7.70 – 
7.62 (m, 2H, Ar-H), 7.48 – 7.28 (m, 3H, Ar-H), 7.25 (q, J = 1.1 Hz, 1H, thymine vinyl-CH), 6.46 
(dd, J = 7.5, 4.2 Hz, 1H, tetrahydrofuran-NCH), 3.75 (t, J = 8.7 Hz, 1H, tetrahydrofuran-CH), 
2.99 (ddd, J = 14.1, 8.9, 7.6 Hz, 1H, tetrahydrofuran-CH2), 2.51 (ddd, J = 14.0, 8.7, 4.2 Hz, 1H, 
tetrahydrofuran-CH2), 1.71 (d, J = 1.3 Hz, 3H, thymine methyl), 1.60 (s, 3H, tetrahydrofuran 
methyl). 
 
13C NMR (101 MHz, Acetone-d6) δ 177.8, 169.4, 156.0, 150.9, 142.1, 133.4, 132.6, 130.5, 
115.2, 92.0, 90.0, 57.2, 39.5, 30.0, 16.7. 
 
IR 3220 (w), 3054 (w), 2925 (w), 2854 (w), 1704 (s), 1660 (m), 1478 (w), 1419 (w), 1271 (w), 
1110 (w), 1058 (w), 855 (w), 800 (w), 769 (w). 
 
HRMS (ESI) calcd for C17H19N2O5+ [M+H]+ 331.1288; found 331.1281. 
 
2-(4-Fluorophenyl)-2-methyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)tetrahydrofuran-3-carboxylic acid (56). 
 
Following the general procedure for hydrolysis and decarboxylation reaction, using compound 
23c (0.040 g, 0.095 mmol, 1 equiv) and KOH (21 mg, 0.38 mmol, 4 equiv) in a mixture of 
MeOH/water (0.1 mL/0.1 mL), a mixture of unseparable monoacids (ratio 10:1 obtained by 
integration of the proton at 6.50 ppm and 6.40 ppm) 56 (0.028 g, 0.080 mmol, 84% yield, ) 
were obtained as a white solid. 
 
RF (DCM/MeOH (9:1)) = 0.15. 
 
MP 193.4-194.2 °C. 
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1H NMR (400 MHz, Acetone-d6) δ 10.08 (br.s, 1H, COOH), 8.17 (s, 1H, NH), 7.68 (dd, J = 8.1, 
4.9 Hz, 2H, Ar-H, major diastereoisomer), 7.55 (dd, J = 8.0, 4.8 Hz, 2H, Ar-H, minor 
diastereoisomer), 7.30 (s, 1H, thymine vinyl-CH, major diastereoisomer), 7.13 (t, J = 8.3 Hz, 
2H, Ar-H, major diastereoisomer), 7.07 (t, J = 8.4 Hz, 2H, , Ar-H, minor diastereoisomer), 6.50 
(t, J = 7.0 Hz, 1H, , tetrahydrofuran-NCH, minor diastereoisomer), 6.40 (dd, J = 8.0, 3.9 Hz, 
1H, tetrahydrofuran-NCH, major diastereoisomer), 3.72 (t, J = 9.1 Hz, 1H, tetrahydrofuran-CH, 
major diastereoisomer), 3.46 (dd, J = 9.2, 4.1 Hz, 1H, tetrahydrofuran-CH, minor 
diastereoisomer), 3.00 (dt, J = 13.4, 8.7 Hz, 1H, tetrahydrofuran-CH2, major diastereoisomer), 
2.93 (dd, J = 15.4, 7.9 Hz, 1H, tetrahydrofuran-CH2, minor diastereoisomer), 2.53 (ddd, J = 
13.7, 8.9, 3.9 Hz, 1H, tetrahydrofuran-CH2, major diastereoisomer), 2.46 – 2.35 (m, 1H, 
tetrahydrofuran-CH2, minor diastereoisomer), 1.80 (s, 3H, thymine methyl, minor 
diastereoisomer), 1.74 (s, 3H, thymine methyl, major diastereoisomer). 
 
13C NMR (101 MHz, Acetone-d6) δ 174.7, 164.3, 164.2, 164.0, 162.8 (d, J = 244.1 Hz), 162.7 
(d, J = 244.1 Hz). 151.4, 151.3, 142.7 (d, J = 3.0 Hz), 139.6 (d, J = 2.9 Hz), 137.8, 137.5, 128.5 
(d, J = 8.1 Hz), 128.4 (d, J = 8.2 Hz), 115.5 (d, J = 21.4 Hz), 115.1 (d, J = 21.4 Hz), 111.0, 
110.9, 86.9, 86.9, 85.5, 83.2, 53.9, 53.2, 35.2, 34.9, 12.7, 12.3. 
 
IR 3530 (w), 3189 (w), 3065 (w), 2927 (w), 1697 (s), 1512 (m), 1268 (m), 1088 (w), 1052 (w), 
839 (m). 
 
HRMS (ESI) calcd for C17FH18N2O5+ [M+H]+ 349.1194; found 349.1194. 
 
 6.2 Alcohols. 
General procedure for reduction of carboxylic acids. 
 
 
The carboxylic acid (1 equiv) was solubilized in dry THF in a dried round bottom flask under 
nitrogen. The reaction mixture under nitrogen was cooled to 0 °C and dimethylsulfide borane 
solution (2 M in THF, 0.042 mL, 0.083 mmol, 2.2 equiv) was added dropwise. The reaction 
was allowed to slowly warm up and was stirred under nitrogen for 16 h. The reaction mixture 
was quenched by addition of a saturated solution of Na2CO3 (0.5 mL) and acidified by addition 
of a 1 M HCl solution (1 mL). Then the mixture was extracted three times with AcOEt (3 mL) 
and the organic layers were dried over anhydrous MgSO4. The crude product was purified by 
column chromatography with a gradient of pure AcOEt to a mixture of AcOEt/MeOH (8:2), 
affording the pure alcohol, as a colorless foam. 
 
4-(Hydroxymethyl)-5-phenyltetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione 
(30a). 
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Following the general procedure for reduction of carboxylic acids, using compound 54 (0.012 
g, 0.038 mmol, 1 equiv) and DMS solution (0.042 mL, 0.083 mmol, 2.2 equiv) in dry THF (0.35 
mL), the alcohol 30a (0.0095 g, 0.031 mmol, 86% yield, 71% over the two steps) was obtained 
as a colorless oil. 
 
RF (AcOEt) = 0.34. 
 
MP 68.1-69.4°C. 
 
1H NMR (400 MHz, Methanol-d4) δ 7.53 – 7.47 (m, 1H, thymine vinyl-CH), 7.49 – 7.28 (m, 5H, 
Ar-H), 6.29 – 6.09 (m, 1H, tetrahydrofuran-NCH), 4.78 (d, J = 8.6 Hz, 1H , tetrahydrofuran-
CH), 3.68 (dd, J = 11.2, 4.4 Hz, 1H , -CH2OH), 3.64 – 3.53 (dd, J = 11.2, 5.6 Hz, 1H , -CH2OH), 
2.61 (ddd, J = 14.2, 8.3, 2.8 Hz, 1H, tetrahydrofuran-CH), 2.49 (ddd, J = 13.7, 8.7, 7.6 Hz, 1H, 
tetrahydrofuran-CH2), 2.35 (ddd, J = 13.6, 9.0, 4.5 Hz, 1H, tetrahydrofuran-CH2), 1.88 (d, J = 
2.4 Hz, 3H, thymine methyl). 
 
13C NMR (101 MHz, Methanol-d4) δ 166.5, 152.6, 141.4, 138.4, 129.85, 129.5, 128.1, 111.9, 
86.7, 84.8, 62.3, 49.1, 35.9, 12.7. 
 
IR 3410 (w), 3207 (w), 2927 (w), 2520 (w), 1686 (s), 1471 (m), 1271 (m), 1055 (m), 911 (w), 
760 (m). 
 
HRMS (ESI) calcd for C16H18N2NaO4+ [M+Na]+ 325.1159; found 325.1159. 
 
4-(Hydroxymethyl)-5-((E)-styryl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-
dione (30b). 
 
Following the general procedure for reduction of carboxylic acids, using the mixture of 
diastereoisomers 55 (0.020 g, 0.058 mmol, 1 equiv) and DMS solution (0.063 mL, 0.13 mmol, 
2.2 equiv) in dry THF (0.53 mL), the mixture of diastereoisomeric alcohols (ratio 5:1 obtained 
by integration of the proton at 4.42 ppm and 4.65 ppm) 30b (0.016 g, 0.049 mmol, 83% yield, 
56% over the two steps) was obtained as colorless oil. 
 
RF (DCM/MeOH (9.5:0.5)) = 0.25. 
 
1H NMR (400 MHz, Chloroform-d, major diastereoisomer) δ 8.24 (br.s, 1H, thymine-NH), 7.40 
– 7.20 (m, 6H, Ar-H and thymine vinyl-CH), 6.67 (d, J = 16.0 Hz, 1H, vinyl-CH), 6.24 (dd, J = 
15.8, 7.1 Hz, 1H, vinyl-CH), 6.07 (dd, J = 6.7, 3.6 Hz, 1H, tetrahydrofuran-NCH), 4.42 (t, J = 
7.5 Hz, 1H, tetrahydrofuran-CH), 3.74 (dd, J = 10.7, 5.0 Hz, 1H, -CH2OH), 3.68 (dd, J = 10.7, 
5.1 Hz, 1H, -CH2OH), 2.46 – 2.26 (m, 2H, tetrahydrofuran-CH2), 2.16 (ddd, J = 12.1, 7.1, 3.5 
Hz, 1H, tetrahydrofuran-CH), 1.86 (d, J = 1.2 Hz, 3H, thymine methyl). 
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13C NMR (101 MHz, Chloroform-d, major diastereoisomer) δ 164.1, 150.6, 136.4, 136.0, 134.5, 
129.3, 129.0, 127.4, 127.3, 111.2, 86.2, 84.1, 62.7, 46.1, 36.3, 13.3. 
 
IR 2962 (w), 2924 (w), 2853 (w), 1687 (s), 1471 (w), 1363 (w), 1268 (m), 1189 (w), 1055 (s), 
967 (m), 744 (m). 
 
HRMS (ESI) calcd for C18H20N2NaO4+ [M+Na]+ 351.1315; found 351.1319. 
 
4-(Hydroxymethyl)-5-methyl-5-phenyltetrahydrofuran-2-yl)-5-methylpyrimidine-
2,4(1H,3H)-dione (30c). 
 
Following the general procedure for reduction of carboxylic acids, using compound 29 (0.018 
g, 0.054 mmol, 1 equiv) and DMS solution (0.060 mL, 0.12 mmol, 2.2 equiv) in dry THF (0.5 
mL), the alcohol 30c (0.013 g, 0.041 mmol, 75% yield, 63% over the two steps) was obtained 
as a colorless foam. 
 
RF (AcOEt) = 0.13. 
 
MP 79.4-83.4°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.60 (s, 1H, thymine-NH), 7.46 (d, J = 7.6 Hz, 2H, Ar-H), 
7.39 – 7.22 (m, 3H, Ar-H), 6.82 (s, 1H, thymine vinyl-CH), 6.21 (d, J = 3.6 Hz, 1H, 
tetrahydrofuran-NCH), 3.96 (dd, J = 10.5, 5.4 Hz, 1H, -CH2OH), 3.74 (dd, J = 10.7, 7.9 Hz, 1H, 
-CH2OH), 2.75 (dd, J = 11.0, 4.6 Hz, 1H, tetrahydrofuran-CH), 2.44 – 2.25 (m, 2H, 
tetrahydrofuran-CH2), 2.04 (br.s, 1H, OH), 1.60 (s, 3H, thymine methyl), 1.42 (s, 3H, 
tetrahydrofuran methyl). 
 
13C NMR (101 MHz, Chloroform-d) δ 163.7, 150.4, 145.6, 136.3, 128.6, 127.7, 125.1, 110.3, 
87.6, 85.0, 62.6, 47.5, 36.6, 24.5, 12.5. 
 
IR 3446 (w), 2959 (w), 1679 (s), 1473 (w), 1448 (w), 1265 (m), 1031 (s), 911 (w), 767 (m), 735 
(m). 
 
HRMS (ESI) calcd for C17H20N2NaO4+ [M+Na]+ 339.1315; found 339.1317. 
 
5-(4-Fluorophenyl)-4-(hydroxymethyl)-5-methyltetrahydrofuran-2-yl)-5-
methylpyrimidine-2,4(1H,3H)-dione (30d). 
 
 
Following the general procedure for reduction of carboxylic acids, using the mixture of 
diastereoisomers 56 (0.027 g, 0.078 mmol, 1 equiv) and DMS solution (0.085 mL, 0.17 mmol, 
2.2 equiv) in dry THF (0.5 mL), the mixture of diastereoisomeric alcohols (ratio 10:1 obtained 
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by integration of the proton at 3.31 ppm and 3.91 ppm) 30d (0.020 g, 0.059 mmol, 76% yield, 
64% over the two steps) was obtained as colorless oil. 
 
RF (AcOEt) = 0.53. 
 
MP 192.3-193.8°C (decomp.). 
 
1H NMR (400 MHz, Chloroform-d) δ 8.40 (s, 1H, thymine-NH, minor and major 
diastereoisomers), 7.58 (d, J = 1.3 Hz, 1H, thymine vinyl-CH, minor diastereoisomer), 7.46 (dd, 
J = 8.9, 5.2 Hz, 2H, Ar-H, major diastereoisomer), 7.33 (dd, J = 8.9, 5.2 Hz, 2H, Ar-H, minor 
diastereoisomer), 7.01 (t, J = 8.7 Hz, 4H, Ar-H, minor and major diastereoisomers), 6.82 (d, J 
= 1.3 Hz, 1H, thymine vinyl-CH, major diastereoisomer), 6.23 (d, J = 7.0 Hz, 1H 
tetrahydrofuran-NCH, minor diastereoisomer), 6.19 (dd, J = 6.9, 3.4 Hz, 1H tetrahydrofuran-
NCH, major diastereoisomer), 3.91 (dd, J = 10.6, 6.0 Hz, 1H, -CH2OH, major diastereoisomer), 
3.75 (dd, J = 10.6, 7.5 Hz, 1H, -CH2OH, major diastereoisomer), 3.31 (dd, J = 11.2, 5.1 Hz, 
0H, -CH2OH, minor diastereoisomer), 3.23 (dd, J = 11.2, 6.0 Hz, 0H, -CH2OH, minor 
diastereoisomer), 2.72 (m, 2H, tetrahydrofuran-CH, minor and major diastereoisomers), 2.45 
– 2.22 (m, 4H, tetrahydrofuran-CH2, minor and major diastereoisomers), 1.89 (d, J = 1.2 Hz, 
3H, thymine methyl, minor diastereoisomer), 1.81 (br.s, 1H, OH, minor and major 
diastereoisomer), 1.66 (d, J = 1.2 Hz, 3H, thymine methyl, major diastereoisomer), 1.57 (s, 3H, 
tetrahydrofuran methyl, minor diastereoisomer), 1.41 (s, 3H, tetrahydrofuran methyl, major 
diastereoisomer). 
 
13C NMR (101 MHz, Chloroform-d, Major diastereoisomer) δ 163.5, 162.1 (d, J = 247.3 Hz), 
150.3, 141.5 (d, J = 3.6 Hz), 136.0, 127.0 (d, J = 8.0 Hz), 115.3 (d, J = 21.3 Hz), 110.5, 87.3, 
84.9, 62.5, 47.8, 36.5, 24.3, 12.6. 
 
IR 2981 (w), 2925 (w), 2860 (w), 1680 (m), 1511 (w), 1473 (w), 1273 (w), 1230 (w), 1055 (m), 
1013 (m), 909 (s), 733 (s). 
 
HRMS (ESI) calcd for C17H19FN2NaO4+ [M+Na]+ 357.1221; found 357.1231. 
 
 6.3 Carbonucleoside alcohol. 
5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl-2-phenylcyclopent-1-ene-1-carboxylic 
acid (31). 
 
Compound 24c (0.10 g, 0.14 mmol, 1.0 equiv) and Pd-C (0.030 g, 0.014 mmol, 0.1 equiv) were 
stirred in a flame-dried flask under H2 at 57 °C with ethanol (10 mL) 5 min to solubilize the 
starting material, then the reaction was let for 10 min to cool down. The reaction mixture was 
filtered on a pore 5 filter with hot ethanol (50 mL) to afford after solvent evaporation, the pure 
diacid 57 as colorless needles. Then the crude product was heated neat at 80 °C for 16 h. 
After column chromatography using DCM to a mixture of DCM/MeOH (9:1) with 1% AcOH as 
solvent, the pure product 31 (28 mg, 0.090 mmol, 64% yield) was obtained as a colorless oil. 
The corresponding TIPS protected carboxylic acid 58 (14 mg, 0.030 mmol, 20% yield) was 
also isolated as a colorless oil. 
 
RF 57 (DCM/MeOH (9:1)) = 0.37. 
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RF 31 (DCM/MeOH (9:1)) = 0.21. 
 
MP 114.1-115.6 °C. 
 
1H NMR (400 MHz, Chloroform-d) δ 9.20 (d, J = 9.1 Hz, 1H, thymine-NH), 7.37 (s, 5H, Ar-H), 
7.08 (d, J = 1.6 Hz, 1H, , thymine vinyl-CH), 5.37 (tt, J = 8.8, 4.3 Hz, 1H, cyclopentane-NCH), 
3.60 – 3.25 (m, 2H, cyclopentane-CH2), 2.96 (dddd, J = 18.9, 8.2, 3.7, 1.9 Hz, 2H, 
cyclopentane-CH2), 1.92 (d, J = 1.2 Hz, 3H, thymine methyl). 
 
13C NMR (101 MHz, Chloroform-d) δ 168.2, 163.7, 153.1, 150.5, 136.2, 134.4, 128.8, 128.0, 
127.7, 125.7, 111.8, 46.2, 40.8, 12.5. 
 
IR 3169 (w), 3026 (w), 2929 (w), 1675 (s), 1472 (w), 1393 (w), 1270 (m), 1221 (w), 909 (m), 
735 (s), 636 (w). 
 
HRMS (ESI) calcd for C17H15[2H]2N2O4+ [M+H]+ 315.1306; found 315.1300. 
 
 
5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl-2-phenylcyclopentane-1-carboxylic 
acid (59). 
 
Carboxylic acid 31 (0.021 g, 0.067 mmol, 1.0 equiv) and Pd-C (0.01 g, 0.007 mmol, 5 % wt, 
0.1 equiv) were stirred in a flame dried flask under H2 at room temperature with ethanol (1 mL). 
TLC shows that the reaction was accomplished after 10 minutes and filtered on pore 5 filter. 
The residue was washed several times with hot ethanol. The pure product 59 (0.018 g, 0.057 
mmol, 85% yield) precipitated directly as white spheres. The stereochemistry was assigned by 
NOE experiment. 
 
RF (DCM/MeOH (8:2) 1% AcOH) = 0.49. 
 
MP 227.8-236.9°C. 
 
1H NMR (400 MHz, DMSO-d6) δ 11.86 (s, 1H, -COOH), 11.20 (s, 1H, -NH), 7.80 (d, J = 1.4 
Hz, 1H, , thymine vinyl-CH), 7.29 – 7.10 (m, 5H, Ar-H), 4.97 (dtd, J = 11.3, 9.1, 6.8 Hz, 1H, 
cyclopentane-NCH), 3.48 (ddd, J = 12.3, 9.1, 6.2 Hz, 1H, cyclopentane-CH), 3.19 – 3.00 (m, 
1H), 2.36 – 2.21 (m, 2H, cyclopentane-H), 2.11 (dt, J = 12.3, 6.5 Hz, 1H, cyclopentane-H), 1.96 
(ddd, J = 14.0, 9.0, 5.5 Hz, 1H, cyclopentane-H), 1.76 (d, J = 1.1 Hz, 3H, thymine methyl). 
 
13C NMR (101 MHz, DMSO-d6) δ 176.3, 164.2, 151.6, 140.8, 137.9, 128.5, 128.4, 126.9, 109.9, 
53.6, 47.2, 45.3, 35.6, 33.9, 12.8. 
The carboxylic acid carbon is not resolved. 
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IR 3225 (w), 2959 (w), 2860 (w), 1686 (s), 1636 (s), 1449 (m), 1380 (m), 1280 (s), 1213 (m), 
1054 (s), 950 (s), 784 (s). 
 
HRMS (ESI) calcd for C17H19N2O4+ [M+H]+ 315.1339; found 315.1344. 
 
5-Methyl-1-(3-phenyl-4-(((triisopropylsilyl)oxy)methyl)cyclopentyl)pyrimidine-
2,4(1H,3H)-dione (32). 
 
Carboxylic acid 59 (0.019 g, 0.060 mmol, 1 equiv) was solubilized in dry THF (0.35 mL) in a 
dried round bottom flask. The reaction mixture was cooled under nitrogen to 0°C and a 2 M 
dimethylsulfide borane solution in THF (0.076 mL, 0.15 mmol, 2.2 equiv) was added dropwise. 
The reaction was stirred at 0 °C for 5 hours, then it was quenched by addition of a 1 M HCl 
solution (1 mL). The mixture was extracted three times with AcOEt (3 mL) and the organic 
layers were dried over anhydrous MgSO4. The crude was directly solubilized into dry and 
degassed DMF (0.7 mL), imidazole (6 mg, 0.09 mmol, 1.5 equiv) and TIPSCl (14 mg, 0.072 
mmol, 1.2 equiv) were added. The mixture was stirred at room temperature for 6 hours. The 
solvent was removed under reduced pressure and the mixture was partitioned between water 
(2 mL) and AcOEt (2 mL). The aqueous layer was extracted 3 times with AcOEt and the organic 
layers were dried over anhydrous Na2CO3 and concentrated under reduced pressure. The 
crude yellow oil was purified by column chromatography, starting with pure DCM and then 
changing gradually to a mixture of DCM/MeOH (9:1), affording the pure protected alcohol 32 
(15 mg, 0.033 mmol, 55%) as a colorless oil. 
 
RF (DCM/MeOH (9:1)) = 0.58. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.54 (s, 1H, -NH), 7.32 – 7.09 (m, 6H, Ar-H and thymine 
vinyl-CH), 5.05 (dtd, J = 11.6, 9.4, 6.5 Hz, 1H, cyclopentane-NCH), 3.42 – 3.21 (m, 3H, CH2O 
and cyclopentane-CH), 2.46 (td, J = 9.0, 4.7 Hz, 1H, cyclopentane-CH), 2.39 – 2.27 (m, 1H 
cyclopentane-CH), 2.27 – 2.13 (m, 2H, cyclopentane-CH), 1.96 – 1.91 (m, 1H, cyclopentane-
CH), 1.89 (d, J = 1.2 Hz, 3H, thymine methyl), 0.93 (m, 3H, TIPS), 0.88 (d, J = 4.9 Hz, 18H, 
TIPS). 
 
13C NMR (101 MHz, Chloroform-d) δ 163.5, 151.2, 139.9, 136.6, 128.3, 128.0, 126.4, 111.0, 
64.0, 54.6, 44.8, 42.1, 35.3, 32.1, 18.0, 18.0, 12.4, 11.8. 
 
IR 3170 (w), 2945 (w), 1687 (s), 1469 (m), 1385 (w), 1272 (w), 1126 (w), 884 (w). 
 
HRMS (ESI) calcd for C26H41N2O3Si+ [M+H]+ 457.2881; found 457.2881. 
 
7. Spectra of new compounds 
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400 MHz, Chloroform-d. 
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400 MHz, Chloroform-d. 
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400 MHz, Chloroform-d. 
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400 MHz, DMSO-d. 
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400 MHz, DMSO-d. 
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400 MHz, Chloroform-d. 
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400 MHz, DMSO-d. 
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400 MHz, Chloroform-d. 
